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ABSTRACT
This study explored the intiacellular signals that control the 
acquisition and maintenance of locomotory capacity in T lymphocyte line 
Jurkat. The majority of the actively dividing Jurkat cells show an immotile 
morphology. It was possible to induce the polarization and locomotion in 
the majority of these cells by culture in the presence of dibutyryl cyclic 
AMP for at least 3 days. Such culture resulted in a decrease in the Jurkat 
cell size, in a block in the first gap phase of the cell cycle and in an 
increased surface expression of CD3. These cells displayed a constitutively 
motile behaviour which was temperature and energy dependent. The 
polarization of the Jurkat cells was permanently reversed, in a short-term 
assay, by PH A and drugs which increase the phosphorylation of 
intracellular proteins (phorbol esters and phosphatase inhibitors) and which 
increase intracellular concentrations of cAMP. In contrast, the polarization 
was reversed transiently following a stimulation of the T cell receptor 
complex by an aCD3 monoclonal antibody or when the intracellular Ca  ^* 
stores were emptied as a result of the inhibition of Ca^  ^ pump by 
thapsigargin. The effect involving PH A, o;CD3 and thapsigargin is 
dependent on the presence of extracellular Ca^ .^ The evidence suggests 
that PKC is the most important and common element in the inhibition of 
the polarization process in Jurkat cells. Indeed, the activity of most agents 
could be partially and dose-dependently inhibited using PKC inhibitors. 
The signal, which leads to the inhibition of polarization in dbcAMP- 
cultured Jurkat cells is coupled by a tyrosine kinase as well as by a 
pertussis toxin-sensitive G protein.
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1. GENERAL INTRODUCTION
1.1. Cells of the immune system
An organism is protected against invasion by foreign substances by 
three lines of defence: ( 1 ) the skin and other epithelial linings in contact 
with the environment; (2 ) the innate immunity comprising non-specific 
mechanisms interfering with the survival and growth of the pathogens; and 
(3) the immune system which defends the body by engaging humoral or 
cell-mediated immune response.
The immune system is mediated by leukocytes which comprise tire 
’white blood cells’. The leukocytes originate fiom primitive precursor 
stem cells residing principally in the bone marrow. Stem cells 
continuously divide and, under appropriate conditions, differentiate into 
cells of myeloid, mononuclear' phagocyte, or lymphoid lineage.
Lymphocytes are small, free-living cells found in the blood and 
lymphatic circulatory systems and in all lymphoid organs and tissues. 
They may be also found in tissues underlying surface epithelium such as 
the lamina propria of the gut. The nucleus fills almost completely the 
perimeter of these cells. The remaining cytoplasm is relatively devoid of 
organelles. In an immune reaction, tire lymphocytes are activated to 
undergo blast transformation and division. The cytoplasm of an activated 
lymphocyte resembles that of a metabolically active cell with abundant 
mitochondria and endoplasmic reticulum. After the infection has been 
eliminated, some of the cells revert to their small, apparently 
undifferentiated, form. However on restimulation, such lymphocytes, 
called memory lymphocytes, are capable of qualitatively different response 
compared to virgin lymphocytes.
Lymphocytes can be divided into thiee major groups based on 
function and cell surface characteristics. T cells undergo final maturation 
in the thymus. T helper cells interact with surface antigens present on the 
surface of B cells and assist them in the maturation process into antibody-
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producing plasma cells. Cytotoxic T cells recognize pathogenic antigen 
structures presented by invaded tissues and destroy the infected cells.
1.2. Leukocyte adhesion
The exit of leukocytes from circulation and their migration to 
lymphoid tissues or inflammatory sites are prerequisites for eliciting an 
immune response. Leukocytes must adhere to endothelial cells to gain 
entry to tissues. Leukocyte adhesiveness is a precisely regulated process 
determined by presence of membrane receptors involved in cell-cell and 
cell-extracellular matrix recognition. Leukocytes express on their surface 
molecules which reflect, among others, their lineage, functional specificity 
and activation status. Similarly, endothelial cells express on their surface 
molecules that reveal the location and immunological state of the 
surrounding tissues. The regulation of differential migration of various 
leukocyte populations is thus mediated by altered expression of these 
surface molecules. Recently, the regulation of avidity of adhesion 
molecules has been implicated (Pardi et a l ,  1995).
1,2.1, Selectins
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The selectin or LEC-CAM family of adhesion molecules mediates 
the initial low-affinity reversible binding of leukocytes to the endothelium. 
Selectins are transmembrane glycoproteins which contain a single N~ 
terminal lectin motif followed by a single epidermal growth factor repeat 
and a varying number of short consensus repeat homology units as found 
in complement binding proteins (Bevilacqua et a l , 1989; Lasky et a l , 
1989; Camerini et a l , 1989; Tedder et a l , 1990; Siegelman et a l , 
1989). AU selectins recognize, via their lectin domain, ligands that are 
associated with fucosylated polylactosamines, such as sialyl-Lewis X 
tetrasaccharide (Rosen and Bertossi, 1994). However, additional tissue- 
specific ligands have been recently identified. These novel ligands are
mucin-like molecules, covered in dense patches of O-linked sugars (Hogg 
and Berlin, 1995). Standard nomenclature designates each family member 
according to the cell type on which it was originally identified: E-selectin 
(endothelium), P-selectin (platelets), and L-selectin (lymphocytes).
E-selectin (ELAM-1) expression is largely restricted to IL-1-, 
TNFcx-, or LPS-activated endothelial cells (Bevilacqua er a /., 1987, 1989). 
Maximal surface expression is observed at 4 to 6  hrs followed by a decline 
toward basal levels by 24 to 48 hrs. IFN-y alone does not induce the 
expression of E-selectin but it prolongs the expression in response to TNFce 
(Doukas and Pober, 1990; Leeuwenberg et a i ,  1990). Although E- 
selectin can be expressed on inflamed endothelium in almost any tissue, it 
shows a biased expression on inflamed endothelium of skin (Picker et a i , 
1991b). E-selectins were initially shown to mediate adhesion of 
neutrophils to cytokine-activated endothelium (Bevilacqua et a l ,  1985; 
Gamble et a l , 1985) via their sialyl-Lewis X determinant. The scope of 
E-selectin binding activity was subsequently extended to monocytes and a 
highly restricted subpopulation of memory T lymphocytes (Graber et a l , 
1990; V iek tre ta l, 1991a; Shimizu a /., 1991; CdxXosetal, 1991; 
Hakkeit et a l ,  1991) marked by CL A.
P-selectin (PADGEM or GMP-140) is found in a  and dense 
granules in resting platelets (Hsu-Lin et a l , 1984; Stenberg et a l , 1985; 
Israels et a l ,  1992) and in Weibel-Palade bodies of endothelial cells 
(McEver et a l ,  1989; Bonfanü et a l ,  1989), A variety of mediators, 
including thrombin, histamine, and terminal complement components 
stimulate rapid surface expression of endothelial P-selectin (McEver et a l , 
1989; Bonfanti gr aZ,, 1989; Hattoii aZ., 1989ab; Patel er «/., 1991). 
The expression of P-selectin at the cell surface is short lived, declining 
substantially within minutes. P-selectin expressed on activated platelets 
(Larsen et a l ,  1989a; Hamburger and McEver, 1990; de Bruijne- 
Adrairaal et a l , 1992) and on endothelium (Etingin et a l ,  1991 ; Geng et 
a l,  1990) supports leukocyte adhesion, including neutrophils, monocytes 
and a subpopulation of T lymphocytes.
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L-selectin (mLHR, Leu8 , TQ-1, LAM-1, orLECAM-1)
is constitutively expressed on lymphocytes, monocytes and neutrophils. 
The ligand for L-selectin has been identified as GlyCAM-1 and MAdCAM- 
1. GlyCAM-1 is a glycoprotein associated with peripheral lymph node 
HEVs (Lasky et al., 1995) whereas MAdCAM-1 is expressed on mucosal 
lymphoid tissues (Hogg and Berlin, 1995).
Transient expression of selectins on activated leukocytes (Tedder et 
al., 1990; Kishimoto et al., 1989a) and endothelial cells (Bevilacqua et 
al., 1989; Hattori et al., 1989a) appeals to be regulated by selective loss 
from the cell surface resulting from a proteolytic susceptibility built into 
selectin molecules.
1.2.2. Integrins
Bimoleculai' interactions between immunoglobulin-related cell 
adhesion molecules (IgCAMs) and integrins play key roles in firm adhesion 
and subsequent transmigiation of blood lymphocytes. Integrins are 
heterodimers of noncovalently associated a and 8  subunits categorized into 
subfamilies with members sharing a common 1Î subunit combined with a 
unique a subunit.
The members of IgCAM family, ICAM-1 (CD54), ICAM-2 
(CD 102) are transmembrane glycoproteins containing 5 and 2 extracellular 
Ig domains respectively (Simmons et al., 1988; Staunton et al., 1988, 
1989). Recently, ICAM-3 has been identified (Defougerolles et al., 1994). 
Resting lymphocytes lack ICAM-1 expression. However, this expression 
increases over days during T and B lymphocyte activation (Dustin et al. , 
1986; Clai’k et al., 1986; Wawryk et al., 1989) to facilitate the cell-cell 
interactions. Activated lymphocytes in germinal centies and in sites of 
inflammation are stiongly positive (Dustin et a l ,  1986; Wantzin et al., 
1989). In contrast, monocytes contain an intracellular store of ICAM-1 
which can be mobilized to the cell surface by adherence to fibronectin 
(Dougheify et al., 1988). ICAM-1 is absent from most cells in normal,
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nonlymphoid tissues, except for expression of low levels on endothelial 
cells. Local inflammation results in a rapid increase in ICAM-1 expression 
on endothelial cells and induction of ICAM-1 on epithelial and 
mesenchymal cells (Dustin et a l ,  1986; Dustin and Springer, 1988; 
Wantzin et a l ,  1989; Munro et a l ,  1989). Like E-selectin, ICAM-1 is 
expressed on vascular endothelium after several hours of stimulation by IL- 
1 or TNFo! (Dustin et a l , 1986; Pober et a l,  1986). However, Üiere is 
a low level ICAM-1 expression on unstimulated endothelium and the 
cytokine-induced increase of expression is slower and prolonged in 
comparison to E-selectin. ICAM-2 expression on vascular endothelium 
does not appear to be regulated by cytokines (Dustin and Springer, 1988; 
Staunton gr a l , 1989; Nortamo er c/., 1991). Neutrophils, monocytes, 
lymphocytes, and NK cells express LFA-1 (0 :1 , 8 2  or CDlla/CD18) which 
binds both ICAM-1 and ICAM-2 (Stoolman, 1989; Carlos and Harlan, 
1990; Springer, 1990; Araaout, 1990). The ICAM-2/LFA-1 interaction 
accounts for two thirds of LFA-1-specific adhesion. In addition, 
neutrophils, monocytes, and NK cells (but not lymphocytes) express Mac-1 
(omBj or CDllb/CDlS) and pl50,95 (« A  or CD 11 c/CD 18) found at the 
cell surface as well as in storage granules. Activation of leukocytes results 
in increased adhesive capacity of 8 2  integrins regulated by quantitative 
changes in the expression of Mac-1 and pl50,95 (Stoolman, 1989; Carlos 
and Haiian, 1990; Springer, 1990; Amaout, 1990) and by qualitative 
changes in LFA-1. Phorbol esters stimulate a rapid (<  1 hi) increase in 
lymphocyte aggregation mediated by LFA-l/ICAM pathway (Patarroyo et 
a l,  1985; Rothlein and Springer, 1986; Rothlein et a l , 1986; Hamann 
et a l , 1986) which does not involve changes in LFA-1 or ICAM-1 surface 
density (Rothlein et a l ,  1986). Indeed, phorbol esters, as well as cross- 
linking TcR on resting T lymphocytes, increase the avidity of cell surface 
LFA-1 for ICAM-1. Such an ’inside-out’ signalling pathway offers a 
mechanism for antigen dependent adhesion (Dustin and Springer, 1989). 
In contrast to the phorbol ester-stimulated increase in LFA-1 avidity which 
persists for several hours, the increase triggered by cross-linking TcR is
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transient, peaking at 10-20 min and decreasing to basal levels by 40 min.
■A fourth memeber of IgCAM family has been identified as VCAM-
1 (INCAM-110) containing 6  extracellular Ig domains (Osborn et al., 
1989). High levels of VCAM-1 are found on endothelial cells at sites of
inflammation (Rice et al., 1990) whereas expression on normal tissues is 
minimal (Rice et al., 1991; Cybulski and Gimbrone, 1991; van Dinther- 
Janssen et al., 1991). Indeed, VCAM-1 is expressed by non-specialized 
endothelial cells only after pretreatment with TNFa, IL-IB, LPS (Rice and 
Bevilacqua, 1989; Osborn et al., 1989) and IL-4 (Thornhill and Haskard,
1990; Schleimer et al., 1992) but not IFN-y (Carlos et al., 1990).
■■Cytokines upregulate the VCAM-1 expression with maximal activity at 6  
to 12 hrs and like that of ICAM-1, the high level of expression is 
prolonged by comparison to E-selectin (Rice and Bevilacqua, 1989; Rice 
et a l ,  1990; Schwartz et a l ,  1990; Wellicome et a l ,  1990). The 
binding of lymphocytes to peripheral lymph node HEV is mediated, in 
part, by VCAM-1 (May et al., 1993). VCAM-1 is constitutively expressed 
by rat HEC in vivo and in vitro and is upregulated by TNFa, IL-18 and 
IFN-y (May et a l ,  1993). So far, VCAM-1 has only been detected on
HEV in inflamed lymph nodes of humans and sheep (Rice et a l ,  1991; 
Mackay et a l , 1992a). VCAM-1 is also expressed on several non-vascular 
cell types, including dendritic cells found in lymph nodes and skin, bone 
marrow stromal cells, and synovial cells in inflamed joints (Rice et al. , 
1991; Miyake et a l ,  1991; Ryan et a l ,  1991; Marlor et a l ,  1992; 
Simmons et a l ,  1992). Endothelial VCAM-1 was shown to support 
adhesion of lymphocytes and monocytes (but not neutrophils) through an 
interaction with the Bi integrin VLA-4 (LPAM-1, « 4 8 1  or CD49d/CD29) 
(Graber et al., 1990; Rice et a l , 1990; Schwartz et al., 1990; Carlos 
et a l ,  1990; Oppenheimer-Marks et a l ,  1991; Elices et al., 1990; 
Osborn et a l , 1989) which also binds fibronectin (Wayner et a l , 1989; 
Guan and Hynes, 1990). In contrast to VCAM-1, the fibronectin binding 
of VLA-4 is upregulated following treatment with IFN-y (May and Ager, 
1992). VLA-4 interacts with at least three HEC fibronectin sites, CS-1 and
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REDV in the type III connecting segment, and H1 in the heparin-binding 
(HepII) region (Ager and Humphries, 1990; Szekanecz et a l ,  1992).
These regions are distinct from the RGD region used by another fii integrin 
VLA-5, the classical fibronectin receptor (Elices et aL, 1990; Guan and 
Hynes, 1990). In addition, other Bi integrins mediate adhesion of different 
cell types to extracellular components such as collagens, fibronectin and 
laminin (Albelda and Bucks, 1990).
Integrin LPAM-2 ( « 4 8 7  or 0 :4 8 ,) is expressed on all peripheral blood 
lymphocytes and mediates their adhesion to VCAM-1 and fibronectin 
(Chan et al., 1992a). In addition to L-selectin, a lymphocyte cell surface 
integrin LPAM-2 («4 8 ? or 0 :4 8 7 ) can support adhesion to mucosal HEV in 
Peyer’s patches (Holzmann et al., 1989; Holzmann and Weissman,
1989a). It is now clear that in the mucosa, the ligand MAdCAM-1 
supports L-selectin binding via its mucin-like domain and LPAM-2 binding 
via its N-terminus ICAM/VCAM-like domain.
1.2.3. Mechanism o f lymphocyte extravasation
The reversible binding mediated by the selectins causes the 
cicrculating leukocytes to decelerate and attach to the luminal surface of 
post-capillary venules. In vivo, leukocytes appear to roll along the 
inflammed endothelium (Arfors et al., 1987; Fiebig et al., 1991; Ley et 
al., 1991; Tengelder and Arfors, 1991). The early phases of the response 
are dominated by P-selectin, followed by either L-selectin or E-selectin 
(Mayada et al., 1993; Arbones et al., 1994; Labow et al., 1994; Ley et 
al., 1995). In addition, lymphocytes use their « 4  integrins, especially 
LPAM-2, to mediate the rolling and firm adhesion under flow conditions 
(Berlin et al., 1995).
The rolling phase occurs independently of leukocyte activation, 
while the phase of integrin-mediated arrest and firm adhesion require a 
leukocyte signalling event. The soluble mediators, released in the 
inflammatory sites, may be captured on endothelial glycosaminoglycans,
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such as CD44 (Hermes-1) and syndecan (Hogg and Berlin, 1995). These 
surface molecules thus ensure localization of these mediators under blood 
flow conditions and act as scaffolding for optimal presentation to 
leukocytes.
The following sequence of events resulting in leukocyte migration 
was suggested by Dustin and Springer (1991). The initial transformation 
from a nonadherent cell in the blood to an adherent and polarized cell 
attached to the blood vessel wall results in activation of integrin cycling. 
Indeed, engagement of LFA-1 was shown to result in the production of 
intracellular secondary messengers known to be associated with lymphocyte 
activation (Wacholtz et al., 1989). Once in the tissue, T lymphocytes 
remain polarized and locomote by forming transient bonds to the 
extracellular matrix and cell surfaces. The direction of migration may be 
dictated by chemotactic factors produced at a focus of inflammation 
(Larsen et al., 1989b) or may be guided by extracellular matrix 
components or counter-receptors such as ICAM-1 induced in inflammatory 
sites (Dustin et a l ,  1986). When lymphocytes encounter cells at their 
leading edge, weak adhesive interactions form which allow TcR time to 
encounter and bind appropriate foreign antigen/MHC complexes if present. 
TcR ligation leads to strengthening of adhesion and subsequent cell-cell 
interaction. Once this interaction is complete, as indicated by a change in 
the antigen-bearing cell, the avidity of integrins decreases to the basal 
migrating levels. The polarity of lymphocytes then becomes random 
resulting in their locomotion away from the target cell. The lymphocytes 
are active in this detachment process, using interactions with neighbouring 
extracellular matrix or cells to undermine the remaining adhesive 
interactions.
1.2.4. Role of extravasation in recruitment
T lymphocytes may leave the blood in peripheral vascular beds, 
particularly within inflammatory lesions. These cells drain to local lymph
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1.2.5. Role o f extravasation in recirculation
i
nodes via afferent lymphatic vessels. The endothelium of the 
microvascular venules is activated by locally released cytokines inducing 
specific adhesion molecules on endotlielial cells. Such adhesion molecules
then bind and tiigger transmigration of specific leukocyte subpopulations. 
P-selectin is translocated to the surface from preformed cytoplasmic stores 
within seconds of stimulation by acute inflammatory mediators (Hattori et 
al., 1989ab; Bonfanti et at., 1989). IL-I, TNFa and LPS induce 
expression of E-selectin (Bevilacqua et al., 1987), VCAM-1 (Elices et al. ,
I
1990), and ICAM-1 (Pober et al., 1986). E-selectin peaks within hours 
after activation returning to baseline within 24 h (Bevilacqua et al., 1987).
In contrast, VCAM-1 peaks after 24 h and remains elevated for days in 
vitro (Elices et al., 1990). These differences have lead to the speculation 
that P- and E-selectins function early in the inflammation with the 
contribution from VCAM-1 increasing as the lesion matures or goes to 
chronicity. Indeed, mAb to E-selectin inhibit neutrophil flux into the lung 
6  h following deposition of immune complexes (Mulligan et al., 1991) and 
mAb to VLA-4 partially inhibit lymphocyte migration into delayed-type :hypersensitivity lesions in the skin and joints (Issekutz and Wykretowicz,
1991; Issekutz, 1991). The sequence observed with monocytes and skin- 
homing memory T lymphocytes indicates that cellular arrest occurring via 
« 4  integrin is followed by firm adhesion and transmigration by means of 
the LFA-1/ICAM-1 interaction (Luscinskas et al., 1994; Babi et al.,
1995). This proposal is supported by the following observations: (1) 
adhesion of T lymphocytes to cultured EC is mostly inhibited by mAb to 
LFA-1 (Haskard et al., 1986); and (2) the kinetics of lymphocyte entiy
into sites of inflammation are similar to kinetics of ICAM-1 upregulation.
Lymphocyte reciiculation differs from recruitment in that trafficking 
through tissues occurs constantly (Yednock and Rosen, 1989; Stoolman, 
1989). The vast majority of T cells recirculates by crossing the walls of
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specialized lymph node post capillary venules lined with high endothelial 
cells (HEV). Following binding to the luminal surface of HEV, 
lymphocytes reach the basal lamina within 5 to 10 min (Fossum et al. ,
1983). After 18 to 20 hr residency in the node, T cells leave through the 
efferent lymphatic duct. HEV of lymphoid organs are the most efficient 
sites of lymphocyte extravasation. HEV also occur at sites of chronic 
inflammation although postcapillary venules can become adhesive for 
lymphocytes in acute inflammation witliout acquiring the high phenotype 
(Duijvestijn and Hamann, 1989; Smith et al. , 1970; Iguchi and Ziff, 
1986). Other abundant leukocytes, such as neutrophils, do not normally 
migrate across these vessels (Gowans and Knight, 1964). The majority of 
unactivated lymphocytes rechculate through the spleen and lymph nodes for 
efficient antigen encounter (Duijvestijn and Hamann, 1989). The terms 
’homing receptor’ and ’vascular addressin’ are used to describe cell surface 
adhesion molecules on lymphocytes and endothelium (usually in HEV) 
respectively. These molecules contribute to tissue-specific localization of 
lymphocytes (Picker and Butcher, 1992; Holzmann and Weissman, 
1989b). L-selectin appeal s to function as a homing receptor for peripheral 
lymph nodes where L-selectin binds the lymph node addressin originally 
identified by antibody MEGA 79 (Streeter et al., 1988). L-selectin 
mediates trafficking or homing of lymphocytes to peripheral and mesenteric 
lymph nodes due to selective expression of a unique counterreceptor for L- 
selectin on the HEV in these organs (Lasky et aL, 1992). An organ 
specific mechanism for lymphocyte adhesion to peripheral lymph node 
HEV is inhibited by mAb MEL-14 to the L-selectin (Gallatin et al, , 1983). 
In contrast, the Bi integrin LPAM-1 appeals to mediate homing to Peyer’s 
patches and mesenteric lymph nodes (Issekutz, 1991; Holzmann et al., 
1989; Holzmann and Weissman, 1989ab). Adhesion to Peyer’s patch 
HEV is inhibited by mAb to LPAM-1, VLA-4 and CD44 (Holzmann and 
Weissman, 1989b; Jalkanen et a l ,  1987). Lymphocyte adhesion to 
peripheral and mucosal lymph node and to synovial HEV is inhibited 50- 
60% by mAb to LFA-1 (Duijvestijn and Hamann, 1989; Hamann et a l .
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1988; Pals et al., 1988). Consistent witli expression of ICAM-2 on 
endothelial cells in vitro, mAb to ICAM-1 does not inhibit lymphocyte 
binding to HEV (Duijvestijn and Hamann, 1989).
1.2.6. Memory versus naive T lymphocytes
Memory and naive lymphocytes recirculate differently, based on 
differences in recirculation patterns in neonatal versus adult animals. 
Although naive and memory T lymphocytes are morphologically 
indistinguishable, stable changes in the expression of a variety of surface 
molecules reflect the prior activation. E-selectins bind only memory-type 
T cells (Picker et al., 1991a) consistent with observations reporting the 
accumulation of memory T cells in inflammatory lesions containing 
antigens or pathogens which the host has encountered previously. Memory 
T cells are also the only T cells which rechculate through uninflamed 
tissues (Mackay et al., 1990b), providing the necessary surveillance. In 
contrast, new antigens drain to local lymph nodes which are frequented by 
lymphocytes of diverse specificities, particularly naive T cells (Mackay et 
a l,  1990b).
Together with other surface molecules, a number of adhesion 
receptors are also increased on memory T lymphocytes. LFA-3 is negative 
on naive and positive on memory T lymphocytes while the expression of 
others, including LFA-1, CD2, 8  ^ integrin (CD29) and CD44, is two- to 
four fold higher on the memory T lymphocytes. In general, the differences 
in naive and meraoiy T cell subpopulations are independent of CD4/CD8 
phenotype although all CD8  cells seem to have higher LFA-1 levels (Pardi 
et al., 1989; Mackay et al., 1990b). It appears that only naive cells enter 
lymph nodes through HEV, while memory lymphocytes leave the blood at 
other sites and enter lymph nodes through lymphatic drainage from these 
tissues (Mackay et al., 1990b). This situation may arise by a more 
efficient binding of memory lymphocytes to other postcapillaiy venules or 
less efficient binding to lymph node HEV. Memory T lymphocytes show
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Stronger adhesion to monokine-stimulated EC cultures than do naive cells 
(Pitzalis et a l ,  1988). Activated T lymphocytes adherent to purified 
ICAM-1 were enriched for cells expressing higher LFA-1 suggesting that, 
in lymphocytes in similar activation state, differences in LFA-1 surface 
expression on the order of 2,5-fold are functionally significant (Dustin et 
a l ,  1988). :|
1.3. Lymphocyte motility
1.3.1. Morphology o f motile lymphocytes
The earliest studies that yielded observations of motile lymphocytes 
were performed by Lewis and Webster (1921) using explants of rat lymph 
nodes. In contrast, McCutcheon (1924) used lymphocytes from blood 
cultured over a period of hours. In his subsequent studies, Lewis (1931) 
used time-lapse cinematography to analyze the locomotion of rat lymph 
node lymphocytes in detail:
"During a period of rest the lymphocyte is spherical but 
pseudopodia are sometimes thrust out and retracted without 
producing more than a slight wobbling motion of the whole 
cell. When, however, the rest period is over and the 
lymphocyte begins to migrate, a single pseudopodium flows 
out from a relatively small area. As the pseudopodium 
enlarges, a groove develops at its base where it joins the 
body of the cell. This groove or constriction ring 
corresponds to the rim about the softened area which gives 
rise to the pseudopod. As the pseudopod increases in length 
and breadth the groove usually becomes more marked.
Thus, when the groove first appears, in front of it is the 
expanding pseudopod and behind it the body of the 
lymphocyte with its large nucleus."
The constriction ring remained stationary while the lymphocyte moved 
towards or away from it. The locomotory lymphoblasts from rabbit lymph 
nodes observed by Rich et a l  (1939) were characterized as having ".. .the
general outlines of a handmmor. " Similar observations were made by de 
Bruin (1944) who recognized that:
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"... a leukocyte moving on flat surface can be divided into 
three portions: ( 1 ) an anterior portion, which is the most 
active in locomotion; this portion gives rise to pseudopodia,
(2) a relatively quiet body, which contains the nucleus, (3) 
a posterior part, the tail, which appears to be completely 
passive."
He suggested that such functional partitioning of a motile lymphocyte may
be expressed as polarity and that:
"It is this polai'isation, or rather the degiee of polarisation, 
which is chaiacteristic for the different leukocytes in 
motion."
1.3.2. Acquisition of locomotory capability by lymphocytes
Soluble chemical substances in the lymphocyte environment may 
determine the speed at which the cells move (chemokinesis), as well as the 
direction of their locomotion (chemotaxis). The early studies reported that 
lymphocytes moved into filters placed over a compartment with culture 
supernatants of immunized guinea pig lymph node cells restimulated with 
the antigen in vitro (Ward et al., 1971) or with proteolytically modified 
immunoglobulin (Higuchi et al., 1975). The methods used were unable to 
distinguish between chemokinesis and chemotaxis. The first report of 
chemotactic response was observed in B lymphoblasts examined in 
checkerboard assays (Russell et al., 1975).
1.3.3. Locomotion in lymphoblasts
The lymphocytes which most clearly localize in inflammatory 
lesions in vivo are members of the blast-transformed population (Asherson 
et a l ,  1973; Moore and Hall, 1973; McGregor and Logie, 1974). 
Indeed, human B lymphoblasts from continuous cell-line cultures showed 
an increase in locomotion in the presence of a chemoattractant {i.e. 
endotoxin-activated plasma or casein) although them motility was low in an 
unstimulated state (Russell et a l , 1975). Several B cell lines showed a
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response consistent with chemotactic reaction. On the other hand, 
oxazolone-sensitized mouse T lymphoblasts showed high unstimulated 
motility and only a chemokinetic response to the chemoattiactants (Russell 
e ta l ,  1975).
1.3.4. The acquisition o f motility during cell culture
The morphological examination of lymphocytes direct from blood 
revealed that these cells are mostly immotile (Wilkinson, 1986). When 
cultured for 24 hrs with only FCS, such cells responded by increased 
polarization to FCS, endotoxin-activated serum and alkali-denatured HSA; 
however, the majority of these cells remained round and unresponsive. In 
addition, human peripheral blood lymphocytes, cultured for 3 days with 
FCS in absence of mitogens, migrated only very short distances into filters 
and were not stimulated by chemoattractants (Wilkinson et al., 1976).
On the other hand, lymphocytes stimulated by T cell mitogens PH A 
and Con A responded by chemokinesis and chemotaxis to casein, alkali- 
denatured HSA, endotoxin-activated plasma and even PH A (Wilkinson et 
al. , 1976). Many of the responding cells were blasts but cells of all sizes 
entered the filters. The need for the presence of mitogen during the culture 
was questioned by O’Neill and PaiTott (1977) who determined that the 
presence of Con A was not essential during culture of human peripheral 
blood lymphocytes to induce locomotor responses to endotoxin-activated 
serum or casein.
The cultures without the mitogen contained vhtually no blasts yet 
showed equivalent chemokinesis towaids the chemoattractants (O’Neill and 
Panott, 1977). Wilkinson et al. (1977) showed that even small post-blast 
cells obtained from lymph nodes of immunized mice, 1 0  days after 
challenge, migrated actively when compared to non-immunized small 
lymphocytes. Time-course studies with PHA revealed that although 80- 
90% of lymphocytes polarized after a 48-hr culture, 50-70% of 
lymphocytes changed shape within 24 hrs which is before the time that
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1.3.5. Locomotory properties o f lymphocyte subpopulations
The proposed physiological activator of lymphocyte locomotion is
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lymphoblasts appear (Wilkinson, 1986).
The examination of various lymphocyte subsets revealed complexity 
reflecting the differences in activation requirements and the ability to 
respond to chemoattractants. Schreiner and Unanue (1975) obseiwed 
spontaneous motility in mouse lymph node T lymphocytes while B 
lymphocytes showed chemokinesis when stimulated with high 
concentrations of alg. In a later study they showed that T-enriched 
lymphocytes from rat spleens were able to respond to supernatants from 
MLC and phagocytosing macrophages while B-enriched cells responded by 
chemotaxis only to low concentrations of cflg (Ward et al., 1977), In 
contrast, separated T and non-T human peripheral blood lymphocytes both 
responded to casein and endotoxin-activated serum; however, T 
lymphocytes had to be cultured to acquire the ability for locomotor 
response while non-T cell population was often motile when isolated from 
blood (O’Neill and Parrott, 1977). Experiments exploring the locomotion 
of human T lymphocyte subsets revealed that the suppressor Ty 
lymphocytes showed little ability to respond to casein while helper T/x 
lymphocytes moved very well into filters placed over the chemoattractant 
(Parrott et a l ,  1978).
1.3.6. Physiological induction o f motility in lymphocytes
antigen. Thus, mouse lymphocytes from the lymph nodes draining a site 
of contact sensitization (Shields et al., 1984) or draining a site of challenge 
with a protein antigen (Wilkinson et a l ,  1977) are more motile than 
lymphocytes from control nodes. Here, the antigenic sensitization could 
be detected in vitro as these lymphocytes responded to the same antigens 
by increased locomotion in a micropore filter assay. The analogue of
s;.
TcR/CD3 in B lymphocytes is the immunoglobulin molecule expressed on 
its surface. Indeed, as stated above, cross-linking of this activation 
molecule with alg  induced motility in B cells. Similarly, direct activation fthrough TcR/CD3 stimulated in MLC or by culture with PPD or aCD3 
induced an increase in number of polarized cells within 24 hrs and reached 
maximum after 48 hrs (Wilkinson, 1986).
The mitogenic activity of aCD3 was demonstrated in many systems 
as a wide range of activation-associated events. Further inquiry into the 
mechanism of o:CD3 action showed that little polarization occurred before 
8  hrs of culture (Wilkinson and Higgins, 1987a). In addition, the 
polarization of lymphocytes exposed to the monoclonal antibody only for 
the first 30 min of the culture was comparable to that in cultures which 
remained in the presence of o;CD3 for the duration of the incubation 
(Wilkinson and Higgins, 1987a). Some original observations suggested 
that mitogen-activated cultures release factors which induce locomotor 
capacity in lymphocytes; these related to the presence of cell density- 
dependent polarization in FCS cultures (Wanger et al., 1985). Active 
factors were identified in Con A stimulated mononuclear cell cultures (Van 
Epps et al. , 1983), in mitogen-stimulated lymphocyte cultures (Center and 
Cruikshank, 1982) and in mixed lymphocyte cultures (El-Naggar et al.,
1982). In contrast, Wilkinson and Higgins (1987a) determined that the 
effect of q:CD3 and Con A, although cell density-dependent, was not 
mediated by a soluble factor but required direct contact with the AC.
Indeed, the effect of o:CD3 was abrogated by an excess of intact human 
IgG molecule or once the Fc portion was removed by pepsin digestion 
(Wilkinson and Higgins, 1987a). Similarly, the polarization in response 
to aCD3, but not PHA, was inhibited in cultures depleted of Fc receptor- 
bearing cells. Thus, it was determined that aCD3 cross-links Fc receptor- 
bearing cells such as monocytes or B cells resulting in activation of 
locomotory capability (Wilkinson and Higgins, 1987a) and of other events 
such as proliferation,
.
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1.3.7. Induction o f lymphocyte motility by phorbol esters
Phorbol esters were shown to induce lymphocyte growth following 
a long-term exposure (Touraine et al., 1977; Abb et a l ,  1979; Kabelitz 
et a l ,  1982). When used with lymphocytes fresh from blood, PMA 
polarized about 40% compared to 43% with colchicine (Wilkinson and 
Higgins, 1987b). The observation of time-course of PMA-induced shape 
change showed that the cells started to deviate from a round morphology 
within 1-2 min and reached maximum effect in 5-15 min (Wilkinson et al 
1988). However, although the short-term PMA treatment resulted in
!„■"
antero-posterior polarity, this was not as well defined as the ’classical’ 
polarized morphology and constriction rings were rare. Many cells showed j
rapidly extended and retracted veils at one or more sites on the cell 
surface. Due to this difficulty, the term non-spherical’ was used to 
describe these morphologies and they constituted 40-50% of all cells treated 
with PMA for 30 min (Wilkinson et a l ,  1988). In addition, these cells 
were determined to be non-motile as they did not enter collagen gels or 
nitrocellulose filters in comparable numbers. The shape change resulting 
from 30 min exposure to PMA was not affected by the absence of divalent 
cations in the medium or by the presence of PKC inhibitors H-7 or W-7 
(Wilkinson et a l , 1988).
When PMA, at a concentration unable to produce a shape change 
in a short-term assay, was added to the culture of lymphocytes for 24 his,
70-80% of these cells displayed a polarized morphology (Wilkinson and 
Higgins, 1987b). Although the morphology induced by PMA was not 
identical to that seen with other activators, these cells vigorously invaded 
collagen gels and nitrocellulose filters (Wilkinson and Higgins, 1987b;
Wilkinson et a l ,  1988). The morphology of these cells was more 
elongated than that seen following a 30 min treatment. Also, the 
protrusions and veils were more persistent and the constriction rings were 
more common. The PMA-induced lymphocyte shape change was not 
affected by culture in divalent cation-free medium (Wilkinson et a l , 1988).
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1.3.8. Induction o f lymphocyte motility by ’cell growth"
The common feature of observations made with the various 
mitogens was the relative length of time required by lymphocytes to 
acquire the locomotor capacity. The reason for this became apparent when 
the motile lymphocytes obtained following a 24-hr culture with PHA were 
found generally larger and more active in RNA and protein synthesis 
(Wilkinson, 1986). Similar observations were made with B cell-enriched 
lymphocytes cultured with growth factors such as IL-4 or IFN-y, where the 
increase in size was associated with motility as measured by polarization 
and collagen gel invasion (Wilkinson and Islam, 1989). Under such 
conditions, the increase in lymphocyte motility preceded the DNA synthesis 
and was inhibited by protein synthesis inhibitor cycloheximide but not by 
DNA synthesis inhibitor mitomycin c (Wilkinson, 1986). Cycloheximide 
had no effect when added to PHA-activated lymphocytes indicating that 
once the motility is acquhed, protein synthesis is not necessary for its 
maintenance (Wilkinson, 1986). This sequence of events suggests that the 
locomotor capacity increases as the cells progress through the Gj phase 
towards the S phase of the cell cycle. Cyclosporin A and FK506 are 
immunosuppressants that inhibit the expression of mRNA for activation 
lymphokines and thereby inhibit activation of lymphocytes at some point 
in Gi (Klaus and Chisholm, 1986; Klaus and Hawrylowicz, 1984). As 
predicted, both of these drugs inhibited dose-dependently the acquisition of 
the locomotory capability as seen in 24-hr cultures of: (1) T lymphocytes 
with aCD3, PHA, or B lymphocytes with Staphylococcus aureus Cowan 
strain in the presence of cyclosporin A (Wilkinson and Higgins, 1987b); 
(2) B-enriched mononuclear lymphocytes with IL-4 in the presence of 
cyclosporin A (Wilkinson and Islam, 1989); (3) T lymphocytes with 
aCD3 and (4) B lymphocytes with IL-4 in the presence of FK506 
(Wilkinson and Watson, 1990). However, motile lymphocytes fresh from 
blood {i.e. stimulated with FCS or PMA) or activated in a culture {i.e. 
with PMA or HSA) were not affected by either cyclosporin A (Wilkinson
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and Higgins, 1987b) or FK506 (Wilkinson and Watson, 1990). Ratner et 
al. (1988) examined, using flow cytometiy, the cell cycle profiles of mouse 
lymphocytes stimulated with Con A and subsequently allowed to invade 
collagen gels. They also concluded that the Con A-induced motility 
commences before S phase and diminishes shortly before or during Gz/M. 
Therefore, does the cellular synthetic activity generate some component of 
locomotory machinery or some element of signal transduction pathway 
linking this machinery to the extracellular signal?
1.3.9. Evidence for constitutively functioning locomotory machinery
The ability of colchicine to polarize about 46% of lymphocytes 
fresh from blood over the period of 30 min (Wilkinson, 1986) showed that 
simple microtubule disassembly allows for the expression of motile 
behaviour. Indeed, lymphocytes treated with colchicine or vinblastine are 
actively motile and rapidly invade collagen gels (Haston et al., 1982; 
Haston and Shields, 1984). Similarly, 80% of fresh neutrophils may be 
polarized by colchicine (Keller et al., 1984). On the other hand, DgO 
which stabilizes microtubule polymers, completely but reversibly inhibited 
polarization of neutrophils (Zimmermann and Keller, 1984; Zimmermann 
et al., 1988) and lymphocytes cultured in the presence of FCS (Wilkinson, 
1986), In addition, the existence of functioning locomotory machinery in 
fresh lymphocytes was suggested by the ability of chemoattractants, such 
as FCS and endotoxin-tieated human serum, to induce a shape change in 
many such cells within 30 min (Wilkinson, 1986). Thus, the 
responsiveness to chemoattractants seems to stem fr om activation of a 
signal transduction pathway which links surface receptors for such factors 
with the intracellulai' locomotory machinery.
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1.3.10. Importance o f chemoattractants in induction and maintenance o f 
lymphocyte motility
The chemoattractants may be generated at the same time as the 
signal pathways aie activated. This point was illustrated in experiments 
where B-enriched cells, activated by culture with IL-4 and washed, were 
able to repolarize only in 24-hr culture supernatant but not in fresh medium 
or in pure IL-4 (Wilkinson and Islam, 1989). Although the existence of 
such chemoattractant was not ascertained by Wilkinson and Higgins 
(1987a) theii experiments monitored an effect of 24-hr culture supernatants 
on lymphocytes cultured without «CDS or Con A. Consequently, such 
cells would not express an activated transduction pathway capable of 
transmitting the stimulatoiy signal for locomotion.
IL-8 , also known as NAP-1 has been recently identified as a 
lymphocyte chemoattractant (Larsen et al. , 1989b; Leonard et al. , 1990). 
In human mononuclear cell cultures containing o:CD3 or PPD, IL - 8  was 
released into the culture medium reaching maximal levels after 48 hrs 
(Wilkinson and Newman, 1992). These supernatants and human 
recombinant IL - 8  induced increase in polarization and collagen gel invasion 
in lymphocytes cultured with FCS; this activity could be inhibited by alL~ 
8 . In orientation assays it was shown that IL - 8  is a true chemotactic factor 
for lymphocytes (Wilkinson and Newman, 1992). Interestingly, although 
the levels of IL- 8  detected in the presence of PPD were superior to those 
observed with aCD3, PPD-activated cultures yielded a smaller proportion 
of polarized cells. In agreement with the suggestion that cells first have to 
be activated through TcR/CD3 before lymphocytes can respond to IL-8 , it 
is clear that PPD-specific lymphocytes would constitute a minority of the 
general population while ceCD3 is a polyclonal activator. This may be 
supported by the superior ability of memory or effector CD45RO ' cells to 
polarize in response to hiIL - 8  and the supernatants compared to naive or 
resting CD45RA^ cells (Wilkinson and Newman, 1992).
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2. AIMS OF THE STUDY
2.1. BACKGROUND
2.1.1. Requirements for physiological T cell activation
Proliferation of T lymphocytes in vivo is driven by response to 
antigens. In general, antigens are recognized by T lymphocytes via the 
TcR during cell-cell interactions with AC. The antigens must be first 
’processed’ by an AC before they are displayed on its surface bound to a 
protein product of the MHC genes. The TcR interacts with the processed 
antigen and simultaneously with a class I or class II MHC glycoprotein. 
Activation of the T cell induced by interaction of TcR with antigen 
presented on the surface of AC results in transmembrane signals, the 
generation of intracellulai’ second messengers and ultimately in the cell 
proliferation.
2.1.2. Events defining T lymphocyte activation
The Go, or resting, T lymphocytes have a relatively low RNA 
content. These lymphocytes, when activated in vivo, respond by 
mitogenesis. The process of activation can be divided in terms of different 
stages of cell cycle as a progress from Go into Gi and finally into the 
S/Gg/M phase.
At 4 to 16 hrs after appropriate stimulation, the cells enter Gi phase 
which is accompanied by the ’early’ events of lymphocyte activation. 
These ’early’ events comprise the increase in RNA content, de novo 
expression of activation-associated surface proteins such as IL-2r (Cotner 
et a l ,  1983; Cantrell and Smith, 1983; Bruszewski et a l ,  1984; 
Williams et al. , 1985) and insulin receptor (Helderman and Strom, 1979). 
The expression of activation-associated antigens correlates highly witli T 
cell entry and transit of the S phase (Cotner et a l,  1983; Cantrell and
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Smith, 1983) and thus may constitute an obligatory step in the induction 
of T lymphocyte proliferation (Cantrell and Smith, 1984). The synthesis 
of IL-2 is dependent upon the availability of AC-derived IL-1 (Larsson et 
al. , 1980) and is followed by proliferation of IL-2r-positive cells tiiggered 
by the interaction of IL-2 with its receptor (Smith, 1980; Cantrell and 
Smith, 1983). The cells in the S/Gj/M phase are characterized by the 
’late’ events of T cell activation namely detectable DNA synthesis and cell 
proliferation.
2.1.3. Polyclonal lymphocyte activation with chemical agents
The AC-dependent molecular events of primary T cell activation 
cannot be examined conveniently in vitro due to the small size of the 
antigen-reactive clone population (Williams et al., 1984b; Ythier et a l,
1985). A possible exception is the use of PPD to induce blast 
transformation and mitogenesis in a relatively large population of human 
lymphocytes from tuberculin-sensitive donors (Schrek, 1963).
The polyclonal proliferation of peripheral T lymphocytes can be 
activated by a variety of chemical agents including lectins (Nowell, 1960), 
sodium periodate (Novogrodsky and Katchalski, 1972), PMA (Touraine et 
a l,  1977), calcium ionophore A23187 (Luckasen el «/,, 1974), galactose 
oxidase (Novogrodsky and Katchalski, 1973), and a range of polyspecific 
antisera which recognize multiple lymphocyte determinants (Brochier etal. , 
1976; Owen and Fanger, 1974; Woody el a/., 1975; Woodruff el a /., 
1967).
Lectins are widely used to induce a polyclonal T cell response. 
These agents mediate then effect via activation signals delivered by binding 
to specific sites on the lymphocyte membrane (Toyoshima et a l , 1972) 
which include a variety of lectin-binding glycoproteins (Henkart and 
Fisher, 1975). The ambiguity of lectin interaction with lymphocytes makes 
these agents unsuitable for in vitro enquiries into specific biochemical 
mechanisms involved in T lymphocyte activation. Furthermore, lectin
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activation is not fully supported by exogenous IL-1 and requires the 
presence of AC (Williams et a l ,  1984a; Hünig et a l ,  1983).
2.1.4. The use of mitogenic monoclonal antibodies
The use of monoclonal antibodies to various components of 
TcR/CD3 complex has facilitated the study of its involvement in signalling 
leading to primal^ activation and proliferation of T cells. Although the 
activation, induced by the antibodies, occurs in a large polyclonal 
population of normal T cells, the mechanisms seem to be analogous to 
activation by specific antigen (Mener et a l , 1983c, 1984; Kammer et a l ,
1984). In addition, these antibodies bind to a specific cell membrane 
structure. Indeed, most epitopes recognized by o;TcR/CD3 are on the 20- 
kDa CD3e subunit (Tunnacliffe et a l , 1989).
Four subgroups depending on «CDS specificity were suggested 
(Tunnacliffe et a l ,  1989). Antibodies in group I {i.e. UCHTl and aLeu- 
4) recognize the native CD3e. Antibodies in group II {i.e. OKT3, WT32 
and BMA030) recognize conformational determinants of CD3e which rely 
on its association with other subunits in the complex. Antibodies in group 
III {i.e. WT31) recognize a nonpolymorphic determinant on the TcRa or 
TcR8  (Spits et a l,  1985).
The use of o;CD3 or aTcR introduced new complexity, such as 
epitope specificity and affinity, and theti effect on the resulting 
mitogenicity (Geppert and Lipsky, 1988; Pichler et a l , 1987) or even on 
the activation mechanisms triggered. For example, although UCHTl and 
OKT3 interact with the same antigenic structure on the T cell surface 
(Burns et a l , 1982) and have comparable affinity and mitogenicity (Tax 
et a l , 1983; Burns et a l , 1982), UCHTl exerts its effect through an IL- 
2-independent pathway while OKT3 activity is IL-2-dependent (Van 
Wauwe et a l,  1984).
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2.1.5. Effect of gTcR/CD3 on unseparated PBMC cultures
Monoclonal aCDS, such as 0KT3 (Van Wauwe et a l ,  1980), 
aLeu-4 (Kaneoka et a l ,  1983; Van Wauwe and Goossens, 1983), and
64,1 (Williams et a l ,  1985) and aTcR (Kappler et a l ,  1983; Mener et 
a l ,  1983b; T axera/., 1983; K ayeefû/., 1984; Weiss and Stobo, 1984) 
antibodies have been used extensively to induce unseparated PBMC to 
express IL-2r (Meuer et a l , 1984; Tsoukas et a l , 1985; Ledbetter et a l ,
1986), to secrete IL-2 or IFN-y (Von Wussow et a l ,  1981; Chang et a l , 
1981; Venuta et a l ,  1983; Van Wauwe et a l ,  1984), and finally to 
proliferate (Van Wauwe et a l , 1980; Chang et a l , 1981).
The mitogenic effect of soluble aCD3 is markedly diminished in 
AC-depleted PBMC cultures indicating that mere binding of the aCD3 to 
T lymphocytes is not sufficient for theii activation (Van Wauwe and 
Goossens, 1981; Tax et a l ,  1983; Williams et a l, 1985; Kaneoka et 
a l , 1983). In the human PBMC, the AC are contained within the adherent 
cell population (Tax et a l ,  1983).
2.1.6. Role of AC in oiCD-induced lymphocyte activation
The first signal in vivo is induced by redistribution of TcR/CD3 via 
interaction with antigen presented on the AC surface in the association with 
class II MHC. This signal can be mimicked by aCD3 bound to Fc 
receptors on AC, or to various artificial substrata.
The second function of the AC is demonstiated by the failure of 
immobilized aCD3 or lectins to induce proliferation of AC-depleted T cells 
(Williams et a l ,  1985; Ledbetter et a l ,  1986; Weiss et a l ,  1986). 
These additional signals are thought to be supplied by soluble materials 
liberated by AC, at least one of which is IL-1 (Mizel, 1982). The IL-1 
receptors are expressed, after antigenic stimulus is perceived (Williams et 
a l ,  1985).
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2.1.7. Signals required for TcR/CD3-mediated lymphocyte activation
In order to distinguish between the involvement of cross-linking and 
IL-1 production by AC, AC-depleted cultures were stimulated with o:CD3 
bound to Sepharose beads (Tax et a l ,  1984; Manger et a l ,  1985; 
Williams et al., 1985; Palacios, 1985; Meuer and Meyer zum 
Buschenfelde, 1986), to polystyrene beads (Halvorsen et a l , 1987) or onto 
the surface of culture dishes (Ceuppens et a l ,  1985). The requirements 
for activation of T cells by q:CD3 or cxTcR presented in this way were 
dependent on the event of T cell activation examined (Tsoukas et a l , 1985 ; 
Ledbetter et a l,  1986), on the aCD3 or aTcR clone and the mode of 
antibody immobilization (Verwilghen et a l , 1991), as well as on the basal 
activation state of the T cells.
There is a fundamental difference in the AC requirement for the re­
activation of antigen-primed T cell clones as compared with the primary 
activation of resting T cells by aCD3. Thus, Seph-aTcR (Meuer et a l,  
1983c; O’Flynn et a l , 1985) or Seph-cxCDS (Meuer et a l , 1984, 1983c; 
Meuer and Meyer zum Buschenfelde, 1986; Manger et a l ,  1985) was 
sufficient to induce IL-2 production and subsequently proliferation in T cell 
clones. Similar observations were made in leukaemic cell lines HUT-78 
and Jurkaf where the former has a phenotype of an activated T cell while 
the latter resembles a resting T cell. Indeed, full IL-2 production was 
induced with Seph-aCD3 in HUT-78 while Jurkat required the 
costimulatory signal of exogenous IL-1 (Manger et a l ,  1985).
2.1.8. Phorbol esters mimic second signal
Exogenous IL-1 substituted for AC and induced IL-2 production and
'The cell line Jurkat was derived from a patient with T lymphoblastic 
lymphoma, whereas HUT 78 cultured from peripheral blood of a patient 
with Sezaiy syndrome (Kaplan et a l , 1976; Gazdar et a l , 1980).
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.DNA synthesis in AC-depleted PBMC cultures activated with Seph-aCDS 
(Manger â /., 1985; Williams aZ., 1985; Palacios, 1985) while others
could not demonstrate such properties of IL-1 (Davis et al., 1986; 
Halvorsen et al. , 1987). The exogenous IL-1 enhanced IL-2r expression, 
IL-2 production, and proliferation in the presence of stimulating
concentrations of aCD3; however, the main role for IL-1 may rest in a 
synergism with suboptimal aCDS concentrations to induce T cell activation 
(Verwilghen et al. , 1991).
PMA was shown to be able to replace the second signal delivered 
by IL-1 in several studies (Rosenstreich and Mizel, 1979; Abraham et al. ,
1987). Indeed, IL-1 can initiate the production of DAG independent of 
phosphoinositide metabolism by the hydrolysis of phosphatidyl choline 
(Rosoff aZ., 1988).
Jurkat cells stimulated with PHA are activated to produce IL-2 and 
this is further increased by the addition of PMA (Gillis and Watson, 1980; 
Weiss et al., 1984c). Although PMA alone was shown to increase IL-2 
production in peripheral blood cell cultures (Sando et al., 1981) it did not 
induce detectable IL-2 production in Jurkat (Weiss et al., 1984c).
In view of the established mitogenicity of aCD3 in PBMC cultures 
the effect of aCD3 (Weiss et al. , 1984c) and aTcR (Imboden et al. , 1985) 
on Jurkat was examined. In the presence of PMA, aCD3 or orTcR activate 
Jurkat to produce IL-2 (Weiss et al. , 1984bc; Imboden et a l ,  1985). 
Neither PMA nor the antibodies alone induced IL-2 production. This 
synergism is not limited to Jurkat but can be obseiwed in peripheral T cells 
(O’Flynn et al. , 1985) and HUT-78 (Manger et al., 1985). The same two 
stimuli were necessary for the appearance of IL-2 mRNA (Weiss et al., 
1984c) or IFN-y mRNA (Weiss et al., 1984a) indicating that the signals 
act on pretranslational events.
2.1.9. Involvement of Ca^  ^ in T cell activation
Early studies measuring cell-associated uptake suggested 1
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increased [Ca'^ '^ ji in mitogen-stimulated T cells (Allwood et a l ,  1971; 
Whitney and Sutherland, 1972). Indeed, when the extracellular was 
removed with citiate, EDTA or EGTA, the lectin-induced lymphocyte 
mitogenesis was inhibited (Alford, 1970; Whitney and Sutherland, 1972). 
The role of Ca  ^' as a mitogenic signal was supported by obseiwations of a 
blastogénie response (Maino et a l , 1974) or of DNA synthesis (Hesketh 
et al., 1977) in lymphocytes exposed to Ca  ^ ionophore.
A more recent technique (Tsien, 1981) for loading intact small cells 
with fluorescent derivatives of the Ca''  ^ chelator EGTA (Tsien, 1980) 
allowed for direct and sensitive determination of [Ca^^k in mouse 
thymocytes and pig lymphocytes (Tsien et al., 1982). The intracellular 
[Ca'" ] of resting cells was about 100 nM; within minutes of stimulation 
with Con A the [Ca^^T increased to 200-250 nM (Tsien et al., 1982).
The Ca''^ ionophores together with PMA were used instead of 
cxCD3 in an successful attempt to activate CD3 mutants of Jurkat cells 
(Weiss et al., 1984b). These mutants fail to respond to PHA (Weiss and 
Stobo, 1984) and aCD3 (Weiss et al., 1984b) even in the presence of 
PMA. The combination of Ca''^ ionophores and phorbol ester was used to 
activate peripheral blood T lymphocytes (Truneh et al., 1985ab; Kaibuchi 
et al., 1985; Granelli-Piperno et a l ,  1986), HUT-78 (Manger et a l ,
1985), immature CD4 CDS' thymocytes unresponsive to surface-acting 
ligands (Lugo et al., 1986) and replaced the antigen-specific signal in T 
cell lines and clones (Albert et a t ,  1985; Isakov and Altman, 1985; 
Koyasu et al., 1987; Goronzy et al., 1987).
The combination of Ca^  ^ ionophore and PMA mimics the effect of 
activation by antigen but cannot replace IL-2-mediated proliferative signal 
in IL-2-dependent cell lines which are dependent on exogenous IL-2 
(Albert et al., 1985; Isakov et al., 1985) indicating that IL-2 triggers a 
pathway distinct from TcR/CD3.
4 5
2.2. EXPERIMENTAL
2.2.1. Intracellular signals involved in the acquisition and maintenance of 
the locomotory capacity in lymphocytes
T lymphocyte proliferation and differentiation into competent cells 
are mediated by a complex series of intracellular signalling events (Isakov 
et a l ,  1987; Altman et a l ,  1990; Klausner and Samelson, 1991). 
Signals through TcR/CD3 lead to expression of early activation genes such 
as those encoding c-fos, c-myb, c-myc, IL-2 and IL-2r (Crabtree, 1989) and 
eventually result in cell proliferation. The wide scope of data reviewed 
above, that defines signalling pathways and mechanisms involved in the 
initiation of many activation-associated events, contrasts with the lack of 
information on specific biochemical events resulting in lymphocyte 
locomotion.
It has been established that ’cell growth’, including the expression 
of new genes, correlates with the acquisition of the locomotory capacity 
(Wilkinson, 1986). Indeed, a mitogenic monoclonal aCD3 antibody has 
the ability to induce polarized morphology in PBL cultures (Wilkinson and 
Higgins, 1987a). In line with the evidence presented above, the acquisition 
of locomotory capacity by PBL exposed to mitogenic monoclonal 
antibodies is dependent on the presence of Fc receptor-positive AC 
(Wilkinson and Higgins, 1987a). In addition, the increase in polarization
of lymphocytes exposed to PMA was demonstrated by Wilkinson et a l 
(1988). However, the mechanism by which this phorbol ester induces the
shape change was not examined. The coupling elements comprising the 
signalling pathway involved in the locomotor response to chemoattractants 
seem to include a pertussis toxin-sensitive G protein (Wilkinson and
Watson, 1990). However, its relative position within the activation 
pathway and the effector enzymes regulated by this G protein are not I
known.
There is an obvious need for specific information that would clarify
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the intiacellular mechanisms and relationships that regulate the acquisition 
and maintenance of locomotory capability in T lympohocytes. For this 
purpose, a study, described in this document, was conducted in an attempt 
to identify the key biochemical components involved in the regulation of 
this important T lymphocyte function.
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3. MATERIALS AND METHODS
3.1. SUPPLIERS
Amersham
Amersham International pic, Amersham Place, Littlechalfont, 
Buckinghamshire, U.K.
Applied Biosystems
Applied Biosystems, W a iT in g to n , Cheshire, U.K.
BDH
BDH Ltd., Poole, Dorset, U.K.
Beckman
Beckman Instruments Inc., 2500 Harbor Boulvard, Fullerton CA, 
U.S.A.
Becton Dickinson
Becton Dickinson, Cowley, Oxon., U.K.
Biological Industries
Biological Industries Ltd., Cumbernauld, Strathclyde, U.K. 
Bio-Rad
Bio-Rad Laboratories, 3300 Regatta Boulvard, Richmond CA, 
U.S.A.
Calbiochem
Calbiochem, Nottingham, U.K.
Canberra Packard
Canberra Packard, Pangbourne, Berks, U.K.
Ciba-Geigy
Ciba-Geigy, Basel, Switzerland 
Coulter
Coulter Electronics, Luton, Beds, U.K.
CP Pharmaceuticals
CP Pharmaceuticals Ltd., Wrexham, U.K.
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Dako
DAKO A/S, Produktionsvej 42, Postbox 1359, DK-2600 Glostiup, 
Denmark.
Dynal
Dynal Laboratories Ltd., Billingshurst, West Sussex, U.K.
Fisons
Fisons Chemicals, Loughborough, Leics., U.K.
Flow
ICN Flow Ltd., High Wycombe, Bucks, U.K.
Gibco
Life Technologies Ltd., Paisley, Strathclyde, U.K.
Graticules Ltd.
Graticules Ltd., Tonbridge, Kent, U.K.
Hoechst Behring
Hoechst U.K. Ltd., Twickenham, Middlesex, U.K.
LKB Wallac
Wallac Oy, Turku, Finland 
Luckham
Luckham Ltd., Burgess Hill, Sussex, U.K.
McQuilkin
McQuilkin & Co., Glasgow, U.K.
Molecular Probes
Molecular Probes, P.O. Box 22010, Eugene, Oregon, U.S.A.
Nikon
Nikon U.K. Ltd., Telford, Shropshire, U.K.
Olympus
Olympus Optical Co. (U.K.), London, U.K.
Ortho
Ortho Diagnostic Systems Inc., Raritan, NJ 08869, U.S.A. 
Packard
Packard Instrument Company Inc., One State Street, Meriden CT, 
U.S.A.
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Perkin-Elmer
Perkin-Elmer Ltd., Beaconsfield, Buckinghamshire, U.K. 
Pharmacia
Pharmacia LKB, Biotechnology AB, Uppsala, Sweden 
Roche Products
Roche Products, Welwyn Garden City, U.K.
SAPU
Scottish Antibody Production Unit, Law Hospital, Carluke, 
Lanarkshire, U.K.
Scotlab
Scotlab, Coatbridge, Strathclyde, U.K.
Sigma
Sigma Chemical Company Ltd., Poole, Dorset, U.K.
Sterilin
Sterilin Ltd., Teddington, Middlesex, U.K.
Transduction Labs
Transduction Laboratories, Affinity, Mamhead Castle, Mamhead, 
Exeter, EX6  8 HD, U.K.
Weber
Weber Scientific International Ltd., Lancing, Sussex, U.K. 
Whatman
Whatman International Ltd., Maidstone, U.K.
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3.2. MATERIALS
3.2.1. Reagents
A23187 (10 ""M)
5.00 mg of calcium ionophore A23187 (Sigma C7522; C2 9 H3 7 N3 O6 ; 
FW 523.6) was dissolved in 955 fû DMSO, aliquoted at 200 
/il/tube and stored at 4°C.
Acetic acid (5%)
5 ml acetic acid (CH3.COOH; MW 60.05; d 1.048-1.050 g/ml; 
glacial 17.5 M) was made up to 100 ml with dHjO,
Acrylamide solution (30%)
29.2 g acrylamide (BDH 44299; CH^iCH.CO.NH^; MW 71.08) 
and 0.8 g N ,N ' -methylenebisaciylamide (Fisons H/P210/46) 
dissolved in 100 ml ddHjO. 
otCD3 (2 fig/ml)
25 fjLg of OKT3 (Ortho) was diluted in 12.5 ml HBSS/MOPS/HSA 
and dialysed against three changes of 1 1 HBSS/2.5 mM MOPS at 
4“C. The solution was then filter-sterilized, aliquoted at 100 
jLtl/tube and stored at -20°C.
Azide (1%)
1.00 g sodium azide (BDH 30111; NaNj; MW 65.0) was 
dissolved in dHgO at room temperature. The reagent was stored at 
4 T .
CaClj (lOOx)
185 mg calcium chloride dihydrate (Sigma C-3881; CaCl2 ,2 H2 0 ; 
FW 147.0) was dissolved to final concentration of 126 mM in 10 
ml dHgO. The solution was then filter-sterilized and stored at 4°C. 
CGP41251 (lO 'M )
The reagent (dissolved in DMSO) was a gift to Prof. P.C. 
Wilkinson from Ciba-Geigy.
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Cholera toxin (200 fig/ml)
1.0 mg from Vibrio cholerae with Tris buffer salts, sodium azide 
and NajEDTA was diluted in 5 ml HBSS/MOPS and dialysed 
against three changes of 500 ml HBSS/2.5 mM MOPS at 4°C. The 
solution was then filter-sterilized, aliquoted at 1 ml/tube and store 
at 4«C.
Collagen (2x)
A stock solution of type I collagen was prepared from rat 
tail tendons using a method described by Elsdale and Bard (1972). 
Briefly, the tails were washed in ethanol and the skin was stripped. 
The four longitudinal bundles of tendons were removed from each 
tail and were placed in 200 ml of 5% acetic acid. The collagen 
was allowed to dissolve at 4°C for 24 to 48 hrs giving a 
tropocollagen in solution. The debris was removed from the 
solution by coarse-filtering through Nitex gauze and then by 
centrifugation at 3,000 g for 45 min at 4°C. The collagen was 
precipitated from the supernatants overnight at 4”C by adding NaCl 
to final concentration of 10% (w/v). The precipitate was collected 
by centrifugation at 3,000 g for 45 min at 4°C. The precipitate was 
removed fiom the top of the centrifuge tubes and redissolved in 
minimal volume of 5% acetic acid overnight at 4°C. The collagen 
was re-precipitated as above and then dialyzed against three changes 
of water at 4°C. A small sample of collagen was fr eeze-dried and 
then redissolved in 5% acetic acid to give a 1 mg/ml solution. A 
standard curve was obtained by reading the absorbance of several 
dilutions on spectrophotometer set at 243 nm. The concentration 
of the stock was determined to be 4.5 mg/ml. The purity of this 
preparation was verified under denaturing conditions by 
polyacrylamide gel electrophoresis (Ian Newman, personal 
communication). The collagen solution was stored in 20 ml 
aliquots at -20°C.
The minimum concentration of collagen giving a satisfactory
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gel matrix is about 1.0 mg/ml (Dr. I. Newman, personal 
communication). In order to assure a reproducible firm collagen 
gel the final concentration of 1.5 mg/ml was used in all the 
experiments. The collagen was prepared as 2x working solution by 
mixing the following for each 1.0 ml; 667 jitl of 4.5 mg/ml stock 
collagen, 100 fil of RPMI 1640 medium (lOx) without L-glutamine 
& NaHCOj (Gibco 042-02511H), 10 fi\ HEPES buffer solution 
(IM; Gibco 043-05630H), 15 /d 1 N NaOH, and 208 fxl of dH^O. 
The RPMI 1640 and HEPES was sometimes replaced by lOx 
Hanks’ balanced salt solution without sodium bicarbonate (Flow 19- 
101-54) and 1 M MOPS respectively. The 2x collagen solution 
obtained was then kept in an ice bath to prevent a premature 
gelling. 
dbcAMP (10 mM)
50.6 mg N‘^ -2’-0-dibutyryl adenosine-3’:5’-cyclic monophosphate 
sodium salt (Sigma D-0627; CigHasNsOgPNa; anhydrous MW 
491.4; 97% pure) was dissolved in 10 ml with RPMI/HEPES or 
HBSS/MOPS, filter-sterilized, aliquoted at 1 ml per sterile vial and 
stored at -20°C. Each vial was used with 9 ml of suspension (final 
concentration of 1 mM dbcAMP) containing Jurkat cells in an 
exponential phase of growth.
2-deoxy“glucose/PBS (5.5 mM)
90.3 mg 2-deoxy-D-glucose (Sigma D-8375; Q H 1 2O5 ; FW 164.2) 
was dissolved in 100 ml PBS.
DMSO
Dimethyl sulphoxide (Sigma; (CHa)2 S0 ; MW 78.1)
EDTA (100 mM)
4.162 g ethylenediaminetetia-acetic acid tetrasodium salt (BDH 
28026; [CH2 .N(CH2 .C0 0 Na)2 ]2 .2 H2 0 ; FW 416.2) was dissolved 
in 100 ml of dH^O, filter-sterilized and stored at 4°C.
EGTA (100 mM)
3.804 mg Ethylene glycol-bis(15-aminoethylether) N,N,N’,N’,
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tetraacetic acid (Sigma E-4378; FW 380.4) was partially dissolved 
in 80 ml dHgO. The pH of the solution was increased using NaOH 
pellets until EGTA is was completely dissolved. The solution was 
made up to 100 ml with dH^O, filter-sterilized and stored at 4°C. 
When added to buffers, final pH was adjusted with HCl.
Forskolin (lO 'M)
10 mg forskolin (Sigma F-6 8 8 6 ; 78-acetoxy-1 a ,6 b ,9a-trihydroxy- 
8,13-epoxy-labd-14-en-l 1-one; from Coleus forskohlii; C2 2 H3 4 O7 ; 
FW 410.5) was dissolved in 244 [il of DMSO and stored at -20°C.
Freezing medium
For every 10 ml of the freezing medium, 1 ml of DMSO was 
mixed with 9 ml of neat foetal calf semm (Biological Industries 04-
001-IB). The medium was made fresh before each freezing.
Fura 2-AM (2 mg/ml)
0.5 mg of Fura 2-AM (Sigma F-0888; FW 1001.9) was dissolved 
in 250 III of DMSO and stored at -20°C.
GF109203X (lO'M)
The reagent purchased from Calbiochem (dissolved in DMSO) was 
a gift to Prof. P.C. Wilkinson from Dr. N. Matthews (Yamanouchi 
Research Institute, Littlemore Hospital, Oxford, U.K.
Glucose/PBS (5.5 mM)
100 mg D-glucose (BDH 10117; 0 \(C H . 0 H)4 GH.CH 2 0 H; FW 
180.16) was dissolved in 100 ml PBS.
Glutaraldehyde (2.5%)
10 ml glutaraldehyde (Sigma G-6257; grade 11; 25% aqueous 
solution; CgHgOg; FW 100.1) was made up to 100 ml with sterile 
saline and stored at 4°C.
H-7 (10 ‘M)
10 mg (l-(5-Isoquinolinylsulphonyl)-2-methylpiperazine dichloride 
(Calbiochem 1-4756; CuHnNaOjSj.HCl; FW 364.29) was 
dissolved in 274 fil DMSO and stored at -20°C.
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HCl (1 M)
8.59 ml glacial hydrochloric acid (36%; 11.6 M) was made up to 
100 ml with dHgO, filter-sterilized and stored at 4°C.
Herbimycin A (1 mg/ml)
100 /ig Herbimycin A (Sigma H-6649) was dissolved in 100 fil of 
DMSO and stored at -20^C. Working solution of 5 /rg/ml was 
obtained by dilution in HBSS/HEPES prior to each experiment. 
IBMX (1 0 'M)
22.22 mg IBMX (Sigma 1-5879; 3-isobutyl-1-methy 1-xanthine; 
C 1 0H 1 4N4 O2 ; FW 222.2) was dissolved in 1.00 ml of DMSO. A 
fresh solution was made before each experiment.
Iso H-7 (lO 'M)
5 mg l-(5-Isoquinolinylsulphonyl)-2-methyl piperazine (Sigma I- 
6891; Q 4 HJ7 N3 O2 S; FW 291.4) was dissolved in 172 jLil DMSO 
and stored at -20°C.
MgCl2 (lOOx)
100 mg magnesium chloride (BDH 10149; MgCli.dHjO; FW 
203.30) was dissolved in 10 ml of dH2 0  to final concentration of 
49 mM. The solution was then filter-sterilized and stored at 4°C. 
MOPS (1 mM)
20.93 g 3-[N-morpholmo]propanesulphonic acid (Sigma M-1254; 
MW 209.3; pH optimum 6 .5-7.9) and 17 sodium hydroxide pellets 
(BDH 10252) were dissolved in 50 ml dH2 0 . The pH was then 
adjusted with 2M NaOH to 7.4. Finally, the solution was made up 
to 100 ml with dHjO, filter-sterilized and stored at 4°C.
NaOH (2 M)
8.00 g sodium hydroxide (BDH 10252; NaOH; MW 40.0) was 
dissolved in 100 ml dHgO, aliquoted and stored at 4°C.
Paraformaldehyde (1 %)
1.00 g paraformaldehyde (BDH 29447 4L; [H.CHO]„) was placed 
in 100 ml of PBS and was dissolved by heating to 60“C for 60 min. 
The reagent was stored at 4°C.
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PDB (lO^M)
5.00 mg porbol 12,13-dibutyrate (Sigma P I269; CagH^ oOg; FW 
504.6) was dissolved in 91 jwl DMSO, aliquoted at 100 fil per tube 
and store at 4°C.
Pertussis toxin (200 fig/mV)
Pertussis toxin solution in sterile distilled water (Sigma P6561) was 
kept at -20^C.
PGE 2  (10 "M)
1 mg prostaglandin Ej (Sigma P-5640; [5Z, 1 la , 13E, 15S]-11,15- 
dihydroxy-9-oxoprosta-5,13-dienoic acid; C2 0 H3 2 O5 ; FW 352.5) 
was dissolved in 284 fû of DMSO and stored at -20°C. 
Phosphorylation lysis buffer
100 fxl 2M Tris (BDH 27119) pH 7.4, 240 fi\ 5M NaCl (BDH 
10241), 80 fxl 100% Nonidet P40 (BDH 56009), 400 fil 20 mM 
sodium orthovanadate (Sigma S-6508), 80 fû 100 mM EDTA, 160 
fil 100 mM EGTA, 80 fil IM NaF, 80 (xl 100 mM DTT (Sigma D- 
9163; DL-dithiothreitol; C^H^AS^; MW 154.2), 80 pil 5 mg/ml 
leupeptin (Sigma L-2884; CzoHsgN^ O^ . I/ 2 H2 SO4 ; MW 475.6), 80 fil 
1.4 mg/ml aprotinin (Sigma A-1153), 40 fil 10 mg/ml PMSF 
(Sigma P-7626; phenyl methylsulphonyl fluoride; C7 H7 FO2 S; MW
174.2) in total volume of 8  ml of ddH2 0 .
Pluronic F-127 (20%)
20 mg pluronic F-127 (Moleculai’ Probes P-1572) was dissolved in 
100 [il of DMSO and stored at -20°C.
PMA (10 "M)
5.00 mg phorbol 12-myristate 13-acetate (Sigma P8139; 
413,9a, 1213,13a,20-pentahydroxytiglia-l, 6-dien-3-ond 28-myristate 
13-acetate; PMA; 12-O-tetradecanoyIphorbol 13-acetate; TPA; 
CsfiHsfiOs; FW 616.8) was dissolved in 811 fil DMSO, aliquoted at 
100 /xl per tube and stored at 4°C.
Propidium iodide
10 mg propidium iodide (Sigma P-4170; 95-98%) was dissolved
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in 2 ml dH^O and stored at 4°C. The final concentration used was 
10 /tig/ml. Working solution of 10 figlmX propidium iodide was 
prepared fresh before each experiment by diluting 1 0  / ^ 1  of stock 
solution in 5 ml of dH^O.
RNase (500 U/ml)
5,000 units ribonuclease (Sigma R-7003; 0.65 mg solid; 9,900 
units/mg solid; 126,000 units/mg protein ILowry]) were dissolved 
in 10 ml phosphate buffer pH 7,4, aliquoted at 1 ml per tube and 
stored at -20°C.
Ro31-8220 (lO^M)
The reagent (dissolved in DMSO) was a gift to Dr. A. Severn and 
Prof. F.Y. Liew from Roche Products.
Separating gel (7.5%)
Mini gel: 1.55 ml 1.5 M Tris pH 8.9, 7.7 ml ddH^O, 3.125 ml 
acrylamide solution (30%), 125 fiX 10% SDS (BDH 10032; sodium 
dodecyl sulphate; Ci^Hz^OSOa.Na; MW 288.38), 20 fiX TEMED 
(Pharmacia 80-1128-13; NNN’N’-tetramethylenediamine; 
(CHg) .^N .CH2 . CHz.N(CHg):) and 25 fiXXO% ammonium persulphate 
(BDH 10032; (NH4)2S20g; MW 228.19).
Separating gel (10%)
Large gel: 4 ml 1.5 M Tris pH 8.9, 19.7 ml ddHjO, 8  ml
acrylamide solution (30%), 320 fil 10% SDS, 80 (jlX TEMED and 
25 fil 10% ammonium persulphate.
Stacking gel (3%)
Large gel: 3.75 ml 0.5 Tris pH 6 . 8 , 8 . 8 8  ml ddHjO, 2.37 ml 30% 
acrylamide solution, 150 fiX 10% SDS, 15 fxX TEMED and 40 fiX 
1 0 % ammonium persulphate
Mini gel: 1.38 ml 0.5 Tris pH 6 .8 , 3.0 ml ddHgO, 0.5 ml
aci-ylamide solution (30%), 50 fiX 10% SDS, 20 fxX TEMED and 20 
j^ l 1 0 % ammonium persulphate.
Staurosporine (10 ^ M)
0.1 mg staurosporine (Sigma S-4400; from Streptomyces sp.;
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CzgHzgN^ Og; FW466.5) was dissolved in 214 fil DMSO and stored 
at -20°C.
Thapsigargin (10 ^ M)
0.5 mg thapsigargin (Sigma T-9033; C3 4 H5 0 O1 6 ; FW 650.8) was 
dissolved in 768 fil DMSO and stored at -20°C.
W-7 (10 ‘M)
25 mg W-7 (N-[6 -aminohexyl] -5-chloro-1 -napthalene sulphonamide; 
Sigma A3281; FW 377.3) was dissolved in 663 fil of DMSO and 
stored at -20^C.
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3.2.2. Buffers 
HBSS/MOPS
10 ml lOx Hanks’ balanced salt solution without sodium 
bicaibonate (Flow 19-101-54) and 1.0 ml of 1 M MOPS were made 
up to 100 ml with ddHzO. The solution was occasionally stored at 
4°C for maximum of a week.
HBSS/MOPS/EDTA
10 ml lOx Hanks’ balanced salt solution without calcium and 
magnesium (Gibco 042-04180M), 1.0 ml 1 M MOPS and 10 ml 
100 mM EDTA were mixed. The pH was adjusted to 7.4 with 
HCl. Finally, the buffer was made up to 100 ml with dH^O. 
HBSS/MOPS/NaHCOa
10 ml lOx Hanks’ balanced salt solution without sodium 
bicaibonate (Flow 19-101-54), 1.0 ml IM MOPS and 3.0 ml 
Sodium bicaibonate (7.5%; Gibco 043-05080H) were made up to 
100 ml with dHjO. The pH was adjusted to 7.4 with NaOH. 
HBSS/MOPS/HSA
100 mg purified lyophilized human albumin (Hoechst-Behiing; 
ORHA 20/21) was dissolved in 10 ml HBSS/MOPS.
Phosphate buffer pH 7.4
35.3 mg sodium dihydrogen orthophosphate (BDH 10245; 
NaH2 P 0 4 .2 H2 0 ; FW 156.01) and 168.9 mg (//-sodium hydrogen 
orthophosphate (Fisons S/4520/53; Na2 HP0 4 ; FW 141.96) were 
dissolved in 1 0  ml dHgO.
PBS pH 7.4 (25x Phosphate Buffered Saline)
200.0 g NaCl (FW 58.44; 137 mM), 28.75 g NazHP0 4  (FW 
141.96; 8  mM), 5.00 g KCl (FW 74.55; 2.7 mM), and 5.00 g 
KH2 PO4  (FW 136.09; 1.5 mM) were dissolved in 11 of dHgO. The 
buffer was autoclaved before use.
PBS
4 ml 25x PBS pH 7.4 was made up to 100 ml with dHgO.
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PBS/azide
4 ml 25x PBS pH 7.4 and 1 ml of 1% azide were made up to 100 
ml with dHsO. The buffer was then stored at 4°C.
Protease inhibitor solution (lOOx)
10 mg TLCK (Sigma T-4376; N-tosyl-L-phenylalanine 
chloromethyl ketone; CnHjgClNOgS; MW 351.8), 75 mg PMSF 
(Sigma P-7626; phenyl methylsulphonyl fluoride; QH^FO^S; MW
174.2), 2.5 mg TPCK (Sigma T-7254; Na-p-tosy 1-L-lysine 
chloromethyl ketone; C 1 4H2 1 CIN2 O3 S.HCI; MW 369.3) in 5 ml of 
ethanol.
Protease inhibitor solution
0.5 ml 2M Tris pH 7.6, 0.5 ml 100 mM EDTA, 1.0 ml 100 mM 
EGTA, and 100 gl protease inhibitor solution (lOOx) in 10 ml of 
ddHzO.
RPMI (10%FCS)
87 ml RPMI 1640 medium (Ix) without L-glutamine and NaHCOg 
(Gibco 042-02511H) was supplemented with 1.0 ml HEPES buffer 
solution (IM; Gibco 043-05630H), 1.0 mi L-glutamine 200mM 
(lOOx; 29.2 mg/ml; Gibco 043-05030H), 1.0 ml Gentamycin (10 
mg/ml; Gibco 043-05710D) or Penicillin-Streptomycin solution 
(10,000 lU/ml - 10,000 ftg/ml; Gibco 043-05140D), and 10 ml 
foetal calf semm (Biological Industiies 04-001-IB).
RPMI (D2O)
1.0 ml RPMI 1640 medium (lOx) without L-glutamine & NaHCOs 
(Gibco 042-02511H) was mixed with 0.3 ml sodium bicarbonate 
(7.5%; Gibco 043-05080H), 0.1 ml HEPES buffer solution (IM; 
Gibco 043-05630H) and the pH was adjusted to 7.4 with NaOH. 
Finally the volume was make up to 10 ml with deuterium oxide 
(Sigma D-4501).
Running buffer (lOx)
30.3 g Tris, 144.1 g glycine (BDH 101196; C2 H5 NO2 ; MW 75.07), 
10 g SDS in total volume of 1 L ddHaO
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Sample buffer (2x)
0.76 g Tris, 10 ml glycerol (BDH 10118; CH2 OH.CHOH.CH 2 OH; 
MW 92.09), 0.78 g DTT (Sigma D-9163; DL-dithiothreitol; 
C4 H 1 0O2 S2 ; MW 154.2) and 2.3 g SDS in total volume of 50 ml of 
ddH20 pH 6 . 8  
TBS/vanadate
1.25 ml 2 M Tris pH 7.6, 3 ml 5M NaCl, 5 ml 20 mM sodium 
orthovanadate (Sigma S-6508) and ddH2 0  to 100 ml final volume. 
Transfer buffer (lOx)
30.3 g Tris, 144.1 g glycine, 20 g SDS in total volume of 1 L of 
ddH2 0 . Final pH should be 8.3 to 8.4.
Transfer buffer
100 ml transfer buffer (lOx), 200 ml metlianol (BDH 10158) and 
700 ml ddHzO.
Tris (1 M)
12.1 g of Tris(hydroxymetliyl)metliylamine (BDH 27119); 
NH2 .C(CH2 0 H)); MW 121.14) was disolved in ddH2 0  to the final 
volume of 100 ml and was stored at 4°C.
T TBS
5 ml 2M Tris pH 7.6, 20 ml 5M NaCl, 1 ml Tween-20 
(polyoxyethylene (20) sorbitan monolaurate; BDH 66368) and 
ddHjO to 1 L final volume.
T TBS (high salt)
5 ml 2M Tris pH 7.6, 50 ml 5M NaCl, 1 ml Tween-20 and ddH2 0  
to 1 L final volume.
61
3.3. METHODS
3.3.1. Preparation of peripheral blood mononuclear cells for experiments
3.3.1.1. Separation o f whole blood
Blood was collected from healthy volunteers into universals 
(Sterilin) each with two drops of hepaiin (CP Pharmaceuticals). The blood 
was then carefully layered onto lymphocyte separation medium (Flow 16- 
922-49) using a pasteur pipette. For each 5 ml of blood, a conical sterile 
tube (McQuilkin) with 2.5 ml of separation medium was used. The tubes 
were centrifuged at 275 g for 30 min. Using a pasteur pipette, the platelet- 
rich plasma was aspirated and discarded, leaving the cloudy interface just 
above the cleai’ separation medium. This layer containing mononuclear 
cells was aspirated and collected in a tube with 5 ml of HBSS/MOPS. The 
volume in the tube was then made up to 1 0  ml and the cells were pelleted 
by centrifugation at 275 g for 10 min. The wash was repeated, collecting 
all of the mononuclear cells in one tube. Finally, the cells were 
resuspended at a desired concentiation in HBSS/MOPS/HSA.
3.3.2.2. Activation by culture with aCD3
The peripheral blood monocytes were cultured at a cell density of
2-3xlOVml. Aliquots of 1 ml were placed in wells of 24-well plates (Flow 
76-063-04) and 5 [A of aCD3 were added to wells to give a final 
concentration of 10 ng/ml. The cells were then cultured in a moist box at 
37^C for 24 to 48 hrs.
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3.3.2. Maintenance of Jurkat cell cultures
3.3.2.1. Cell culture conditions
Jurkat cells used in this project were a kind gift of Dr. Cushley of 
the Department of Biochemistry, University of Glasgow. The cells were 
maintained in 50 ml flasks (Flow 3013; 25 cm  ^growth area) containing 
10 ml RPMI (10% FCS) and incubated at 37°C in humid atmosphere 
containing 5% CO2 . The cultures were regularly {i.e. every 2 to 3 days) 
split by removing an aliquot of the ’old’ culture into a new 25 cm  ^tissue 
culture flask and adding RPMI (10% FCS) to the final volume of 10 ml. 
On the other hand, prior to tlie freezing or the dibutyryl cAMP treatment, 
10 ml of RPMI (10% FCS) were added to the culture one day before the 
procedure. Thus, a sufficient number of cells at an exponential phase of 
growth was obtained.
3.3.2.2. Freezing o f cells
Jurkat cells were harvested at an exponential phase of growth by 
centrifugation at 275 g for 10 min. The cells were tapped loose from the 
bottom of the centrifuge tube and the freezing medium was added to give 
a suspension with a density of 5x10^ cells per ml. The cells were 
distributed in 1 ml aliquots into sterile 1.8-ml cryovials (Gibco 3-68632A) 
and were placed in a styrofoam box. The cells were left for at least two 
days at -70°C and then were transfeiTed into a liquid nitiogen storage.
3.3.3. Counting of cells
Cells were placed on the bridge of a Neubauer Improved 
haemocytometer (Weber) and the number of cells within the 1 mm  ^ area 
was counted under the inverted microscope with phase contiast optics 
(Nikon Diaphot). To assure a consistent count, cells lying on the upper
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and left border were excluded from the count. All the cells lying within 
the area and on the right and bottom border were included in the final cell 
count. Knowing that the distance between the surface of the bridge and the 
bottom surface of the coverslip is 0 . 1  mm, the count could be expressed 
as cells/ml by multiplying the count by the factor of 10^ . In the counts 
where the number of viable cells was evaluated, the trypan blue exclusion 
test was performed. Just prior to the count, 50 /d of the cell suspension 
was mixed with 50 (A of 0.4% trypan blue (Flow 16-910-49). The cells 
were then counted as above, keeping in mind that viable cells actively 
exclude the stain. Such cells appear, under phase contrast, as phase-bright 
images. On the other hand, dead cells take up the stain resulting in a dark 
blue appearance.
3.3.4. Methods for evaluation of lymphocyte locomotion
3.3.4.1. Collagen gel invasion o f chromium^  ^ labelled cells
The cells were collected by centrifugation at 275 g for 10 min, 
saving the supernatant if necessary. The cells were then washed twice with 
a buffer {i.e. RPMI/HEPES or HBSS/MOPS). The cells were placed in 
a glass tube with four drops of neat FCS. NaCri^ (1 MBq/ml) was added 
to final activity of 0.5 MBq per 1x10® cells and the tube was placed at 
37°C in 5 %C0 2  atmosphere for 1 hr. The cells were then collected by 
centrifugation as above and were washed three times with the buffer. A 
2 0 0  fA sample was taken after each wash and was kept as a ’wash control’.
Equal volumes of 2x collagen solution and test media {i.e. 
supernatants or a buffer with or without chemotactic agents) were mixed 
and the pH was adjusted if necessary. An aliquot of 0.5 ml was placed in 
a plastic luminometer tube (Luckham LP3; 10.5 x 63.5 mm) and was 
allowed to gel for 30 min at room temperature. After this time, 50 fil of 
a buffer was added to each tube to prevent the gel surface from drying.
A 200 fil aliquot of the cell suspension at 2x10® cells/ml was added
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to each tube making certain that the surface of the gel was not disturbed by 
the pressure of the liquid. The tubes were then incubated for 2 hrs at 37°C 
in 5 % CO2  atmosphere or at 4°C for the negative controls. After this time, 
the cells on the surface of the gel were gently agitated by pipetting with a 
200 fjtX pipette and were finally removed into a small test tube. A 200 fû 
aliquot of a fresh buffer was added to the surface of the gel and was 
removed into a tube as above. This washing procedure, aimed to recover 
any residual cells, was repeated three times. The tubes with collected loose 
cells from the gel surface and the corresponding gels were finally counted 
on a Compugamma Universal Gamma Counter (LKB Wallac 1282). In 
addition the ’wash controls’ were counted to asses the efficiency of the 
washing procedure.
To determine the contribution of cell adhesion to the surface of the 
gel as a source of radioactivity retention by the gels, a short term 
collagenase heatment was used to strip a thin layer of collagen gel. Thus, 
it was possible to count the radioactivity and therefore relative number of 
cells contained on or near the surface of the gel. For this modified gel 
invasion procedure, cells were washed from the surface and collected as 
desciibed above. Then, collagenase (BDH 39058 2E) was added to each 
tube to a final activity of 12.5 U/ml and the gels were incubated at 37"C 
for various time intervals. The washing procedure described above was 
then repeated for each tube and the collagen and the cells contained in the 
collagenase digest were collected as a third fraction. The remaining gels, 
the digests and the cells washed off the gel surface were then counted on 
a gamma counter.
3.3.4.2, Collagen invasion o f lymphocytes determined by visual method
The cells were collected by centrifugation at 275 g for 10 min, 
saving the supernatant if necessary. The cells were then washed twice with 
a buffer {i.e. RPMI/HEPES or HBSS/MOPS).
Gels were prepared as described above. However, they were
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poured into a well of a 24-well tissue culture plate (Flow 76-063-04). An 
aliquot of 400 fil of a buffer was used to cover the surface of the gel to 
prevent it from drying out.
An aliquot of 600 fil containing 2x10® cells was carefully added to 
each of the gels and the plate was incubated at 37°C for 2 hrs. After this 
time the gels were examined using x400 magnification on an inverted 
microscope (Nikon Diaphot) equipped with phase contrast optics and a 
graticule (Graticules Ltd.) with a 1 mm  ^ area inled into 10 x 10 grid. 
First, tlie number of cells, lying on the surface of the gel within the grid 
area, was counted. Then, by focusing into the gel interior the number of 
cells, which entered the gel within the grid area, was determined. Four 
independent fields within each well were calculated and the mean 
percentage of cells entering the gel was calculated for each well.
3.3.4,3. Polarization assay
Previous section described in detail the early observations which 
identified the ’cell polaiization’ as an initial and crucial phase of a 
locomotory response of lymphocytes. The polaiization assay, described by 
Haston and Wilkinson (1988), takes advantage of this correlation between 
lymphocyte moiphology and the ability of the cell to locomote. 
Essentially, a 1 ml test sample containing at least 5x10® lymphocytes was 
isolated. The cells were fixed with an equal volume of 2.5% 
glutaraldehyde and were incubated for 10 min at 37°C. The cells were 
then collected by centrifugation at 500 g for 10 min and were washed twice 
with saline and finally resuspended in the remaining drop {i.e. 50 to 100 
fil) of saline. Cells fixed in such a manner could be stored at 4®C for 
several days if necessary.
To analyze the polarized cells, slide-and-coverslip preparations were 
viewed under a x40 phase contrast objective (Olympus BH-2). When 
necessary, microphotographs were taken using the attached camera system 
(Olympus PM-lOAK-1). To prepare a slide for enumeration, the sample
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contents were mixed by tapping and a 1 0  [A drop was placed on the 
coverslip. The slide was then lowered at an angle over the coverslip until 
the contents of the drop spread over the entire area of the coverslip. Six 
fields of 50 cells each were counted representing a random sample from 
different areas of the slide. Eveiy such count, where cell morphology is 
evaluated and a categoiy is assigned, is associated with standaid error 
which is defined by the binomial distribution:
S.E. = Vp(l-p) / \/(n-l), 
where p is the proportion of cells falling into a particular category and n 
is the total number of cells counted. All the polarization assay data 
presented here were calculated based on the total of 300 cells counted. 
Standard error was calculated and expressed as a function of number of 
cells counted for the full range of 0-100% (figure 1). It can be seen that 
the function has a maximum corresponding to a standard error of 3.3% for 
counts of 50%. Thus, when examining the polarization assay data, the 
reader may conseiwatively assume standard error to be 4-5%.
For the purpose of reproducible enumeration, the following 
categories of cell morphology were defined. Polarized cells included any 
cell with a defined anterior leading edge, tapered body and uropod, as well 
as any cell with a well defined constriction ring. The cells were considered 
round if they projected a circular contour with the occasional ’veil’ or 
spike on its smface. Any other cell morphologies were considered to be 
irregular.
3.3.5. FACS analysis of surface markers
3.3.5.1. Monoclonal antibodies used
The primary monoclonal antibodies used were as follows: mouse 
anti-human CD3 (UCHTl fiom Dako M 835 or SAPU S048-201; OKT3 
from Ortho 0KT3), mouse anti-human CD25 (ACT-1 from Dako M 731), 
mouse anti-human CD4 (fluorescein isothiocyanate-conjugated MT310 from
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Figure 1: Standard error for counts of cells determined by the
polarization assay. The standard error function Vp(l-p) / v'(n-l) is based 
on binomial distribution, where p  is the propoition of cells in a particular 
category and n is the total number of cells counted (set to 300).
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3.3.5.2. Staining procedure
3.3.6. Coating polystyrene beads
Dynabeads*  ^M-450 are uniform, magnétisable, polystyrene beads 
with the following physical characteristics: diameter 4.5 fim (CVm« 5%),
Dako F 766), mouse anti-human CDS (R-phycoerythi in-conjugated DK25 
from Dako R 806), mouse anti-human CD2 (RFTll from SAPU S051- 
201), anti-CD45RO (UCHLl, a gift of Prof. P.C.L. Beverley, Imperial 
Cancer Relief Fund, London, U.K.), and anti-CD45RA (2H4LDH11LDB9 
from Coulter). The secondaiy antibody used was rabbit anti-mouse 
immunoglobulin (fluorescein isothiocyanate-conjugated F(ab’)a fragment 
from Dako F 313). The working dilution of the secondary antibody (1:100 
in PBS/azide) was prepared prior to each staining with an non-conjugated 
mouse monoclonal antibody.
A staining procedure published on a Dako "Specification sheet’ 
supplied with the monoclonal antibodies was used with some modifications. 
Briefly, an aliquot of cell suspension containing about 5x10® cells was 
washed in PBS/azide and the pellet was resuspended in the remaining drop 
of about 100 jLtl. A 10 fil aliquot of the primary antibody was added to the 
resuspended cells and the tubes were incubated on ice at 4°C for at least 30 
min. The antibody was diluted in a single wash with 10 ml PBS/azide and 
the cells were pelleted by centrifugation at 275 g for 10 min. If required, 
50 fil of secondary antibody dilution was added to 50 fil of resuspended 
cells and the tubes were again incubated on ice at 4°C for at least 30 min. 
The antibody was removed as above. Finally, the cells were fixed by 
adding 50 fil 1% paraformaldehyde to 50 fil resuspended cells. After a 
minimum of 10 min on ice, additional 250 fil 0.5% paraformaldehyde was 
added and the contents were transferred into a labelled tube. The data 
acquisition and analysis was performed on FACScan (Becton Dickinson).
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3.3.7. Measurement of intracellular cAMP concentration
3.3.7.2. Cyclic AMP assay
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specific gravity 1.5 g/cm\ surface area 3-5 mVg, per g dry weight 
1.4xl0^®/g, supplied as suspension 4x10® beads/ml (30 mg/ml). The beads 
were coated with o=CD3 as follows. Fifty fil of sheep anti-mouse IgG 
(Dynal 110.01) was mixed with 50 fil aCD3 (OKT3) and placed at 4°C for 
2 hrs with occasional mixing. The beads were washed twice in 
HBSS/MOPS, resuspended in 2.0 ml, counted and the suspension was 
adjusted to 8x10^ beads/ml. In experiments, 0.5 ml of the suspension was 
added to wells containing 10® cells in a 0.5 ml volume.
For the intracellular cAMP determination, a commercial ’Cyclic 
AMP pH] assay system’ from Amersham (TRK 432) was used. All the
reagents used were those supplied with the kit.
I3,3.7.1. Cyclic AMP extraction
The method outlined in ’Simple buffer extraction’ section of the 
literature supplied was used with some modifications. Briefly, the cells 
were centrifuged at 10,000 rpm in microcentrifuge (MSB micro centaur 
from Scotlab) for 20 sec and the supernatant was pipetted off using a 
pasteur pipette. The tube was placed in a boiling waterbath and 250 fil of 
hot ’Assay buffer’ (Tris/EDTA) were added and the pelleted cells were 
resuspended by pipetting. After 10 min of incubation in boiling water the 
cells were sonicated for 30 min. Finally, the cell debris was collected by 
centrifugation for 10 min at 13,000 rpm in microcentrifuge and the 
supernatant was collected for subsequent cAMP determination.
The ’Assay protocol’ was used as published in the literature 
supplied. The charcoal blank consisted of 150 fil of ’Assay buffer’ and 50
I:
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Ill of ’Tracer’ (18 nM [8 -®H]adenosine 3’,5’-cyclic phosphate). The 
negative control consisted of 50 fil of ’Assay buffer’, 50 fil of Tracer’ and 
100 fil of ’Binding protein’ (bovine muscle cAMP-binding protein). Each 
of the tests consisted of 50 fil of the unknown sample or of a ’Standard’ 
(adenosine 3’,5’-cyclic phosphate standard) dilution, 50 fil of ’Tracer’ and 
100 fil of ’Binding protein’. Each of the tubes was mixed by vortexing for 
5 sec and placed in a ice bath. All of the tubes were then incubated at 4^C 
for at least 2 hrs. Working with 12 tubes at a time, 100 fil of ice cold 
’Charcoal’ (charcoal adsorbent resuspended in ’Assay buffer’) was added 
to all the tubes and 2 min after addition to the last tube they were 
centrifuged for 10 min at 13,000 rpm in the microcentrifuge. A 200 fil 
aliquot of the clear supernatant was removed from each tube and added to 
a scintillation vial with 10 ml of liquid scintillation cocktail (Betaplate Scint 
from Fisons). All the samples were finally counted on a beta scintillation 
counter (Minaxi Tricarb 4000 Series from Canberra Packard).
Each of the counts was corrected by subtraction of the charcoal 
blank and the ratio of Cq/C,, was calculated for each sample. Here Co is the 
corrected count for the negative contiol and Cx is a corrected count for
each of the unknowns. A standard curve was used to convert the ratio into 
the absolute cAMP concentration for each of the unknowns.
3.3.8. Measurement of changes in intracellular Ca^ + concentration
1^;
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Jurkat cells were cultured for 3 days in the presence 1 Mm 
dbcAMP. The cells were pelleted by centrifugation at 275 g and washed 
twice with HBSS without phenol red (Gibco 14065-049).
Cells were resuspended at 2x10® cells/ml in total volume of 10 ml 
of HBSS without phenol red supplemented with 1 % HSA. Aliquots of 20 
fil 2 mg/ml Fura 2-AM and 20 fil 20% pluronic F-127 were mixed and 
vortexed. An aliquot containing 20 fil of the mixture were then added to 
the cell suspension in a container wrapped in aluminum foil. The cells 
were incubated for 20 min at room temperature. Finally, the cells were
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3.3.9. Cell cycle analysis
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washed twice as above, were resuspended at 2x10® cells/ml in HBSS 
without phenol red and were left to equilibrate for 15 min at room 
temperature.
An aliquot containing 1 ml of cell suspension was placed in a 
disposable methacrylate cuvette (Whatman 6602 4008). The cuvette was 
then inserted into a temperature controlled chamber of Perkin-Elmer LS- 
50B spectrofluorimeter equipped with a magnet stirrer. After initial :
baseline was established, 10 [aI of activator (5 /tg/ml OKT3, 0.1 mg/ml 
PHA, or 100 fiM thapsigaigin) were added and the fluorescence was 
recorded at 510 nm using a dual excitation source at 340 nm and 380 nm.
The data were collected for 5 min and saved in a computer data file. At 
the end of the experiment, the instrument was calibrated for by adding 
10 [xl of calcium ionophore 100 fiM A23187 and for R^ io by adding 50 fil 
of 100 mM EGTA buffered to pH 9.4 with 1 M Tris. The data were 
imported into Microsoft Excel and intracellular Ca^  ^ levels were calculated 
according to the formula:
nlVl = x (8%/:%,:),
where R is the ratio of fluorescence intensities I3 4 0 /I3 8 0 , Ki is the effective 
dissociation constant of Fura 2-AM for calcium binding (225 at pH 7.15,
37°C), and Sp /^S  ^ is the ratio of the fluorescence intensity at blue 
wavelengths of the calcium-free and bound dye (an instrument constant).
The data for the three activators were then plotted and a polynomial 
regression curve was drawn through the data points.
A modification of method for cell cycle analysis by flow cytometry 
by Gray and Coffino (1979) was used. The cells were pelleted by 
centrifugation at 275 g for 10 min, the culture medium was decanted and 
the pellet was tapped loose. The cells were fixed by adding 70% ethanol 
and incubated at 4®C for at least 30 min. The cells were centrifuged again, 
the ethanol was decanted and replaced with 1 ml of 500 U/ml RNase. The
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cells were mixed by vortexing and incubated at 37®C for 15 min. The cells
were pelleted again by centrifugation, the RNase solution was removed and 
replaced with 1 ml of 10 /^g/ml propidium iodide. The cells were mixed 
again by vortexing, incubated at room temperature for 30 min and finally 
analyzed on FACScan (Becton Dickinson).
3.3.10. Western blot analysis of protein tyrosine-phosphorylation
3.3.10.1. Extraction o f total cell protein
;|Jurkat cells were cultured for 3 days in the presence of 1 mM 
dbcAMP. Prior to the experiment, the cells were washed twice with 
HBSS/HEPES and resuspended at 6.25x10® cells/ml and 1 ml of cell 
suspension each was placed in four test tubes.
Two aliquots were preincubated at 37°C for 30 min with 50 ng/ml 
Herbimycin A and two in the buffer only. Then, 20 fil of 5 pglml OKT3 
were added, one aliquot to the Herbimycin A preincubated cells and one 
to the buffer control. The incubation was continued for another 15 min.
The test samples were mixed with an equal volume of ice-cold 
TBS/vanadate and the cells were collected by centrifugation at 400 g for 
5 min. The cells were washed once with 10 ml of ice-cold TBS/vanadate. 
Finally, the pellet was tapped loose and 200 pi of PTK lysis buffer were 
added. The cells were lysed at 4°C for 15 min. The particulate matter 
was sedimented by centrifugation in microfuge at 13,000 rpm for 15 min 
at 4°C. The concentration of protein (440 ^g/ml) in the supernatants was 
determined using Micro BCA Protein Assay Kit (Pierce 23235).
. . . .
3.3.10.2. Polyacrylamide gel electrophoresis under denaturing conditions 
(SDS-PAGE)
Mixture for 10% polyacrylamide separating gel was prepared and 
poured between two clean glass plates (16 x 19 cm) fitted with 0.75 mm
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spacers. After the separating gel polymerized, 3% stacking gel mixture 
was prepared, poured and comb for 8 mm wells was inserted. The gel was 
stored at 4^C overnight. Prior to the use the wells were washed with three 
changes of running buffer. A 180 jul aliquot of each of the supernatants 
was mixed with 30 pi of sample buffer and boiled for 5 min. A 70 pi 
aliquot of each sample (26.4 pg of protein) was applied to the wells in 
duplicate. The apparatus was assembled, filled with the running buffer and 
the current was applied at 100 V/30 mA for about 2 hr s.
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3.3.10.3. Western blot
Following the electrophoretic separation, the apparatus was 
disassembled and the gels were submerged in transfer buffer, while the 
transfer casette (Scotchbrite pad, Whatman filter paper, gel, Trans-Blot 
nitrocellulose membrane [Bio-Rad 162-0115], filter paper, pad) was 
assembled and inserted in the chamber of the transfer appaiatus. The 
chamber was filled with transfer buffer and the current was applied at 30 
V/200 mA overnight at 4°C.
f.
3.3.10.4. Immunodetection
,.S
The transfer casettes were disassembled and the nitrocellulose 
membranes were blocked in T-TBS with 2% BSA for 1 hr at room 
temperature with gentle shaking. Subsequently the HRPO-conjugated anti- 
phosphotyrosine monoclonal antibody RC-20 was diluted in blocking buffer 
and was applied to the membranes for 1 hr as above. The membranes 
were then washed for 10 min at room temperature with low-salt T-TBS, 
then 10 min with high-salt T-TBS (to decrease non-specific binding) and
finally for 10 min with low-salt T-TBS again. The specific bands were 
visualized using the ECL immunodetection kit (Amersham RPN 2105) and 
Kodak X-OMAT AR film (Sigma F-5513).
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3.3.11.3. Western blot
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3.3.11. Western blot analysis of PKC isoform expression
3.3.11.1. Extraction o f total cell protein
Jurkat cells were cultured for 3 days in the presence or absence of 
1 mM dbcAMP. One batch of Jurkat with 1 mM dbcAMP was treated 
with 10’ M PMA throughout the culture. The cells were washed twice 
with HBSS/HEPES.
The pellet was tapped loose and 750 p\ of lysis buffer were added.
The cells were lysed at 4°C for 15 min. The particulate matter was 
sedimented by centrifugation in microfuge at 13,000 rpm for 15 min at 
4°C. The concentration of protein in the supernatants (2.3, 2.2, and 2.2 
mg/ml for control, dbcAMP, and dbcAMP/PMA cells respectively) was 
determined using Micro BCA Protein Assay Kit (Pierce 23235). Several 
aliquots of 14 pi each of the samples were mixed with 6 pi of sample 
buffer and stored at -20°C for future use.
3.3.11.2. Polyacrylamide gel electrophoresis under denaturing conditions 
(SDS-PAGE)
■
■V.
Mixture of 7.5% polyacrylamide separating gel was prepaied and 
poured between two clean glass plates (8 x 10 cm) fitted with 0.75 mm 
spacers. After the separating gel polymerized, 3% stacking gel was 
prepared, poured and comb for 5 mm wells was inserted. The Mini-Gel 
apparatus was assembled, the tank was filled with running buffer and 20 
pi of each sample were applied to the wells. The current was applied at 
100 V/30 mA for about 45 rain.
Following the electrophoretic separation, the apparatus was 
disassembled and the gels were submerged in transfer buffer, while the
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transfer casette (Scotchbrite pad, Whatman filter paper, gel, Trans-Blot 
nitrocellulose membrane [Bio-Rad 162-0115], filter paper, pad) was 
assembled and inserted in the chamber of the transfer apparatus. An 
icepack was inserted into the tank and the chamber was filled with transfer 
buffer. Current was applied at 100 V/400 mA for 2 hrs at 4°C.
3.3.11.4, Immunodetection
The transfer casettes were disassembled and the nitrocellulose 
membranes were blocked in T-TBS with 5 % non-fat dry milk for 1 hr at
3.3.12. Measurements of PKC activity
room temperature with gentle shaking. Subsequently, monoclonal 
antibodies specific for the PKC isoforms (Transduction Labs S85080) were 
diluted (1:1000 for a , 15, y, 6; 1:500 for e, i, À, p, C; and 1:250 for 0) 
in blocking buffer and were applied to the membranes as 5 ml aliquots 
inside a sealed plastic bag. The membranes were incubated for 1 hr as 
above. The membranes were then washed in three 5 min changes of T- 
TBS. HRPO-conjugated sheep anti-mouse IgG monoclonal antibody 
(SAPU S081-201) was diluted 1:1000 in blocking buffer and was applied 
to the membranes for 1 hi as above. Finally, the membranes were washed 
in six 5 min changes of T-TBS and the specific bands were visualized using 
the ECL immunodetection kit (Amersham RPN 2105) and Kodak X-OMAT 
AR film (Sigma F-5513).
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Jurkat cells were cultured for 3 days in the presence 1 mM 
dbcAMP. The cells were washed twice with HBSS/HEPES and 
resuspended at 12-16x10® cells/ml.
Cells were preincubated at 37°C for 30 min. Then, 10 pi of the 
activators (5 pg/mi OKT3, 0.1 mg/ml PHA, 100 pM thapsigargin, or Iff :.:a
®M PMA) were added. The incubation was then continued for various time
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periods. At the end of each time period an aliquot of 250 pi was 
withdrawn into a tube with 250 pi of ice-cold protease inhibitor solution.
At the end of the experiment, the cells were collected by centrifugation at 
300 g for 15 min at 4°C. The cells were washed once with the ice-cold 
protease inhibitor solution and finally resuspended in 200 pi of the 
solution. The cells were then disrupted by 3 series of 6 bursts using 
sonicator set at 20, cooling the sample on ice after each set. The probe 
was cooled in ice after each sample was processed. The particular fraction 
was collected by centrifugation at 23,000 g for 1 hi at 4°C. The resulting 
supernatants was transferred into a second set of tubes and the pellets were 
resuspended in 50 pi of the protease inhibitor solution by rapid pipetting.
The PKC activity in each of the fractions was determined using a kit
(Amersham RPN77). The incorporation oflabelled phosphorus supplied 
by pTjATP (Amersham PB 168) was measured using a scintillation counter 
(Beckman LS 6500) and scintillation fluid Ultima-FLO AF (Packard 
6013589). Finally, the counts were interpreted as percent increase in the 
membrane-associated activity compared to the unstimulated control.
Î
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4. THE GROWTH AND MORPHOLOGY OF JURKAT CELLS FROM 
ROTTTINE CELL CULTURE
4.1. BACKGROUND
The acquisition of locomotor capacity is a physiologically essential 
event which determines the ability of a lymphocyte to seek the sites of 
inflammation. The locomotory capacity is acquired during the process of 
antigen-stimulated lymphocyte activation (Wilkinson, 1986). The 
investigations into signalling pathways, utilizing blood lymphocytes, 
present difficulties with the interpretation of the data mostly due to the 
heterogeneity of the lymphocyte populations. In addition, the presence of 
various other cell types adds to the complexity of the signalling systems. 
Indeed, in an attempt to manipulate the lymphocyte population, these 
contaminating cell types may themselves be affected resulting in the 
secretion of various factors and in the initiation of cell-to-cell interactions 
whose impact would further obscure the investigations.
In an attempt to simplify the experimental system, a leukaemic T 
cell line Jurkat was selected. The additional advantage of this system is the 
vast information on signal transduction derived from experiments with this 
leukaemic T cell line.
4.2. EXPERIMENTAL
4.2.1. Growth characteristics of normal Jurkat cells
The Jurkat cells were maintained at 37°C in a 5% CO2  atmosphere. 
The growth medium consisted of RPMI-1640 medium containing sodium 
bicarbonate, supplemented with 100 mM HEPES buffer, 2 mM L- 
glutamine, 100 U penicillin, 100 pg streptomycin, and 10% ECS. The 
cells displayed characteristic growth kinetics typical of actively dividing 
cell culture populations. Three cycles of two cultures grown in parallel are
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4.2.2. Morphology of normal Jurkat cells
4.3. SUMMARY
sS
shown in figure 2.
In general, a two-day Tag’ phase was followed by the Tog’ phase 
with doubling time of about 16 hours and finally the ’stationary’ phase.
In normal culture, the cells were never allowed to reach this phase. To 
ensure a well growing population, the cells were maintained at a cell 
density between 5 and 15x10* cells per ml. Cells sub-cultured at the log 
phase resumed growth without any noticeable decrease in growth rate.
I
The cultured Jurkat cells in culture, observed under phase contrast, 
appeared mostly as clusters of round cells. When filmed under phase 
contrast using a time-lapse video camera, several polarized cells could be 
observed as they performed shape changes usually associated with 
locomotion. However, the inability of Jurkat cells to adhere to the plastic 
culture dish made an actual translocation of the cell difficult. At times, the 
cells were able to push off the surrounding cells and cell clusters.
Figure 3 shows cells removed from routine culture, washed, 
incubated at 37°C for 30 min and analyzed by the polarization assay. 
Usually, several shapes resembling typical locomotory cells were observed 
in glutaraldehyde-fixed cell samples from routine Jurkat cell cultures. 
However, in all the tests performed, about 70% of the cells were round.
■3;
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In conclusion, normal Jurkat cells were shown to have the capability 
to locomote, or at least to become polarized. However, only a small 
proportion of the population displays this morphology at any given time. 
What are the conditions which would result in the acquisition of the 
locomotory morphology in the majority of constitutively dividing Jurkat 
cells?
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Figure 2: Growth curves of Jurkat cell from routine culture. The cells 
were maintained in RPMI 1640 medium with sodium bicaibonate 
supplemented with 100 mM HEPES buffer, 2 mM L-glutamine, 100 U 
penicillin, 100 /tg streptomycin, and 10% PCS. The cultures were kept at 
37°C in an incubator with a moist atmosphere containing 5% CO2 . The 
cells were subcultured on day 1,7,  and 13, The viable cells capable of 
exclusion of 0.4% trypan blue stain were counted using a haemocytometer. 
The symbols represent two independent cultures examined in parallel.
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Figure 3: Morphology of Jurkat cells from routine culture. The cells 
were maintained in RPMI 1640 medium with sodium bicarbonate 
supplemented with 100 mM HEPES buffer, 2 mM L-glutamine, 100 U 
penicillin, 100 fig streptomycin, and 10% FCS. The cultures were kept at 
37®C in an incubator with a moist atmosphere containing 5% CO2 . A 
sample was withdrawn from the culture, was washed at room temperature 
with HBSS/MOPS, and then incubated in 1 ml of HBSS/HSA at 37°C for 
30 min. The cells were finally fixed with glutaraldehyde and photographed 
under phase contrast (x400).
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5. EFFECT OF cAMP ON GROWTH AND LOCOMOTOR ACTIVITY 
OF JURKAT CELLS IN LONG-TERM CULTURE
5.1. BACKGROUND
Only very few Jurkat cells in routine culture resemble motile 
lymphocytes. It was suggested that only cells at Gq/Gj phase of the 
reproductive cycle have the ability to polarize and to become motile 
(Wilkinson, 1986). It is conceivable that only a minority of actively 
dividing Jurkat cells would be passing through Go/Gi. The ability to slow 
down or to anest the dividing cells at this phase of the cycle should 
'synchronize’ the cell cultures and subsequently result in an increased 
proportion of polarized cells.
The conüol of mammalian cell proliferation is a very complex 
process affected by numerous environmental signals such as hormones, 
growth and differentiation factors and extracellular matrix. The 
development of cell lines which are able to grow, to become quiescent, or 
to differentiate in response to pure hormones and growth factors in 
chemically defined media has facilitated the studies. An actively growing 
cell line, such as Jurkat, maintained in the absence of growth factors
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therefore lacks certain intracellular signals responsible for the cell growth 
inhibition. There is much evidence that cAMP and agents which cause an
increase in intracellular cAMP levels are potent growth inhibitors for 
lymphocytes, smooth muscle cells and many types of fibroblasts 
(Pouysségur et al. , 1990). The effect of dbcAMP resulting in a block at 
the Gi phase of cell cycle has been reported by Coffino and Gray (1978).
In a subsequent study the effectiveness of the physiological second 
messenger, cAMP, in arresting Jurkat T lymphocytes in Gi and inducing 
the polarization, was investigated.
Î
5.1.2. PKA stincture
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5.1.1. PKA is the intracellular target of cAMP
The second messenger, cAMP, exerts nearly all its effects by 
activating PKA which is ubiquitous and phospliorylates many intracellular 
proteins (Cohen, 1992). The resulting intracellular physiologic effects of 
cAMP are mediated by the phosphorylation of protein hydroxy-amino acid 
residues by the PKA catalytic subunits while the cAMP-regulatory subunit 
complex was shown to enter the nucleus, bind to DNA and alter gene 
transcription (Krebs and Beavo, 1979). The phosphorylation patterns 
induced by cAMP are distinct from those induced by mitogen, antireceptor 
antibodies, PMA or Ca^  ^ ionophore (Dasch and Stavitski, 1985). Several 
PKA-specific protein substrates have been identified in human T cells 
(Kammer et a l , 1988), however the physiological substrates of PKA in 
lymphocytes remain mostly unknown (Perlmutter et a l ,  1993).
Î
The intracellular receptors for cAMP are two isozymes of cAMP- 
dependent protein kinase that have identical 40-kDa catalytic subunits but 
differ in their regulatoiy subunits (Krebs and Beavo, 1979; Flockhart and 
Corbin, 1982). These isozymes, designated type I and type II PKA, 
comprise 48-kDa Ri and 54-kDa R„ regulatory subunits. Both PKA 
isozymes are activated by binding of cAMP to the regulatory subunits 
resulting in dissociation of the holoenzyme into a dimer of cAMP-bound 
regulatory subunits and a couple of active catalytic subunits. The two PKA 
isozymes are distinguished on the basis of the different properties of Ri and 
R„. In resting lymphocytes, type I PKA is localized in the cytoplasm; 
type II associates with the plasma membrane (Kammer, 1988) and its 
activity did not seem to be translocated to the membrane upon lymphocyte 
activation (Farrar and Anderson, 1985).
1
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5.1.3. Inhibition of lymphocyte activation
The pretreatment of lymphocytes with PGEi, a cAMP-inducing 
ligand, inhibited Con A-induced phosphorylation (Chaplin et al., 1980), 
contradicting some reports which suggested cAMP to have a role in 
mitogen-induced T cell activation (Byus et al., 1977). Indeed, the increase 
of intracellular cAMP through physiological or pharmacological 
interference results in general T cell activation inhibition (Bourne et al. ,
1975).
The activity of cAMP was shown to interfere with several events 
associated with TcR/CD3-mediated T cell activation such as 
phosphatidylinositol hydrolysis (Klausner et al., 1987; Patel et al., 1987;
Muthusamy et nA, 1991; Bismuth et a l ,  1988; Lerner et a l ,  1988),
CD3y serine and CD3C tyrosine phosphorylation (Klausner et a l ,  1987;
,1, .Patel et a l ,  1987; O’Shea et a l ,  1987), lymphokine production and 
secretion (Rappaport and Dodge, 1982; Baker et a l ,  1981; Chouaib and 
Fradelizi, 1982) and proliferation (Isakov and Altman, 1985; Kim et a l ,
1988; Goodwyn et a l , 1977). The phosphatidylinositol metabolism was 
suggested to be uncoupled by phosphorylation and inhibition of PLCyi 
(Park et a l,  1992; Kim et a l ,  1989). In addition, the inhibition of 
[Ca^ j^i increase (Gray et a l ,  1988) may result from PKA-mediated 
phosphorylation of Ca^  ^ channels (Curtis and Catterall, 1985) or IP3  
receptor (Supattapone et a l ,  1988a). However, increased cAMP was 
found to inhibit also activation induced by Ca^  ^ ionophore and phorbol 
esters (Chouaib et a l , 1987; Isakov and Altman, 1985; Takayama et al.,
1988) which bypass the generation of phosphatidyUnositol-derived second 
messengers. Indeed, evidence suggests that cAMP interferes in various 
ways with ’downstream’ activation events. The IL-2-induced transcription 
resulting in activation-associated mRNA such as IL-2, and c-myc is 
inhibited while the accumulation of IL-2r, c-fos and c-myb mRNA is 
enhanced; however, the translation of these activation products is 
invariably reduced (Kammer, 1988). Thus, an effect of cAMP on cell
I
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12cycle control mechanisms may be expected. 
5.1.4. Inhibition of cell cycle progression
JT
Activation of B lymphocytes leads to proliferation, differentiation 
and finally to antibody production. In order to proceed from Gi to S phase 
of the cell cycle a decrease in intracellular cAMP is necessary in the late 
Gi (Jegasothy et a l ,  1978; Wang et al. , 1978). Resting B cells activated 
in the presence of forskolin, an activator of adenylate cyclase, increased in 
size and RNA content (Gq to GJ but did not synthesize DNA (Gj to S) in 
response to B cell growth factor (Muraguchi et a l ,  1984). Similarly, 
forskolin and a cAMP analogue blocked cell cycle progression from Gi to 
S phase in normal B lymphocytes and in a neoplastic B cell line (Blomhoff 
et al. , 1987). In T cells, cAMP interfered with IL-2-induced proliferation 
at the early Gj phase (Isakov and Altman, 1985; Beckner and Farrar,
1986; Johnson et al. , 1988).
Studies done with PKA mutants (Coffino et al. , 1975a; Bourne et 
al., 1975; Insel et a l ,  1975) and ’deathless’ mutants (Lemaire and 
Coffino, 1977) of S49 mouse T cell lymphoma revealed that one 
consequence of PKA activation by cAMP is inhibition of cell growth 
(Coffino et a l ,  1975b). The DNA content and size of ’deathless’ S49 
treated with dbcAMP was examined by flow cytometry (Coffino and Gray, %1978). The data revealed that only about 30% of the S49 exponentially 
growing population is in Gj and comprises the smallest cells. The 
treatment with dbcAMP induced progressive depletion first of the S phase 
cells and subsequently of the G^/M cells. However, even under the most 
efficient conditions, the G, population reached maximum of about 90%.
Thus, it was suggested that the cAMP block is not absolute but rather 
results in a reduced rate of progression thr ough Gj.
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5.2. EXPERIMENTAL
5.2.1. Growth and morphology of .Turkat cells cultured in the presence of 
dhcAMP
5.2.L I . Growth o f dhcAMP-cultured Jurkat cells
The typical gr owth curwe of a cell culture of Jurkat supplemented 
with 1 mM dbcAMP is shown in figure 4. The cells were sub-cultured 
from a log-phase population on day 1. The rate of growth of the cells 
decreased slightly just one day after the introduction of dbcAMP as 
compared to a normal logarithmic growth seen between day 0 and 1. The 
growth was almost completely abrogated after 3 days of the dbcAMP 
treatment. The viability of cells maintained at such a culture usually 
started to deteriorate after 7 to 8 days probably due to the exhaustion of 
nutrients in the culture medium.
5.2.1.2. Size o f the dbcAMP-treated Jurkat cells
The Jurkat cells cultured with 1 mM dbcAMP for 3 days, washed 
at room temperature, glutaraldehyde fixed and observed under phase 
contrast (x400) appeared to be smaller and more phase-bright than those 
obtained from routine cultures (figure 5). The appearance of the dbcAMP- 
cultured cells was found to resemble the PEL observed under similar 
conditions.
This apparent decrease in size was confirmed by a decrease in 
forward scatter as detected by FACScan and presented as a dot plot (figure 
6a) and a histogram (figme 6b). The FACScan results show that the ESC 
of the normal population shifted toward the range consistent with a smaller 
size following the 3 day culture with 1 mM dbcAMP. In addition to this 
shift, the size of the cells was more uniform as indicated by the narrower 
peak. The granularity of the dbcAMP cultured cells remained constant as
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Figure 4: Growth curve of Jurkat cells in a regular culture medium 
supplemented with dbcAMP. The Jurkat cells from a routine culture, in 
log phase of growth, were subcultured on day 1 and dbcAMP was added 
to final concentration of ImM. The viable cells capable of exclusion of 
0.4% trypan blue stain were counted daily using a haemocytometer.
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Figure 5: Size of Jurkat cells from routine culture (A) or following a 
culture in the presence of dbcAMP (B). Samples were removed from a 
routine culture and from a 3-day culture containing 1 mM dbcAMP and 
each sample was washed at room temperature with HBSS/MOPS. The 
cells were finally fixed with glutaraldehyde and photographed under phase 
contrast (x400).
A.
B.
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Figure 6a: Size of Jurkat cells from a routine culture (right panel) or 
following a culture in the presence of dbcAMP (left panel). Samples were 
removed from a routine culture and from a 3-day culture containing 1 mM 
dbcAMP and each sample was washed at room temperature with PBS. The 
cells were finally fixed with paraformaldehyde and examined using 
FACScan. The cell size is associated with the magnitude of the FSC while 
the SSC reflects the granularity of the cells.
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Figure 6b: Comparison of the cell size (left panel) and granularity (right 
panel) for Jurkat cells from a routine culture (grey opened curve) or 
following a culture in the presence of dbcAMP (filled black curve). The 
histograms were derived ft om data shown in figure 5a.
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observed from the unchanged SSC.
5.2. i. 3, The morphology o f dbcAMP-treated Jurkat cells
Microscopic observation of Jurkat cells cultured with 1 mM 
dbcAMP and kept at 37°C revealed that a large proportion of these cells 
displayed polarized or irregular shape (figure 7-A and 7-C). For the sake 
of consistent identification three categories were defined as follows:
Polarized cells with anterior leading edge, tapered body and uropod or 
with a visible constriction ring (figure 7-A); Round cells with circular 
contour with possible ’veiF or spike present (figure 7-B); and irregular 
cells that do not conform to either of the other two categories (figure 7-C).
Typical results from two experiments aimed at a quantitation of the 
extent of polarization in dbcAMP-cultured Jurkat cells are shown in table 
1. The polar ization of such cells was reversed following the wash at room 
temperature. However, full repolarization was achieved upon reincubation 
of the cells at 37°C for 30 min. The presence of FCS in the repolarization 
medium did not increase the proportion of repolarized cells. In contrast,
FCS induces an increase in polarized morphology in PBL (Wilkinson,
1986). Thus, the process of polarization in dbcAMP-cultured Jurkat cells 
appears to be both temperature dependent and constitutive. The
■■■temperature dependence, and cooling of the sample prior to the 
glutaraldehyde treatment, may explain the discrepancy in experiment 1 
between the polarization obtained directly from the culture and after the 
reincubation.
The need for incubation at a physiological temperature for the 
polarization and the constitutive nature of this process in dbcAMP-cultured 
Jurkat cells has been demonstrated. Furthermore, it was shown that the 
wash prior to the reincubation will not affect the final extent of 
polarization. Such wash may increase the reproducibility of the 
repolarization results as the various factors and toxins, that may accumulate 
in the medium during the prolonged culture, are removed.
I90
i:f
:Table 1 : Morphology of dbcAMP-cultured cells treated repolarized under 
various conditions. The cells were washed twice at room temperature in 
HBSS/MOPS, resuspended in 1 ml HBSS/MOPS (with or without 10% 
FCS) and then were incubated at 37°C in waterbath for 30 min. The cell 
moiphology was recorded as polarized (Pol), irregular (In) or round 
(Rnd).
Test
conditions
Experiment 1 Experiment 2
Pol Irr Rnd Pol Irr Rnd
Cells from 
culture
37.3 19.0 43.7 58.0 27.0 15.0
Cells after 
wash
2.3 3.7 94.0 2.0 2.0 96.0
Incubation 
- 10% FCS
70.0 22.0 8.0 55.0 24.3 20.3
Incubation 
+ 10% FCS
69,3 21.3 9.4 ND ND ND
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Figure 7: Three categories defining Jurkat cell morphology. Jurkat cells 
were cultured for 3 days in the presence of 1 mM dbcAMP, and then were 
washed in HBSS/MOPS and repolarized at 37°C for 30 min. Finally, the 
cells were fixed with glutaraldehyde and photographed under phase contrast 
(x400). Polarized cells (A) with anterior leading edge, tapered body and 
uropod (left) or with a visible constriction ring (right), round cells (B) with 
a smooth circular contour (left) including a possible ’veil’ (upper right) or 
spike (B) and irregular cells (C) that do not conform to either of the other 
two categories. The latter two categories are contrasted with a polarized 
cell.
B.
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5.2. L 4, The cell-cycle distribution o f dbcAMP-treated Jurkat cells
The distribution of Jurkat cells in the cell cycle was determined by 
the FACS analysis of propidium iodide stained DNA content of individual 
cells. The cells in the Gq/G i phase contain only one set of chromosomes 
(1 arbitrary DNA unit). The cells in S phase are actively synthesizing 
DNA in preparation for the division and thus contain a variable amount of 
DNA. Finally, the cells in M/Gj phase are just about to undergo the 
mitotic division. These cells therefore contain two complete sets of 
chromosomes (2 arbitrary DNA units).
The distribution as determined by FACS is shown in figure 8, 
where the intensity of propidium iodide staining on the ’FL-3’ axis of the 
dot-plot is drawn against the relative cell size represented by the FSC. The 
right panel shows the distribution of cells taken from a routine culture 
while the left one represents Jurkat cells cultured for 3 days with 1 mM 
dbcAMP. The vertical clusters at 200 and 400 ’FL-3’ units indicate cells 
at Gq/G i and M/G^ phases respectively.
Compared to the control culture, the dbcAMP-cultured Jurkat cells 
display a noticeable increase in numbers of cells registering within the 
Go/Gi cluster. In addition, the Go/Gi cells compared to M/Gz cells display 
a shift towards lower FSC values consistent with smaller cell size. This 
observation is consistent not only with the arrest of division in dbcAMP- 
cultured cells but also with the apparent decrease in the size of these cells twhich was observed eailier.
Histograms describing the distribution of propidium iodide emission 
(figure 8-B) were used to determine the proportions of cells present at each 
of the cell cycle phases (table 2). The fraction of cells in Gq/Gi phase 
increased from about 50% to 80% following the dbcAMP treatment.
;
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Figure 8: Cell-cycle distribution of Jurkat cells cultured witli (left panel) 
or without 1 mM dbcAMP (right panel). The DNA content of the cells 
was stained with propidium iodide, the fluorescence emission was detected 
by FACS and displayed as a dot-plot (A) as a histogram (B).
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Table 2: Cell cycle distribution of Jurkat cells cultured with or without 
cAMP. The percentages shown were estimated based on DNA staining 
with propidium iodide presented in figure 8.
Cell-cycle
phase
% Total cells
-dbcAMP + dbcAMP
Go/Gi 49.5 77.9
S 22.5 10.4
M/Gz 28.0 11.7
95
'I
%
j
a%
g
I
Î
5.2.2. The characteristics of the long-term effect of dbcAMP on Juikat
cells
5.2.2. L Time-course o f acquisition o f polarized morphology by Jurkat 
cells cultured in the presence o f dbcAMP
Figure 9 shows the increase in the polarized cell population during 
the culture with 1 mM dbcAMP. It can be seen that the population of the 
round cells reached minimum after just two days of culture. The 
proportion of polarized cells increased most mpidly until day three and 
only slightly afterwards. The growth of the cells was arrested, as expected 
after two to three days of culture in the presence of dbcAMP.
5.2.2.2. Dose-dependent effect on Jurkat cell division o f dbcAMP used in 
a long-term culture
The effect of various doses of dbcAMP on the division and 
acquisition of the polarized morphology by Jurkat cells was followed over 
a seven-day period (figure 10). The growth-curve in the absence of 
dbcAMP is described by the dotted line for the first three days. After tliis 
time, the viability of these cells decreased due to the exhaustion of the 
culture medium. The term ’cell growth’ used below stands for the increase 
in the number of cells in a culture rather than for an increase in the cell 
size.
The rate of growth of the total cell population was lower in the 
presence of dbcAMP as compared to the untreated control culture. At 
dbcAMP concentrations between 0.25 mM and 0.50 mM, the cell numbers 
increased linearly as compared to the logarithmic increase observed in the 
untreated cultures. The slope decreased slightly at the higher dbcAMP 
concentration. Thus, the cell culture supplemented with 0.50 mM 
dbcAMP, compared to one with 0.25 mM dbcAMP, required an additional 
48 hrs to arrive at the stationary phase. The addition of 0.75 mM and
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Figure 9: Tirae-course of effect of dbcAMP, used in long-term culture, 
on the growth (dotted line) and polaiization (solid line) of Jurkat cells. 
Jurkat cells were incubated with 1 mM dbcAMP at 37®C and samples were 
taken daily to determine the number of viable cells and their morphology. 
The viable cells capable of exclusion of 0.4% trypan blue stain were 
counted using a haemocytometer. The cells were washed, resuspended, 
repolarized at for 30 rain and finally fixed with glutaraldehyde. The 
morphology was examined and quantified under phase contrast. Round 
cells (circle), inegular cell (square) and polarized cells (triangles).
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Figure 10: Dose-dependent action of dbcAMP on growth and polarization 
of Jurkat cells. The cells were incubated with various doses of dbcAMP 
at 37°C and samples were taken daily to determine the number of viable 
cells and their morphology. The viable cells capable of exclusion of 0.4% 
trypan blue stain were counted using a haemocytometer. The cells were 
washed, resuspended and repolarized at 37°C for 30 min. Finally the cells 
were fixed with glutaraldehyde and the morphology was examined and 
quantified under phase contrast. The percentage of polarized cells was 
converted to an absolute number using the total cell count. Cell growth of 
a culture lacking dbcAMP is shown by a dotted line. Total number of cells 
(circles) and number of polarized cells (triangles).
■f
Experiment 1
3 5 0  -n
3 0 0  -
2 5 0  -
2 0 0  -
'^o
E 150 -
(/) 100 -
50 -
0 -
Total
Polarized
0 .2 5  mM rn—I—I I' I—rn 
0 1 2 3 4 5 6 7
t /  0 .5 0  mM
T  i l  I I  I  I I
0  1 2 3 4  5 6 7
Time (d ays)
.V I 00 mM
Y _ t - | - , . -  ,  "  I
0 1 2  5  4 5 6 7
i
Î
«in
.1
1
31
Experiment 2
3 5 0  -|
3 0 0  -
2 5 0  -
2 0 0  -
E
150  -
Ü 100  -
5 0  -
0 -
0 .2 5  mM 0 .7 5  mM0 .5 0  mM
0 1 2  3 4 5 6 7
“T-|
0 1 2 3 4 5 6 7
r I I r I I -| "I
0 1 2  3 4  5 6 7
Time (days)
1 .0 0  mM 
r"'r~n—r r 'T - i  
0  1 2  3 4 5 6 7
98
"îT
, . T ; :
1.00 mM dbcAMP resulted in progressive decrease in the cell-growth rate. 
The maximum cell growth inhibition in the presence of these dbcAMP 
concentrations occurred after 48 his of treatment. However, after this time 
the 0.75 mM dose allowed for a sustained slow increase in cell density, 
while the 1.00 mM dose resulted in a complete cell-growth inhibition. 
Overall, the observed inhibition of the Jurkat cell-growth, in the presence 
of dbcAMP, was dose-dependent.
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5.2.2.3. Dose-dependent effect on Jurkat cell morphology o f dbcAMP used 
in a long-term culture
The acquisition of polaiized morphology did not follow a simple 
pattern as did the cell-growth inhibition. This observation reflects the fact 
that the process of acquisition of the polarized morphology is either 
connected with or at least dependent on the decrease in the rate of division 
of the cells.
The results for 0.25 mM dbcAMP in experiment 1 and 2 gave an 
interesting insight into this problem. The treatment with 0.25 mM 
dbcAMP results only in a relatively small change in the logarithmic giowth 
rate, resulting, at best, in a steep lineai' rate. In experiment 2 the number 
of polarized cells in such a culture increased noticeably, however the rate 
of acquisition of the polaiized morphology decreased steadily. Experiment 
1 was initiated at a lower cell density of 3.8x10^ cell/ml which resulted in 
a two-day lag phase of slower cell division. This non-dbcAMP-induced 
decrease in the rate of cell-giowth synergized with the low dbcAMP 
concentration to produce an increase in the numbers of polarized cells 
comparable with 0.50 mM dbcAMP. After the cell reestablished in the
near-logaiithmic cell-growth the number of polarized cells levelled off 
indicating that actively dividing cells were unable to acquire the polarized 
morphology.
A concentration of dbcAMP of 0.50 mM and higher was necessaiy 
for the numbers of polarized cells to increase in a manner that paralleled
1 0 0
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the growth of total cell population. At these concentrations, the differential 
effect of dbcAMP on the cell giowth and on the acquisition of polarized 
morphology resulted in a dose-dependent increase in the proportion of the 
polarized cells witliin the total cell population.
-5.2.2.4. Efficiency o f the cAMP treatment in the acquisition oflocomotory 
morphology
-The maximum increase in the propoition of polarized cells was 
observed within the first 48 his of culture with dbcAMP. After this time, 
the proportion increased only slightly or remained constant. Interestingly, 
even in cell cultures whose growth had been arrested for several days, the 
proportion of polarized cells always remained relatively constant between 
50% and 70%, depending on the experiment. This observed incomplete 
change to polarized morphology may be explained in three ways; (1) a 
proportion of cells in routine culture was resistant to dbcAMP-induced
shape change so that their ability to divide was impaired while the systems
needed for the locomotory morphology remained inactive; (2) the cAMP- 
induced block is not absolute but rather decreases the rate of progiession 
through Gi allowing a proportion of the population to enter the S phase 
(Coffino and Gray, 1978); and finally (3) a steady state was established 
where the cells exhibited a reversible conversion between the polarized and 
round morphology.
Although the contribution of (2) is possible, (3) appears to be most 
likely based on a result obtained using microtubule depolymerizing agents 
nocodazole and colchicine (figure 11). The polarized morphology was
observed in 50% to 60% of normal Jurkat cells treated with these non­
specific agents compared to 50% to 70% obtained following culture with 
dbcAMP. It does not seem probable that a homogeneous population of 
Jurkat cells would vaiy in their sensitivity to microtubule depolymerization. 
Thus, the apparent partial effect may be explained by a steady state 
involving the polarized and round morphology. In parallel with the results
Figure 11: Effect of lO^M colchicine and lO^M nocodazole on the
morphology of normal Jurkat cells. The cells were washed and exposed 
to the drugs for 1 hi at 37°C. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast.
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obtained with dbcAMP-cuitured Jurkat cells, Wilkinson (1986) showed that 
under 50% of lymphocytes direct from blood can be induced to assume the 
locomotory morphology following a treatment with lO^M colchicine 
compared to under 5% seen in untreated blood cells. A similar observation 
was made by Keller et al. (1984) who induced polarization in over 80% of 
neutrophils. Also, the motility of chronic lymphocytic leukaemia 
lymphocytes from patients with high white blood cell counts could be 
induced by colchicine although these cells responded very poorly to PCS 
or PMA in a short term assay (Wilkinson et at. , 1988). Thus, the integrity 
of the microtubule network appeals to stabilize the round lymphocyte 
morphology although the systems involved in the motility may be 
permanently active.
Based on the above preliminary experiments, it was judged that the 
most reproducible system, with respect to the proportion of polarized cells, 
would be obtained following a complete arrest of the cell culture growth. 
This was achieved with the minimum of 1.00 mM dbcAMP. At this 
concentration the polarized cell population reached equilibrium within 3 
days of dbcAMP treatment. In subsequent sections, such cells will be 
referred to as ’dbcAMP-cultured Jurkat cells’.
i
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5.2,2.5. Locomotory capacity o f dbcAMP-cultured Jurkat cells
■t:
The correlation between the extent of polarization and the locomotor 
capacity of PEL has been established (Wilkinson, 1986). To ensure that 
polarization reflects an increase in the locomotion of Jurkat cells, a series
of collagen invasion experiments was performed. A new method using 
chromium-labelled cells was used. The percentage of radioactivity retained 
by the gel correlated with the percentage of cells which had entered the 
collagen gels. In a series of thiee experiments it was determined that on 
average 47.1% (±  2.2%) of dbc AMP-cultured Jurkat cells invaded the gels 
as compared to 4.4% (±  1.8%) of cells rounded up at 4°C. When these 
cells were examined by the polarization assay, 59.1 % (+  2.2%) cells were
polarized and 24.2% (±  3.0%) were irregular. The polarization assay 
offers a ’snapshot’ of motile activity of the constitutively motile dbcAMP- 
cultured Jurkat cells and therefore a proportion of cells with the potential 
to enter the collagen gel matiix. Although many of these randomly motile 
cells would do so, a small proportion would be expected to exit or remain 
on the surface. Thus, the slight discrepancy between the gel invasion and 
the polarization assay.
Jurkat cells from regular culture were examined in the same way. 
Interestingly, 31.5% (+  3.8%) of these cells invaded gels although only 
9.1% (±  3.9%) were found to have assumed a polarized and 11.0% (±  
2.4%) an irregular morphology in the polarization assay. A possible 
explanation implicated a non-specifrc adhesion to the surface of the 
collagen gel. Such an effect surely would be noticeable also at 4°C. 
However, at this temperature, only 3.3% (±  1.0%) of normal Jurkat cells 
were retained by the collagen gels. In a related explanation, a ’veil’ or a 
membrane protrusion extended by the non polar cells would attach them to 
the collagen matrix. Indeed, these stractures are dependent on the fluidity 
of the plasma membrane and thus would be present only at the 
physiological temperature. To examine this possibility, the top layer of 
collagen was digested off using collagenase. In two independent 
experiments, 13.0% (±  4.7%) of the dbcAMP-cuItured and 19.6% (±
0.9%) of normal Jurkats were removed in a 5-min collagenase treatment. 
This observation suggests that the normal Jurkat cells, retained by the 
collagen gels, have in fact entered them. The reason for the discrepancy 
between the polarization assay and the gel invasion of the normal Jurkat 
cells has not been further investigated. However, it is possible (and time- 
lapse video recordings support this suggestion) that when the temperature 
of the medium is increased from room temperature to 37°C, these cells 
undergo a short burst of locomotor activity, enter the gel and then round 
up. Although many cells may be able to do so over a period of time, only 
very few will appear to be active at any given time as reflected by a 
polarization assay.
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5.2.2.6. Surface-marker expression in dbcAMP-cultured Jurkat cells
1 0 4
The phenotype of Jurkat cells cultured with 1 mM dbcAMP for 3
■4
days was compared to that of Jurkat cells removed from a routine culture 
(figure 12a-c). The FACS profiles for six major T cells markers indicate 
that the Jurkat cells are C D 3\ C D 4\ CDS , CD45RO+ (UCHL1+), 
CD45RA' (2H4 ), and CD25 . The most interesting observation was the 
increased expression of the CD3 molecule on the surface of the cells 
cultured with dbcAMP. This resembled the extent of CD3 expression 
detected on the surface of the HUT-78 T cell line (figure 17a) which 
constitutively displays polarized morphology.
The time-course of the increase in the CD3 expression was 
examined in an attempt to detect a correlation with the increased 
locomotion of dbcAMP-cultured Jurkat cells. Two batches of Jurkat cells 
were cultured in parallel where one was supplemented with 1 mM dbcAMP 
and the other reflected normal culture conditions used to maintain the cell 
line. Samples were removed daily from each culture flask and were 
stained with phycoerythrin-conjugated aCD3 for FACS analysis (figure 
13). While the routine culture showed an unchanged level of surface CD3, 
the dbcAMP-cultured cells displayed a significant increase in surface CD3 
after only an overnight culture. The higher level of CD3 was detected on 
these cells for the duration of the 7-day experiment.
%
5.3. SUMMARY
f
In conclusion, the above experiments showed that a long-term 
culture of Jurkat cells in the presence of dbcAMP caused a dose-dependent 
inhibition of cell division as demonstrated by the increase in cell population 
present in Go/Gi phase of cell cycle. In conjunction with this inhibition, 
the majority of these cells became smaller, polarized, motile and express 
higher levels of CD3.
Figure 12a: Expression of CD3 and CD25 on the surface of Jurkat cells 
cultured without (A) or with (B) 1 mM dbcAMP or on HUT-78 cells (C). 
The cells were stained with fluorescein- or phycoeiythrin-conjugated 
monoclonal antibodies and were analyzed on FACScan. The grey open 
curve represents negative control.
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Figure 12b: Expression of CD4 and CD8 on the surface of Jurkat cells 
cultured without (A) or with (B) 1 mM dbcAMP or on HUT-78 cells (C). 
The cells were stained with fluorescein- or phycoerythrin-conjugated 
monoclonal antibodies and were analyzed on FACScan. The grey open 
curve represents negative control.
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Figure 12c: The expression of CD45R0 and CD45RA on the surface of 
Jurkat cells cultured without (A) or with (B) 1 mM dbcAMP. The cells 
were stained with fluorescein- or phycoerythrin-conjugated monoclonal 
antibodies and were analyzed on FACScan. The grey open curve 
represents negative control.
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Figure 13: Effect of culture with 1 mM dbcAMP on the expression of 
CD3 on the surface of Jurkat cells. The cells were removed from the 
culture daily, stained with phycoerythrin-conjugated monoclonal antibody 
and analyzed on FACScan. The grey open curve represents negative 
control.
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6 . CHARACTERISTICS OF THE REPOLARIZATION PROCESS IN 
dhcAMP-CULTURED JURKAT CELLS FOLLOWING WASHING
6.1. BACKGROUND
In the previous set of experiments, the Jurkat cells were shown to 
adopt a polarized morphology when cultured in the presence of 1 mM 
dbcAMP. The change in the morphology of such cells occurred within 3 
days of culture. The dbcAMP-cultured Jurkat cells rounded up when 
washed at room temperature but repolarized when placed at 37°C.
The kinetics of polaiization in PBL stimulated with neat PCS or 
treated with colchicine was studied by Wilkinson (1986). The FCS- 
stimulated polarization of PBL was essentially complete in 5 min. In 
contrast, the action of colchicine was slow, requiring at least 15 min to 
approach maximum polarization. It was speculated that the slower rate of 
polarization reflected the fact that the drug needed to cross the plasma 
membrane to gain access to the intracellular components. The dynamics 
of polarization induced by FCS resembled that of a neutrophil stimulated 
with chemoattractant fMLP (McKay et al., 1991).
The next set of experiments addressed the kinetics and other 
characteristics of the repolarization process in dbcAMP-cultured Jurkat 
cells.
6.2. EXPERIMENTAL
6.2.1. The kinetics of the repolarization process
6.2.1.1. Time-course o f repolarization o f Jurkat cells from routine culture
Figure 14 shows the time-dependent variation in cell morphology 
observed with Jurkat cells from routine culture. The cells were washed 
and then incubated at 37°C. Typically, 10-20% of the normal cells were
I
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Figure 14: Time-course of change in morphology of Jurkat cells from 
routine culture. The cells were maintained in RPMI 1640 medium with 
sodium bicarbonate supplemented with 100 mM HEPES buffer, 2 mM L- 
glutamine, 100 U penicillin, 100 fig streptomycin, and 10% FCS. The 
cultuies were kept at 37°C in an incubator with a moist atmosphere 
containing 5% COg. The cells were washed in HBSS/MOPS and the pellet 
was resuspended in 50 fil of the medium at room temperature. The 
repolarization was initiated by the addition of 1 ml HBSS/MOPS preheated 
at 37“C and was allowed to continue for various time intervals at 37°C. 
The cells were finally fixed with glutaraldehyde and the morphology 
examined and quantified under phase contrast. Round cells (circle), 
irregular cells (square) and polarized cells (triangles).
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polarized, 20-30% were inegular and 60-70% were round. In line with 
the previous observations, no major valuations in cell moiphologies were 
observed.
6.2. L 2. Time-course o f repolarization of dbcAMP-cultured Jurkat cells
To define the time-course of shape change of Jurkat cells cultured 
in the presence of 1 mM dbcAMP, the cells were washed in HBSS/MOPS 
at room temperature and the pellet was resuspended in 50 pi of the 
medium. HBSS/MOPS, prewarmed in a waterbath at 37°C, was then 
added and the incubation was continued for various time intervals. Figure 
15 shows time-course cuiwes representing the number of cells assigned to 
the three different classes based on the cell morphology.
The increase in the irregular population occuiTed within 30 sec and 
preceded a similar increase in the polarized population by about 2  min. 
The population of round cells reached its minimum after 5 min. Similarly, 
the polarized population experienced the maximum rate of growth for the 
first 4 min. Thereafter, the number of polarized cells increased only 
slightly, although it continued to do so for 10 to 15 min. This appeared 
to be due to a slower transition of the irregular cells to the polarized 
morphology. After 15 min, the three populations seemed to have reached 
an equilibrium. Thus, the following scheme for polarization was 
suggested:
Ri Rz
Round 4 — ^ IrrcgulaT ^ Polarized
where the rate Ri is 3-4 times the rate R .^
In order to ensure the full repolarization of Jurkat cells in the 
subsequent experiments, an incubation period of 30 min at 37^C was used 
to repolarize the cells using medium kept at the room temperature.
I l l
Figure 15: Time-course of repolarization of dbcAMP-cultured Jurkat 
cells. The routine medium was supplemented with 1 mM dbcAMP and the 
incubation was continued for 3 days. The cells were washed in 
HBSS/MOPS and the pellet was resuspended in 50 jul of the medium at 
room temperature. The repolarization was initiated by the addition of 
HBSS/MOPS preheated at 37^C and was allowed to continue for vaiious 
time intervals at 37^C. The results shown are a mean of three 
experiments; the error bars correspond to standard deviation. The cells 
were finally fixed with glutaraldehyde and the morphology was examined 
and quantified under phase contrast. Round cells (circle), irTegular cells 
(square) and polarized cells (triangles).
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6.2.2. Energy-dependent character of the repolarization process
I
The lymphocytes have very limited stores of D-glucose which is the 
main energy source for these cells. In the initial experiment, 100 mM 2- 
deoxyglucose was added to HBSS which is formulated with D-glucose 
(figure 16). The dynamics of the repolarization process remained 
unchanged. However, only 33% of the 2-deoxyglucose treated cells 
repolarized compared to 53% of the control cells. In a subsequent 
experiment it was shown that the Jurkat cells repolarize almost equally well 
in PBS lacking and containing 5.5 mM D-glucose (figure 17). However, 
when 5.5 mM 2-deoxyglucose was included in PBS the initial increase in 
polarized cells was reversed after about 5 min, resulting in a slow 
decrease, in polarized and irregular forms, which continued until the end 
of the 30 min observation period. This indicates that 2-deoxyglucose, 
having penetrated the cell, competes with the internally stored D-glucose 
and thus interferes with the production of energy necessary to maintain the 
polarized morphology of dbcAMP-cultured Jurkat cells.
6.2.3. Mechanism of the repolarization process in dbcAMP-cultured Jurkat 
cells
The general pattern of the repolarization process in dbcAMP- 
cultured Jurkat cells resembles that of FCS-stimulated PBL and fMLP- 
activated neutrophils. The rapid repolarization of the Jurkat cells may 
indicate that a chemotactic factor is rapidly produced by the cells which 
causes the rapid change in morphology. On the other hand, the 
temperature-sensitive biochemical processes, engaged in the cell 
polarization, may be rapidly activated when brought to a physiological 
temperature.
II
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Figure 16: Effect of 100 mM 2-deoxyglucose added to HBSS/MOPS on 
repolarization of dbcAMP-cultured Jurkat cells. The routine medium was 
supplemented with 1 mM dbcAMP and the incubation was continued for 
3 days. The cells were washed in HBSS/MOPS and the pellet was 
resuspended in 50 fd of the medium at room temperatme. The 
repolarization was initiated by the addition of the different media preheated 
at 37“C and was allowed to continue for various time intervals at 37°C. 
The cells were finally fixed with glutaraldehyde and the morphology 
examined and quantified under phase contrast. Round cells (circle), 
irregular cells (square) and polarized cells (triangles).
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Figure 17: Effect of 5.5 mM D-glucose or 5.5 mM 2-deoxyglucose on 
repolarization of dbcAMP-cultured Jurkat cells. The routine medium was 
supplemented with 1 mM dbcAMP and the incubation was continued for 
4 days. The cells were washed in HBSS/MOPS and the pellet was 
resuspended in 50 fû of the medium at room temperature. The 
repolarization was initiated by the addition of the different media preheated 
at 37°C and was allowed to continue for various time intervals at 37°C. 
The cells were finally fixed with glutaraldehyde and the morphology 
examined and quantified under phase contrast. Round cells (circle), 
irregular cells (square) and polarized cells (triangles).
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6.2.3 J .  Involvement o f a soluble factor in the repolarization o f dbcAMP-
cultured Jurkat cells
The possibility that this change is induced by a soluble chemotactic 
molecule released into the growth medium during the culture was 
examined. To obtain an independent evidence of such a chemotactic 
factor, o:CD3-activated PBL were subjected to various media, including 
supernatants obtained fiom dbcAMP-cultured Jurkat cells. Figure 18-A 
shows the effect of these media and supernatants on PBL cultured for 3 
days in the presence of o:CD3 included in the RPMI (10% FCS) medium. 
The aCD3-containing supernatant in which the PBL had been cultured, 
fresh medium with or without 10% FCS, as well as supernatant obtained 
from routine culture of Jurkat cells gave equivalent levels of polarization 
of the PBL. However, supernatant from dbcAMP-cultured Jurkat cells 
showed a significant inhibition of polarization. A similar observation was 
made when Jurkat cell-culture supernatant containing dbcAMP was added 
back to Jurkat and the cells were repolarized (figure 18-B). Thus it was 
suggested that even though cAMP stimulates long-term growth-induced 
polarization of Jurkat cells, it may be inhibitory to the short-term 
polarization of PBL or Jurkat cells.
The release of chemotactic factor IL- 8  has been described in 
mononuclear cell cultures however, the source is most likely the population 
of monocytes or other accessory cells (Wilkinson and Newman, 1992). 
Even then, hours of culture are required for IL- 8  to be released and for the 
lymphocytes to respond by an increased polarization. Thus, it appears that 
the dynamics of repolarization of dbcAMP-cultured Jurkat cells reflect the 
temperature-sensitive nature of the biochemical processes responsible for 
the shape change. It appears that these biochemical mechanisms are 
engaged only after a prolonged culture of Jurkat cells in the presence of 
dbcAMP and correlate with the cell being in the Gi phase.
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Figure 18: Effect of various cell culture media and supernatants on the 
extent of repolarization of PBL cultured with aCD3 for 48 hrs (A) and 
Jurkat cells cultured with 1 mM dbcAMP for 3 days (B). The cells were 
washed with HBSS/MOPS and resuspended in various media as indicated. 
In some instances, the cells remained in the original culture supernatant. 
The cells were then repolarized at 37®C for 30 min, fixed and the 
morphology was examined and quantified under phase contrast.
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6.23.2. Temperature-dependent character o f the repolarization process
Further examination of the time-course of Jurkat cell repolarization 
at 37°C and at room temperature revealed that both, the rate and the extent 
of repolarization, were affected by the lower temperature (figure 19), The 
rate of repolarization at 23°C was slower, requiring extra 5 min to reach 
the maximum repolarization. In addition, the proportion of polarized cells 
observed at 23°C was more than 3-fold lower than that observed at 37°C.
6.3. SUMMARY {
In conclusion, the above experiments suggest that the process, 
whereby the dbcAMP-cultured Jurkat cells acquire the locomotory 
morphology, is energy and temperature dependent. Furthermore, this 
process appears to be constitutive and is inhibited upon addition of 
dbcAMP in a short-term assay.
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Figure 19: Effect of temperature on the repolarization of dbcAMP-
cultured Jurkat cells. The routine medium was supplemented with 1 mM 
dbcAMP and the incubation was continued for 7 days. The cells were 
washed in HBSS/MOPS and the pellet was resuspended in 50 /xl of the 
medium at room temperature. The repolarization was initiated by the 
addition of HBSS/MOPS preheated at 37°C or at 23®C and was allowed to 
continue for various time intervals at 37®C or at 23°C respectively. The 
cells were finally fixed with glutaraldehyde and the morphology examined 
and quantified under phase contrast. Round cells (ciicle), hregular cells 
(squaie) and polarized cells (triangles).
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7. INVOLVEMENT OF cAMP SECOND MESSENGER SYSTEM IN 
POLARIZATION OF dbc AMP-CULTURED JURKAT CELLS
7.L BACKGROUND
In the previous set of experiments, the repolarization process of 
dbcAMP-cultured Jurkat cells was shown to be constitutive, as well as 
energy- and temperature-dependent. In addition, dbcAMP-containing 
supernatant from dbcAMP-cultured Jurkat cells was shown to interfere with 
the repolarization process both in aCD3-activated PBL and in dbcAMP- 
cultured Jurkat cells. Thus, the involvement of the cAMP-based signalling 
system was examined in the following series of experiments.
7.1.1. Signal transduction and intracellular second messengers
Signal transduction, in general, refers to the process whereby a 
messenger, bound to a ligand-specific transmembrane protein receptor on 
the outside surface of the cell, induces a chemical change on the 
cytoplasmic surface of the membrane. Such a signal transduction 
mechanism may take a shape of ligand-gated ion channels, second 
messenger systems, and receptors with integral enzyme activity.
Second messenger systems respond to the binding of a ligand to its 
receptor on the cell membrane by activation of an enzyme on the 
cytoplasmic side. This enzyme generates second messengers increasing 
their intracellular concentration. Finally, the second messengers activate 
some system which modulates a variety of cell functions resulting in 
physiological changes.
7.1.2. Cyclic AMP as a second messenger
Cyclic AMP was the earliest second messenger identified by its 
involvement in the control of glycogenolysis in liver cells stimulated with
1 2 0
7.1.3. G protein couples a surface receptor to adenylate cyclase
adrenaline (Sutherland and Rail, 1958). The system responsible for the 
maintenance of cAMP levels was eventually identified as one involving 
adenylate cyclase, which uses ATP to synthesize cAMP, and 
phosphodiesterase, which hydrolyzes the 3’-phosphate ester to give 5’-AMP 
(figure 2 0 ).
The involvement of a second messenger, such as cAMP, is 
generally accepted if two criteria are fulfilled: ( 1 ) the fiist messenger 
increases the concentration of the second messenger inside the tai'get cell, 
and (2 ) increasing the concentration of the second messenger inside the cell
mimics the effect of the first messenger. The first criterion can be readily 
tested using sensitive assays. In order to test the second criterion, polar
analogues of cAMP were developed which are not only more cell 
permeable but are also resistant to breakdown by phosphodiesterases. 
There are also phaimacological agents available which elevate cAMP inside 
the cell by interfering with the second messenger biosynthetic pathway at 
two key points. Thus, caffeine and IBMX inhibit the breakdown of cAMP 
by phosphodiesterases while the plant terpenoid forskolin directly activates 
adenylate cyclase. Alternatively, PGEj can be used to stimulate this 
enzyme via a receptor-activated pathway. Another indirect method 
involves the irreversible activation of the G^  a subunit by cholera toxin. 
This G protein then constitutively activates adenylate cyclase which in turn 
produces a massive increase in the intracellular cAMP concentration.
The simplest model for the second messenger system would 
physically associate the intracellular effector enzyme with the ligand- 
specific receptor. However, adipose cells were used to show that five 
different hormones stimulate a single adenyl cyclase by combining with 
separate and independent binding sites (Birnbaumer and Rodbell, 1969). 
The physical autonomy of the receptor and the adenyl cyclase was 
confirmed when transfer of an active receptor from a cell with inactive
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Figure 20; Structure of cAMP and mechanism of its formation and 
breakdown (from Hardie, 1991).
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adenyl cyclase confen*ed ligand-responsiveness to a cell with a defective 
receptor but an active adenylate cyclase (Orly and Schramm, 1976).
In early experiments, GTP was shown to be required for adenylate 
cyclase activity (Rodbell et aL, 1971). In addition, adenylate cyclase 
activity was stimulated by GTP and its non-hydrolyzable analogues
responsible for the stimulatory actions of GTP in the GTP-dependent 
hormonal stimulation of adenylate cyclase (Ross et a l ,  1978).
-m;(Londos et a l ,  1974). Eventually it was shown that a distinct factor, a 
GTP-binding protein present in a detergent membrane extract, was
7.1.4. Classification of GTP-binding proteins
Signal-transducing GTP-binding proteins known today are classified 
into two groups. One is the high-molecular weight or heterotrimeric GTP- 
binding proteins (G proteins); the other contains the low-molecular weight, 
monomeric GTP-binding proteins of the ras superfamily (small G 
proteins). The general mechanism of action of all of these GTP-binding 
proteins is similar. The GTF-bound form of these proteins is an active 
conformation. The intrinsic GTPase activity is required to hydrolyze GTP 
to GDP and thus to shift the G protein to an inactive form.
Interconversion of GTP- and GDP-bound form is controlled by two 
mechanisms. First, the conversion of GDP- to GTP-bound form is 
stimulated by an exchange-promoting protein. In small G proteins this 
activity is regulatyed by the exchange factors (GDP dissociation 
stimulators), while in G proteins the activated receptor assumes the role of 
the exchange-promoting protein. Second, the conversion of GTP- to GDP- 
bound form is accelerated by GTPase-activating protein in small G proteins 
(Kaziro et a l ,  1991), while G proteins use their intrinsic GTPase activity.
The small G proteins are involved in different areas cell biology, shared by 
all cell types: the Ras proteins represent major control check in signal 
transduction and cell proliferation; the Rho proteins appear to regulate 
organization of tlie cytoskeleton network; and the Rab proteins are
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involved in the control of intracellular membrane traffic (Chavrier et al. 
1993).
7.1.5. Types of G proteins
G proteins are protein complexes involved in receptor-regulated 
signal transduction affecting the adenyl cyclase, the transducin-activated 
cyclic GMP phosphodiesterase, ion channels, phospholipases and other 
effectors (Gilman, 1987). The best known G proteins are the ubiquitous 
Gg and Gj which, respectively, stimulate and inhibit adenylate cyclase; G^  
(transducin), a tissue specific G protein that regulates retinal cyclic GMP 
phosphodiesterase; and Go which appears to regulate Ca^  ^ channels 
(Gilman, 1987).
7.1.6. Structure and function of G proteins
G proteins are heterotrimers composed of three distinct subunits:
39-46-kDa G„ 37-kDa G, and 8 -kDa G, (Hepler and Gilman, 1992). G, 
and G, exist as a tightly bound complex G«y functioning as a unit which 
can associate with different G„. Thus, G„ determines the G protein 
specificity. The G„ have a high affinity binding site for guanine 
nucleotides GTP and GDP. The GDP-bound G„ associates widi Gg^  and 
is inactive. G proteins interact with the receptor molecule via unique 
amino acid sequences on both the receptor and the G protein. The ligand- 
activated cell-surface receptors associated with G proteins appear to share 
a common motif of seven membrane-spanning domains (O’Dowd et al.,
1989). The activation of the receptor induces an exchange of GDP for 
GTP causing the GTP-bound G„ to dissociates from Ga^ . The free G„ then 
binds to and regulates the effector enzyme. The G« also has an intrinsic 
slow-rate GTPase activity; as a result GTP is hydrolyzed to yield GDP 
and free inorganic phosphate and thus binds to Gg^  and becomes 
deactivated. The cycle of G protein activation continues as long as the
124
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receptor is occupied.
7.1.7. Structure of G protein a-subunit
Thi ee regions within G„ fold to produce a GTP-binding site (Bourne 
et a l ,  1991; Masters et a l ,  1986). Indeed, the amino acid sequence 
GAGES at position 47 in % ( 6  in a small GTP-binding protein ras) is 
essential for normal GTPase activity; mutation within this sequence in ras 
results in inhibition of regulation by GTPase-activating protein (Gilman, 
1987; Bourne et a l ,  1991) while analogous mutation in results in 
decrease of GTPase activity (Freissmuth and Gilman, 1989; Masters et 
a l,  1989). The carboxyl terminus of G„ appear to be at least in part 
responsible for receptor-G protein interaction (Hamm et a l , 1988) and thus 
posses the principal determinants of specificity for G protein-effector 
interactions (O’Dowd et a l ,  1989; Masters et a/., 1988; Woon et a l,  
1989); the association of G  ^ with Gg^  is thought to involve the amino 
terminus of G„ (Neer et a l , 1988).
7.1.8. Susceptibility of G proteins to bacterial toxins
A number of studies suggested that the cellular target protein 
modified by pertussis toxin activity is a G protein involved in the 
regulation of the adenylate cyclase complex (Godina et a l ,  1983). 
Hormone-stimulated, but not basal, levels of cAMP were found to be 
supraoptimal within pertussis toxin-treated organ explants or tissue-cultured 
cell lines (Katada et a l , 1982). On the other hand, pertussis toxin-treated 
lymphocytes were unable to increase intracellular cAMP in response to 
PGEa (Parker and Morse, 1973). However, murine lymph node 
lymphocytes treated with pertussis toxin showed normal basal levels of 
cAMP and a normal response to PGEj (Spangrude et a l ,  1985a).
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The conserved arginine at position 201 of a, is the site of ADP- 
ribosylation catalyzed by cholera toxin. Modification of a, with cholera
î
toxin constitutively activates the G protein by inhibiting its GTPase 
activity. On the other hand, ADP~ribosyltransferase, a subunit of pertussis 
toxin, penetrates cells and uses endogenous nicotinamide-adenine 
dinucleotide to ADP-ribosylate a cysteine near the carboxyl terminus of o^ , 
«t, and « 0  (West et a l , 1985; Sunyer et a l , 1989). The which lacks 
a cysteine residue in this position, is not affected. ADP-ribosylation by 
pertussis toxin appears to cause uncoupling of G proteins from activated 
receptors (Ui, 1984) resulting in the inhibition of the relevant agonist- 
activated pathways.
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7.1.9. General activators of G proteins
Fluoride, in the millimolar concentration range, is a general 
activator of G proteins. AIF4 ' formed from F and AP+ binds to GTP and 
thus mimics y-phosphate of GTP, converting GDP-bound inactive G 
protein to an activated form. In a number of cell types addition of NaF to 
pre-labeled cells or isolated membranes has been shown to stimulate the 
formation of inositol phosphates. In addition, non-hydrolyzable analogues 
of GTP, such as GTPyS, have been used for sustained activation of G 
proteins.
7.2. EXPERIMENTAL
7.2.1. Effect of DMSQ on repolarization of Jurkat cells
The application of drugs non-soluble in aqueous media called for 
the utilization of DMSO as a solvent. To determine the effect of this 
solvent on the polarization of Jurkat cells and its toxicity a preliminary 
experiment was conducted. It was thought important to always use DMSO 
at a dilution which would not interfere with the assay. Several dose- 
response experiments showed that DMSO diluted 1:100 had a severe effect 
on the cell polarization and seemed to be noticeable even at the dilution of
Ï
I
1:200 (figure 21). In the subsequent experiments, DMSO was always 
diluted to at least 1 : 1 0 0 0  to effectively eliminate its negative effect on the 
polarized cells.
7.2.2. Effect of cAMP and agents that modify intracellular cAMP on 
repolarization of dbcAMP-cultured Jurkat cells
7.2.2.7. Effect o f dbcAMP on repolarization o f dbcAMP-cultured Jurkat 
cells
The effect of the dbcAMP-containing supernatant from dbcAMP- 
cultured Jurkat cells on the short-term repolarization of these and of aCD3- 
activated PBL was explored further. First, the possibility of accumulation 
of an inhibitoiy factor in these supernatants during the cell culture was 
tested when fresh medium containing 1 mM dbcAMP was added to aCD3- 
stimulated PBL. Clearly, cAMP gradually reversed the polarization 
process observed in PBL repolarized in plain medium (figure 22-A). A 
similar observation was made with repolarized Jurkat cells exposed to 1 
mM dbcAMP (figure 22-B). However, the dynamics of the response were 
different. The slow, almost linear, response observed with PBL was 
replaced by a rapid decrease in polarized morphology in Jurkat cells. The 
decrease in the proportion of polarized and irregular cells was reflected by 
an appropriate increase in the proportion of round cells. The change was 
virtually complete by 1 0  min of the time-course experiment.
The dose-response curve for the polarization inhibition by dbcAMP 
indicated that the minimum effective dose is between 62 and 125 pM with 
EDso of about 750 fiM (figure 23-A). The dose-response curves obtained 
in the presence or absence of EDTA added to the repolarization medium 
were virtually identical with similar ED5 0  (figure 23-B). The only notable 
difference was a slightly lower repolarization of Jurkat cells in the Ca^^- 
free medium compared to the normal, Ca^^-supplemented HBSS. In any 
case, the stimulus supplied by dbcAMP was shown to be independent of
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Figure 21 : Dose-dependent action of DMSO on dbcAMP-cultured Jurkat 
cells. The routine medium was supplemented with 1 mM dbcAMP and the 
incubation was continued for 3 days. The cells were washed with 
HBSS/MOPS and repolaiized at 37®C for 30 min. 10 fû of dilutions of 
DMSO were added and the incubation was continued for 30 min. The 
cells were finally fixed and the morphology was examined and quantified 
under phase contrast. Round cells (circle), irregular cells (square) and 
polarized cells (triangles).
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Figure 22: Time-course of the effect of 1 mM dbcAMP on PBL cultured 
with ceCD3 for 48 hrs (A) and Jurkat cells cultured with 1 mM dbcAMP 
for 3 days (B). The cells were washed, resuspended in HBSS/MOPS and 
repolarized at 37°C for 30 min. dbcAMP was added to final concentration 
of 1 mM and the incubation was continued for various time intervals. The 
cells were finally fixed and the morphology was examined and quantified 
under phase contrast. (A) Round cells in the absence (open circles) or 
presence (full circles) of dbcAMP; (B) Round cells (circle), irregular 
cells (square) and polarized cells (triangles) in the presence of dbcAMP.
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Figure 23; Dose-dependent action of dbcAMP on the morphology of 
Jurkat cells cultured with 1 mM dbcAMP for 3 days. The cells were 
washed twice with HBSS/MOPS containing Ca^  ^ (A) or in Ca^'-free 
HBSS/MOPS supplemented with EDTA. The same medium then was used 
to resuspended and repolarize the cells at 37°C for 30 min. dbcAMP 
dilutions were added and the incubation was continued for 30 min. The 
cells were finally fixed and the morphology was examined and quantified 
under phase contrast. Round cells (circle), irregular' cells (square) and 
polarized cells (triangles).
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^The formula used was:
%I-(Po - P3 0 ) / Po X 100%, 
where %I is percent inhibition, and Pq and P3 0  is the proportion of 
polarized cells at time 0 and 30 min after the agent was added.
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the presence of extracellular Ca .
7.2.2.2. Effect o f increase in intracellular cAMP concentrations on PBL 
morphology
.Experiments with aCD3-activated PBL revealed that forskolin,
PGEj and IBMX induced a gradual decrease in the proportion of polarized 
cells (figure 24-A to 24-C). The maximum change in morphology by 
either of the drugs separately was achieved by 30 min. The percent 
inhibition^ achieved at this time was 23% for forskolin, 19% for PGE2  and 
23% for IBMX. The change in response to PGEa and IBMX appears to be 
more permanent while the forskolin-induced rounding up was partially 
reversed by 60 min.
When PBL were preincubated with IBMX and then forskolin was 
added, a faster (within 15 min) and a sustained decrease in polarized PBL 
was observed (figure 25-A). The forskolin-stimulated inhibition of PBL 
polarization at 30 min was 29%, while the presence of IBMX increased the 
efficiency of forskolin inhibition to 48 %.
The similarity of the sustained rounding up in response to IBMX or 
PGE2  alone suggests that in the latter case, an inactivation of 
phosphodiesterase may play a supportive role. Although PGE2  activates 
adenylate cyclase, it is possible that tlie signal through the PGEg receptor
Î
?
induces a concominant inactivation of phosphodiesterase.
The diiect activation of adenylate cyclase with forskolin, and the 
resulting increase in intracellular cAMP concentrations, may activate a 
feedback pathway which results in an increase of phosphodiesterase 
activity. Thus, the observed decrease in cAMP effect on PBL morphology 
was reversed after 60 min while the PBL remained rounded up for up to
- I #
Figure 24: Effect of 1 0 forskolin (A&D), lO^M PGE^ (B&E), and 10 
"M IBMX (C&F) on the morphology of repolarized PBL previously 
stimulated with aCD3 (A-C) or of repolarized dbcAMP-cultured Jurkat 
cells (D-F). PBL were cultured in the presence of 10 ng/ml OKT3 for 48 
hr while Jurkat cells were cultured with 1 mM dbcAMP for 3 days. The 
cells were washed twice, resuspended in HBSS/MOPS and repolarized at 
37°C for 30 min. 10 (A of appropriate dilutions of the drugs were added 
and the incubation was continued for various time intervals. The cells 
were finally fixed and the morphology was examined and quantified under 
phase contrast. Round cells (circle), irregular cells (square) and polarized 
cells (triangles).
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Figure 25: Effect of preincubation with lO'^M IBMX on the
morphological changes induced by 10  ^ forskolin in repolarized PBL 
previously stimulated with o:CD3 (A) and by lO^M forskolin or 10®M 
PGE2  in repolarized dbc AMP-cultured Jurkat cells (B). PBL were cultured 
in the presence of 10 ng/ml OKT3 for 48 hi while Jurkat cells were 
cultured with 1 mM dbcAMP for 3 days. The cells were washed twice, 
resuspended in HBSS/MOPS and repolarized at 37®C for 30 min. 10 fil 
of lO^M IBMX were added and the incubation was continued for 1 hr. 
Then, appropriate dilutions of the drugs were added and the incubation was 
continued for various time intervals. The cells were finally fixed and the 
morphology was examined and quantified under phase contrast. (A) 
Polarized PBL in the presence (full triangle) or the absence (open tiiangle) 
of IBMX; (B) Polarized Jurkat cells in the presence of PGE2  (full triangle) 
or forskolin (open triangle).
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90 min when the phosphodiesterase was inhibited by IBMX.
7.2.2.3. Effect o f increase in intracellular cAMP concentration on the 
morphology o f dbcAMP-cultured Jurkat cells
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Forskolin, PGE^, and IBMX alone, at concentrations that were 
active in PBL, failed to induce any change in morphology in repolarized 
Jurkat cells that had been cultured with dbcAMP for 4 days (figure 24-D 
to 24-F). The background effect of DMSO did not allow for a further
increase in tlie drug dose.
The preincubation of Jurkat cells with IBMX yielded a response to 
10 ^ M forskolin and lO^M PGE^ (figure 25-B). The dynamics of the 
response, as observed by the reduction of the polaiized Jurkat cell •f'population, were noticeably different for the two drugs. The onset of the 
response to PGE^ was apparent and maximal by 5 min, while 15 min were 
necessary for forskolin to reach the maximum effect. The time-delay in 
the action of forskolin was most likely due to its need to cross the plasma 
membrane before it can act on the intiacellular enzyme. In contrast, PGEj 
acts thiough a surface receptor, giving it a rapid access to the intracellular 
components. Indeed, the dynamics of action of forskolin and PGE^ in 
intracellular cAMP regulation resemble the dynamics of action of 
colchicine and fMLP respectively in the acquisition of motility by the 
neutrophils.
The response to both forskolin and PGE; was transient, returning 
to the near-initial state by 30 min. Taken together, the observations 
suggest that Jurkat cells may have an extremely active phosphodiesterase, 
even after lO'^M IBMX had been used.
The treatment with cholera toxin resulted in an interesting 
observation (figure 26). The Jurkat cells showed a gradual decline in 
polarized morphology with near-maximal response by 2 hrs of incubation.
The inhibition at this time point was 65%. Thus, cholera toxin must 
induce in Jurkat cells a massive increase of cAMP, sufficient to counteract
I
Figure 26: Time-course of the effect of 1 fiM cholera toxin on dbcAMP- 
cultured Jurkat cells cultured with 1 mM dbcAMP for 3 days. The routine 
medium was supplemented with 1 mM dbcAMP and the incubation was 
continued for 3 days. The cells were washed with HBSS/MOPS and 
repolarized at 37®C for 30 min. 10 jitl of cholera toxin were added to final 
concentration of 1 jixM and the incubation was continued for various time 
inteiwals. The cells were finally fixed and the morphology was examined 
and quantified under phase contiast. Round cells (circle), irregular cells 
(square) and polarized cells (triangles).
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the hyperactive phosphodiesterase even in the absence of IBMX.
7.2.2.4. Absolute cAMP levels in Jurkat cells stimulated with forskolin, 
PGE2 and IBMX
The measurement of cAMP levels was performed using a 
competitive method utilizing a known concentration of radiolabelled cAMP 
and a specific cAMP-binding protein.
IBMX alone was shown not to have a detectable effect on the 
[cAMP]i, The cAMP levels measured in Jurkat cells treated with forskolin 
and PGE2 alone or following preincubation with IBMX are shown in figure 
27.
Forskolin and PGE2  alone induced a significantly smaller increase 
in [cAMPJi compared to the Jurkat cells pretreated with IBMX. Even in 
the absence of IBMX, forskolin induced about 8-fold more intracellular 
cAMP compared to PGE2 . The time-course of [cAMP]i change was 
different for these two agents as illustrated by the time needed to achieve 
maximum cAMP production: 10 to 15 min for forskolin and 5 to 10 min 
for PGE2 . This time-course characteristics resembled those of the 
polarization inhibition observed in Jurkat cells in the presence of IBMX.
The addition of IBMX resulted in a 2-fold increase in [cAMP], 
induced by forskolin and about 4-fold increase with PGE2 . The dynamics 
characterizing the increase to maximal cAMP concentration were 
unaffected by the presence of IBMX. However, the inactivation of 
phosphodiesterase resulted in a sustained cAMP increase in Jurkat cells 
stimulated with forskolin. In contrast, PGE2  induced a transient increase 
in [cAMP]i even in the presence of IBMX. Thus, the activation of PGEg 
receptor engages mechanisms of [cAMP]; regulation that are independent 
of phosphodiesterase. A downregulation of the PGEj receptor may be one 
of such mechanisms.
A sustained increase in [cAMP]j, resulting from combined IBMX 
and forskolin action, causes a transient effect on the locomotory
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Figure 27 : Time-course of changes in intracellular cAMP concentration 
in Jurkat cells following addition of lO’^ M forskolin (A) or 10 ®M PGEz 
(B). The cells were washed, resuspended in HBSS/MOPS and repolarized 
at 37°C for 1 hr with or without lO'^M IBMX. The appropriate 
concentrations of the drugs were then added and the incubation was 
continued for vaiious time intervals. At each time point, cAMP was 
extracted and assayed. Concentration of cAMP in cells preincubated in the 
absence (full diamonds) or presence (open diamonds) of IBMX.
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morphology of dbcAMP-cultured Jurkat cells. Thus, the rounding up must 
be reversed in these cells by feedback mechanism other than the activation 
of phosphodiesterase. The effect of forskolin may thus be reversed at the 
level of PKA-catalyzed phosphorylation by inducing a specific phosphatase.
7,2.2.5. Effect o f cAMP-dependentprotein kinase inhibitor on the effect 
induced by forskolin and PGE2
Cyclic AMP exerts most of its intracellular activity through the ;activation of PKA. An attempt was made to determine if in fact these 
protein kinases are involved in the rounding up seen with forskolin or 
PGE,.
Adenosine-3 ’, 5 ’ -cyclic monophosphothioate (Rp-isomer), a specific 
inhibitor of PKA, was used in an effort to diminish or eliminate the effect 
of forskolin or PGE2  (figure 28). The maximum available concentration 
of 10 ^  was used but no effect on the change of cell morphology was 
observed.
Having no positive control, it was difficult to determine if this lack 
of effect is due to an insufficient inhibitor concentration or, if in fact, the 
cAMP-stimulated rounding up is mediated by mechanisms not involving 
PKA.
I
7 .3 . SUMMARY
■iIn conclusion, the above experiments showed that incubation of 
Jurkat cells with dbcAMP, resulted within minutes in a dose-dependent 
permanent reversal of polarized morphology. The action of cholera toxin 
required hours to achieve permanent reversal of polarized morphology, 
while PGEa and forskolin, in conjunction with IBMX, resulted within 
minutes in a transient polarization reversal.
I
Figure 28: Effect of 1 0 adenosine-3’,5’-cyclic monophosphothioate 
(Rp-isomer; cAMPS-Rp) on (A) forskolin- (B) and PGEz-induced rounding 
up of dbcAMP-cultured Jurkat cells. The cells cultured with 1 mM 
dbcAMP for 3 days, washed twice, resuspended in HBSS/MOPS and 
repolarized at 37®C for 30 min in the presence of lO'^M IBMX. Forskolin 
or PGEg were added to final concentration of lO^M and lO^M respectively 
and the incubation was continued for various time intervals. The cells 
were finally fixed and the morphology was examined and quantified under 
phase contrast. Polarized cells in the absence (open hiangles) or presence 
(full triangles) of cAMPS-Rp.
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8. EFFECT OF «CD3 ON THE MORPHOLOGY OF dbcAMP- 
CULTURED JURKAT CELLS
8.1. BACKGROUND
The Jurkat cells cultured in the presence of dbcAMP acquire the 
ability to locomote. A possible involvement of a signalling pathway, 
involving the adenylate cyclase, in the regulation of polarized morphology 
of these cells was identified. In addition, the expression of the CD3 
antigen increased on the surface of dbcAMP-cultured Jurkat cells. The 
significance of this observation was examined in the next series of 
experiments where the effect of stimulation through the TcR/CD3 complex 
on the Jurkat cell motility was examined.
8.1.1. Stricture of TcR/CD3 complex
8.1.1.1. Structure o f TcR
The recognition by T lymphocytes of antigens associated with MHC 
surface proteins is mediated by the specific TcR ceB or yd disulphide-linked 
heterodimers (Yagüe et a l ,  1985; Dembic et al., 1986). Here, the 
former is expressed by most of the peripheral mature T cells while the 
latter is expressed on most of the lymphocytes residing in the tissue 
epithelia. The polymorphic a and 6 chains are members of 
immunoglobulin superfamily and undergo gene rearrangement of V/J gene 
segments in the a  chain and V/D/J gene segments in the fi chain. The TcR 
(Mener et al. , 1983a; Oettgen et al. , 1984) non-covalently associates with 
invariant CD3 complex (Weiss and Imboden, 1987) and a dimer of Ç 
chains (Samelson et al. , 1985b; Oettgen et al. , 1986; Weissmann et al. ,
1986).
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8.1.1.2. Structure o f CD3 complex
The CD3 complex consists of two distinct glycoproteins, CD3y and 
CD3Ô, and a polypeptide CDSe (Borst et a l,  1982, 1983ab, 1984;
Kanellopoulos et al., 1983; Pessano et al., 1985). The CD3 subunits 
have extracellular immunoglobulin-like domains and, compared to the 5 
amino acid intr acellular portion of TcR chains, lar ge cytoplasmic domains 
of 40 to 80 amino acids (van den Elsen et al. , 1984; Gold et al. , 1986;
Rrissansen a/., 1986; Weiss er a /., 1986; devers gf rzA, 1988). CD3 
subunits exist in the receptor complex as two non-covalent heterodimers 
CD3ye and CD3ôe (Konig et a l ,  1990; Blumberg et a l ,  1990; De la 
Herra et a l,  1991). The TcRo:B/CD3yôe complex is formed on the 
surface of the endoplasmic reticulum and then is transported to the cell 
surface through the Golgi apparatus. The assembly of the complex appears 
to be regulated by CD3w (Terhorst et al., 1990).
8.1.1.3. Structure o f (  chain-associated subunit
The C chain is a transmembrane protein with a 9 amino acid 
extracellular domain, a transmembrane domain and a 113 amino acid 
intracellular domain (Baniyash et a l ,  1989; Weissman et a l,  1988). 
Approximately 90% of C chain exists as a CC disulphide-linked homodimer 
(Baniyash et a l ,  1988a). A small percentage of (  chains forms a 
heterodimer with the r\ chain, an alternatively spliced form of the C chain 
(Baniyash et a l , 1988a; Orloff et al., 1989; Jin et al. , 1990) or the y 
chain of the multi-subunit high affinity IgE receptor FCcRI (Orloff et a l ,
1990). Although these peptides were considered to be components of CD3 
complex, it appears that CC and Ç-n independently associate not only with 
the TcR/CD3 complex but also with other signal transducing receptors 
(Finkelera/., 1991). I
I
8.1.2. CD3 and (  chain are signal transducing elements of TcR/CD3
The importance of TcR/CD3 was clearly demonstrated when the 
modulation of the complex from the surface of T cells resulted in their 
inability to be activated, followed by recovery of activation upon re­
expression of CD3 (Reinherz et a l ,  1982). Initially, the role of TcR- 
associated subunits in a signal transduction was deduced, primarily, from 
the existence of their prominent cytoplasmic domains (Weiss and Imboden, 
1987). Indeed, the cell surface TcR expression and function could be 
restored in a C chain-negative murine T cell hybridoma variant 
reconstituted with full-length (  chain (Sussman et al., 1988). The 
importance of the cytoplasmic domain was underscorred when 
reconstitution with molecules truncated in this domain resulted in impaired 
cell activation (Frank et al., 1990). Further evidence was obtained from 
experiments with chimeric receptors consisting of extracellular domains of 
CD4, CD8, or IL2Ror and cytoplasmic domains of C, or FQRJy chains 
(Irving and Weiss, 1991; Romeo and Seed, 1991; Letourneur and 
Klausner, 1991). The role of CD3e in TcR signalling was demonstrated 
in a murine hybridoma which could be activated in the absence of C chain 
cytoplasmic domain (Wegener etal., 1992; Hermans and Malissen, 1993).
The comparison of (  chain- and CD3e-mediated activation events 
revealed that stimulation thi ough the different cytoplasmic domains resulted 
in a different patterns of protein phosphorylation (Letourneur and Klausner, 
1992). Thus, two distinct and autonomous biochemical pathways appear 
to be activated upon stimulation of the TcR/CD3 complex. While odCD3 
can signal through either signal-transduction module (Wegener et al., 
1992), aThy-1 and q:CD2 appears to signal exclusively through the CC 
dimer (Wegener et al., 1992; Moingeon et al., 1992). The coupling of the 
various TcR/CD3 complex structures to intracellular biochemical pathways 
is addressed in a subsequent chapter.
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8.2. EXPERIMENTAL
8.2.1. Effect of QiCD3 on the morphology of dbcAMP-cultmed Jurkat 
ceils
A
8.2.1.1. Dose-dependent effect ofaCDS on the extent o f repolarization of 
dbcAMP-cultured Jurkat cells
The activation of normal blood lymphocytes thiough the TcR/CD3
■ :
complex for a minimum of 24 hrs, in the presence of monocytes, was 
shown to result in an increased proportion of polarized cells when 
compaied to cells cultured only in HBSS/HSA medium (Wilkinson and 
Higgins, 1987a). However, no short-term effect of aCD3 on the 
morphology of PBL was demonstrated. To establish, whether stimulation 
through the TcR/CD3 complex affects the extent of repolarization of 
dbcAMP-cultured Jurkat cells, a preliminary dose-response experiment was 
performed. Suiprisingly, a dose-dependent decrease in the number of A
polarized cells was observed after a 30 min incubation with the monoclonal 
antibody (figure 29).
8.2.1.2. Effect ofaCDS on the time-course o f repolarization ofdbcAMP- 
treated Jurkat cells
To examine this effect further, a time-course of repolarization was 
observed in the presence and in the absence of the highest aCD3 dose. 
The control series showed a repolarization similar to that observed 
previously (figure 15). However, in the cells repolarized in the presence 
of aCD3, the initial increase in number of polarized cells was reversed 
after 5-10 min, reaching a minimum at 15 min. After this time, the 
number of polarized cells started to recover to the levels established by the 
cells in the control series.
143
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Figure 29: Dose-dependent action of aCD3 on the morphology of
dbcAMP-cuitured Jurkat cells. The routine medium was supplemented 
with 1 mM dbcAMP and the incubation was continued for 3 days. The 
cells were washed with HBSS/MOPS and repolarized at 37^C for 30 min. 
ofCD3 was added and the incubation was continued at 37°C for 30 min. 
The cells were finally fixed and the morphology was examined and 
quantified under phase contrast.
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8.2.1.3. Effect o faC D S on the morphology o f repolarlzed, dbcAMP-
cultured Jurkat cells
1 4 5
To isolate the time-course of the effect of o;CD3 from the normal 
dynamics of cell repolarization, the cells were repolarized for 30 min prior 
to the addition of the antibody (figure 30). This experiment revealed that 
the maximum effect of aCD3 occurs 10-15 min after addition of the 
antibody. After this time, the cells began the repolaiization process and 
returned to the initial state after 90 rain. A time-course of action of 
ofCD2, antibody to another surface molecule implicated in lymphocyte 
activation, was shown to have no effect on the morphology of repolarized 
dbcAMP-cultured Jurkat cells (results not shown).
The transient effect of aC 03 could be explained in three ways. 
First, the CD3 molecule on the cell surface is known to be internalized as 
a response to the binding of <%CD3. Thus, even in the presence of the 
aCD3 in the medium the cells would be lacking the structures necessary 
for the delivery of negative signals to the cells. Second, the CD3 molecule 
follows the cycle of internalization, dissociation and reexpression, thus 
depleting the extracellular ofCD3. Third, the intracellular signal 
messengers generated as a response to the binding of aCD3 are removed 
after a feedback pathway has been triggered.
8.2.2. Cause of the transient nature of o;CD3 effect on dbcAMP-cultured 
Jurkat cell morphology
8.2.2.1. TcRiCDS internalization
The first possibility was examined using the otCD3 antibody 
immobilized on the surface of magnetic beads. The internalization of the 
monoclonal antibody was thus prevented. Figure 31 shows the result of an 
experiment where the time-couise of action of immobilized and soluble 
otCD3 was examined. Although the bound aCD3 was not as effective as
%
Figure 30: Time-course of action of aCD3 on repolarized dbcAMP- 
cultured Jurkat cells. The routine medium was supplemented with 1 mM 
dbcAMP and the incubation was continued for 3 days. The cells were 
washed twice with HBSS/MOPS, resuspended in 1 ml of the medium and 
repolarized at 37°C for 30 min. OKT3 was added to the cells to the final 
concentration of 20 ng/ml and the incubation was continued at 37®C for 
various time intervals. The cells were finally fixed and the morphology 
was examined and quantified under phase contrast. Round cells (circle), 
irregular cells (square) and polaiized cells (triangles).
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Figure 31: Time-course of action of immobilized or soluble aCD3 on 
repolarized dbcAMP-cultured Jiirkat cells. The cells were cultured with 1 
mM dbcAMP for 3 days, washed twice with HBSS/MOPS, resuspended 
in 1 ml of the medium and repolarized at 37°C for 30 min. OKT3, eitlier 
immobilized onto Dynabeads® or in HBSS/MOPS/HSA was added to the 
final concentration of 20 ng/ml and the incubation was continued at 37°C 
for various time intervals. The cells were finally fixed with glutaraldehyde 
and the morphology was examined and quantified under phase contrast. 
Polarized cells in the presence of immobilized aCD3 (open triangles) or 
soluble aCD3 (full triangles).
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8.3. SUMMARY
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the soluble antibody, the transient character of its action was clearly 
demonstrated. The lower efficiency of the bound aCD3, when compared 
to the soluble antibody, may be due to slightly lower concentiation of 
ttCD3 retained by the beads. Another line of evidence against the 
disappearance of the surface CD3 molecule was the FACS examination of 
the Jurkat cells incubated with aCD3 for various time intervals (figure 32). 
Clearly, a short term incubation of the cells with this antibody did not 
significantly affect the surface CD3 density. Moreover, the CD3 molecule 
was still present on the cell-surface following an overnight culture.
8,2.2.2. otCD3 depletion ;i,.3 
. . . : r
The depletion of the extracellular aCD3 was examined in an 
experiment, where dbcAMP-cultured Jurkat cells were pretreated with 
aCD3 and allowed to repolarize for 90 min after the addition of the 
antibody (figure 33). After this time, an equal dose of aCD3 was added.
The cells were shown to be refractory to further stimulation by aCD3 as 
the proportion of polarized cells remained virtually unchanged. Thus, it 
appears that the stimulation of TcR/CD3 complex results in a transient 
generation or release of intracellular signals which interfere with the 
maintenance of the locomotory capacity in dbcAMP-cultured Jurkat cells.
In addition, these intracellular messengers are exhaustible. The nature of 
such signals, known to be generated in response to TcR/CD3-mediated 
stimulus, was addressed in subsequent experiments.
s
In conclusion, the above experiments showed that incubation of 
dbcAMP-cultured Jurkat cells with «CD3 transiently inhibited the process 
of repolarization and even transiently rounded up repolarized cells. Once 
the polarization was restored in these cells, they became refractory to a 
subsequent aCD3 treatment.
Figure 32: Time-course of CD3 expression on the surface of dbcAMP- 
cultured Jurkat cells exposed to soluble «CDS. The cells were cultured 
with 1 mM dbcAMP for 3 days, washed twice with HBSS/MOPS and 
resuspended in 50 fil of the medium at room temperature. The experiment 
was initiated by the addition of HBSS/MOPS/HSA containing 20 ng/ml 
OKT3 and the cells were incubated at 37°C for various intervals. Finally 
the cells were washed with ice-cold PBS/azide and stained witli wCD3 for 
FACScan analysis.
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Figure 33: Effect of aCD3 on dbcAMP-cultured Jurkat cells pretreated 
with aCDB for 60 min. The cells were cultured with 1 mM dbcAMP for 
3 days, washed twice with HBSS/MOPS, resuspended in 1 ml of the 
medium and repolarized at 37®C for 30 min. An aliquot of 10 fil of 2 
/Ag/ml OKT3 was added as indicated and the incubation was continued at 
37^C for various time intervals. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast. Polarized cells (triangle).
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9. EFFECT OF MITOGENS ON THE POLARIZATION OF dbcAMP- 
CULTURED JURKAT CELLS
9.1. BACKGROUND
PHA was shown to increase the proportion of blood lymphocytes 
following a 72 hr incubation but was inactive in a 30 min assay 
(Wilkinson, 1986). Similarly, aCD3 was capable of inducing the 
locomotory activity in PBL only after a prolonged cell culture (Wilkinson 
and Higgins, 1987a). Thus, this effect of #CD3 and PHA is related to an 
activation of resting PBL resulting in the expression of new activation- 
associated genes (Wilkinson, 1986). In contrast, aCD3 was capable of 
inducing rounding up within minutes of applying this monoclonal antibody 
to the constitutively polarized dbcAMP-cultured Jurkat cells. In 
lymphocyte activation studies, PHA was reported to induce a similar 
increase in [Ca^ ]^i observed following stimulation with aCD3 (Tsien et al. , 
1982). In addition, experiments with TcR negative mutants of Jurkat cells 
showed that these cells could not be activated by PHA (Weis and Stobo, 
1984). This suggests that the PHA signal is mediated through a pathway 
similar or identical to the one stimulated by aCD3. To further explore the 
similaiities between the pathways utilized by o:CD3 and PHA, the next 
series of experiments was performed.
9.2.1. Effect of PHA on the polarization of dbcAMP-cultured Jurkat cells
9.2.1.1. Effect o f PHA on the morphology of dbcAMP-cultured Jurkat cells
The time-course of an effect stimulated by a mitogenic PHA dose 
(figure 34) confirmed that this mitogen induces rounding up of the
Figure 34; Time-course of the effect of 1 jtig/ml PHA on repolarized 
dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 3 days, washed twice with HBSS/MOPS, resuspended in 1 ml 
of the medium and repolarized at 37°C for 30 min. PHA was added to the 
cells and the incubation was continued at 37®C for various time intervals. 
The cells were finally fixed with glutaraldehyde and the morphology was 
examined and quantified under phase contrast. Round cells (circle), 
iixegular cells (square) and polarized cells (triangles).
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dbcAMP-cultured Jurkat cells within 15 min. The important difference 
between this and the aCDS-stimulated response was that PHA induced a 
permanent change in morphology compared to the transient effect of 
q!CD3. The PHA effect was dose-dependent, detectable at 100 ng/ml and 
reaching 86% inhibition at 10 figfwl (figure 35).
9.2.1.2. Effect o f PHA on the morphology o f dbcAMP-cultured Jurkat cells 
preincubated with olCD3
Having previously shown that Jurkat cells, pre-incubated with 
aCD3, become refractory to repeated stimulation with this antibody, the 
effect of similar pre-treatment on the PHA signal was examined (figure 
36). It can be seen that the pre-treatment with aCD3 did not affect the 
response obtained following the addition of PHA.
9.2.2. Effect of Con A on the morphology of dbcAMP-cultured .Turkat 
cells
The other mitogen widely used to activate the lymphocytes is Con 
A. To determine if the effect stimulated by PHA is also mediated by a 
mitogenic dose of Con A, a time-course of its action on polarized Jurkat 
cells was observed (figure 37). As can be seen there was virtually no
action distinct from PHA,
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Îchange in any of the populations defined on the basis of their morphology.
9.3. SUMMARY
In conclusion, the above experiments showed that incubation of 
dbcAMP-cultured Jurkat cells with PHA caused a dose-dependent and 
permanent reversal of polarized morphology. The preincubation of Jurkat 
cells with aCD3 did not interfere with the PHA effect suggesting that the 
two mitogens affect the Jmkat cell morphology through different pathways. 
Con A had no effect on Jurkat cell morphology indicating a pathway of
I
Figure 35: Dose-dependent action of PHA on repolarized dbcAMP-
cultured Jurkat cells. The cells were cultured with 1 mM dbcAMP for 3 
days, washed twice with HBSS/MOPS, resuspended in 1 ml of the medium 
and repolarized at 37®C for 30 min. Different doses of PHA were added 
to the cells and the incubation was continued at 37®C for 15 min. The 
cells were finally fixed with glutaraldehyde and the morphology was 
examined and quantified under phase contrast. Round cells (circle), 
irregular cells (square) and polarized cells (triangles).
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Figure 36: Effect of PHA on dbcAMP-cultured Jurkat cells pretreated 
with œCDS for 60 min. The cells were cultured with 1 mM dbcAMP for 
3 days, washed twice with HBSS/MOPS, resuspended in 1 ml of the 
medium and repolarized at 37^C for 30 min. An aliquot of 10 fil of 2 
jMg/ml 0KT3 was added as indicated and the incubation was continued at 
37®C. Subsequently, PHA was added to the final concentration of 1 ptg/ml 
and the incubation was continued for various time intervals. The cells 
were finally fixed with glutaraldehyde and the morphology was examined 
and quantified under phase contrast. Polarized cells stimulated with aCD3 
and PHA (triangles), undisturbed (dotted line).
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Figure 37: Time-course of the effect of 1 pig/ml Con A on repolaiized 
dbcAMP-cultured Jurkat. The cells were cultured with 1 mM dbcAMP for 
3 days, washed twice with HBSS/MOPS, resuspended in 1 ml of the 
medium and repolarized at 37®C for 30 min. Con A was added to the cells 
and the incubation was continued at 37°C for various time intervals. The 
cells were finally fixed with glutaraldehyde and the morphology was 
examined and quantified under phase contrast. Round cells (circle), 
irregular cells (square) and polarized cells (triangles).
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10. INVOLVEMENT OF IN THE CONTROT. OF THE
LOCOMOTORY CAPACITY ACQUIRED BY dhcAMP-CULTURED 
JURKAT CELLS
10.1. BACKGROUND
Jurkat cells cultured in the presence of dbcAMP acquire locomotor 
morphology and become motile. The data so far have indicated that the 
activation of the cAMP signalling pathway results in the loss of this ability. 
In addition, stimulation through the TcR/CD3 complex results in a transient 
rounding up of the cells. The increase in [Ca^  ^]j of Jurkat cells, stimulated 
by a monoclonal aCD3 or ckTcR, has been documented (Weiss et a l ,  
1984b; Imboden et al. , 1985). To further explore the aCDS-induced 
change in the morphology of dbcAMP-cultured Jurkat cells, the 
involvement of Ca^  ^ was investigated in the next series of experiments.
10.1.1. Increase in intracellular Ca^ ^
The concentration of intiacellular Ca^  ^is very low and in most cells 
[Ca^ l^i oscillates between 100 and 200 nM (Carafoli, 1991) while the 
concentration of extracellular Ca  ^*^ and Ca^  ^ sequestered in specialized 
intracellular compartments exceeds 1 mM. Thus, a large concentration 
gradient drives Ca^  ^across the plasma membrane into the cytoplasm. The 
plasma membrane has a limited and carefully controlled Ca^ + permeability. 
The control of [Ca^ ]^i is performed by an importing system (Ca^  ^channel) 
and an exporting system (the Ca  ^^  pump and Na^/Ca^^ exchanger) of the 
plasma membrane.
10.1.2. Plasma membrane Ca^  ^ channels
The Ca^  ^ channels can be described as voltage-dependent or 
receptor-triggered. Voltage-dependent Ca^ + channels are regulated by
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membrane potential. These Ca^  ^ channels are opened by depolarization, 
generally caused by increased Na^ permeability. These channels are 
present on excitable cell types, however were not found on lymphocytes 
(Gelfand et a l , 1987).
The channels identified on lymphocytes by the patch-clamp 
technique are voltage insensitive (Kuno et a l,  1986). The channels are 
mostly closed in resting cells but open in response to stimulation with PHA 
(Kuno et a l,  1986), aCD3 or o;CD2 (Gardner et a l ,  1989). The Ca^  ^
channels are physically separate from CD3 and CD2 surface molecules
: > ' i(Gardner et a l ,  1989) and the secondary messengers mediating their 'opening appear to be IP3  (Kuno and Gardner, 1987), IP4  (Michell, 1986) 
or their combination (Morris et a l ,  1987). These Ca^  ^ channels are 
autoregulated by Ca^  ^ which causes tliem to close when [Ca^ j^i reaches 
about 1 fiM (Gardner et a l ,  1989).
Ca^  ^ channels can be blocked by several organic compounds, such 
as tertiary amines, like verapamil and its derivatives. These agents block 
the channel from inside, after having entered it in the open state (Lee and 
Tsien, 1983).
I
10.1.3. Ca^  ^ pump I
The active transport of Ca^  ^ is used by cells to maintain high 
concentr ation gradients of this cation across membranes delimiting cells and 
intracellular organelles. The sarcoplasmic reticulum membrane is highly 
differentiated for the active transport of Ca^  ^ and fragments of such 
membranes were used in characterization of Ca^  ^ transport (Ebashi and 
Lipmann, 1962). Ca^^-dependent ATPase is the sole operator of the Ca  ^' 
pump. The enzyme is a 110-kDa amphiphilic protein (MacLennan, 1970) 
with a globular head protruding from the cytoplasmic surface of 
sarcoplasmic reticulum and nonpolar segments crossing the lipid bilayer.
The enzyme sequentially binds two Ca^  ^ ions within the protein 
crevice (Inesi et a l ,  1980, 1988) where they are shielded from the
i
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ïmembrane phospholipid surface charge (Scofano et al. , 1985). The ATP 
interacts with the catalytic site of ATPase on the cytoplasmic side resulting 
in translocation of the ions, phosphorylation of the catalytic site and 
subsequent reduction of the Ca^  ^ pump binding constant for (Inesi,
1985; Pickart and Jencks, 1984). Thus, Ca^  ^ ions are released in the 
lumen, the phosphoenzyme undergoes hydrolytic cleavage and a new cycle 
begins (Inesi, 1987; Khananshvili and Jencks, 1988).
10.1.4. Dynamics of the increase in
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Cytosolic concenUations can be mobilized from either
intracellular stores or from the extracellular compartment. In most cells, 
activation by Ca^^-mobilizing agonists leads to two distinct phases of Ca^  ^
mobilization. Initially Ca^  ^ is mobilized from the intracellular stores and 
this is followed by an influx of extracellular Ca^ + (Rasmussen and Barrett,
1984). This latter activity is responsible for a sustained increase in [Ca^ J^i 
and also helps to replenish the depleted intracellular stores.
The role of intracellular in the TcR/CD3-mediated lymphocyte
activation, suggested by the effectiveness of Ca^  ^ ionophores, was
'examined in quin-2-loaded Jurkat cells stimulated with PHA, cxCD3 (Weiss 
et al., 1984b), or aTcR (Imboden et al., 1985). Indeed, the increase in 
ICa  ^ ]; during T cell activation consisted of two distinct phases. The 
addition of soluble monoclonal antibodies to Jurkat cells induced within 1 
min [Ca^+]i increase from the basal level of 80-100 nM to a peak value of 
350-750 nM (Weiss et a l ,  1984b; Imboden et a l ,  1985). The initial 
transient increase occurred independently of the presence of extracellular 
Ca^  ^ thus implicating the mobilization of intracellular Ca^ + (Imboden and 
Stobo, 1985). Following this rapid increase, the [Ca  ^ fell by 10 min to 
a new plateau of 200-250 nM and remained elevated above baseline levels 
for at least 30 min (Imboden and Stobo, 1985). Similarly, a cloned bovine 
insulin-specific T hybridoma (Shapiro et a l , 1985) and tetanus toxoid- 
specific T cells (Nisbet-Brown et a l , 1985), physiologically activated with
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appropriate antigen-pulsed AC, responded by an increase in [Ca  ^'^ ]i within 
10 min. PMA slightly lowers basal but does not prevent TcR/CD3- 
mediated [Ca^ J^i increase in Jurkat (Imboden et a l ,  1985) as well as in 
other T cell lines and T cell clones (O’Flynn et a l ,  1985; Weiss et a l ,  
1984a; Oettgen gr a /., 1985).
10.1.5. IP  ^ is a second messenger for release of from intracellular 
stom
Based on the hypothesis first put forward by Michell (1975), the 
mobilization of Ca^  ^ from intracellulai stores was shown to correlate with 
the appearance of a second messenger generated during the breakdown of 
phosphoinositides (Fain and Berridge, 1979ab).
The response to the stimulation of the cell surface, resulting in 
phosphatidylinositol changes, was first observed in brain cells (Hokin and 
Hokin, 1958). In these cells, acetylcholine, acting via muscarinic 
receptors, stimulated a specific incorporation of an isotope into the minor 
membrane phospholipid PP. A mechanism called the ’PI-PA' cycle was 
shown to be responsible for this incorporation. Thus, on stimulation with 
the ligand, PI is hydrolysed to DAG and IP in a reaction catalyzed by a 
Ca^^-dependent (Ryu et ah, 1987ab) phosphoinositide-specific PLC 
(Dawson, 1959; Kemp et a l , 1961b) and DAG is phosphorylated by ATP 
to form PA (Hokin and Hokin, 1959), Once the ligand is removed, PA is 
converted to PI by sequential action of CTP-PA cytidyl transferase and PI 
syntliase (Agranoff et a l ,  1958; Paulus and Kennedy, 1960).
The cleavage of PI(4,5)Pz by PLC (Kemp et a l ,  1961ab;
I
Tnositol-containing phospholipids constitute 2-8% of die total 
membrane phospholipid and are preferentially localized on the internal 
leaflet of the plasma membrane. Although inositol can be phosphorylated 
to a total of 66 possible arrangements of inositol phosphates (Majerus et 
a l , 1988) there are three major 7 ^ 0 -inositol containing phospholipids: PI, 
PI(4)P, and PI(4,5)P2 (phosphoinositides).
I
Thompson and Dawson, 1964) leads to the formation of soluble ÎP3 , which 
diffuses into the cytoplasm, and lipophilic DAG, which remains associated 
with the membrane (Majerus et ah, 1986). A single enzyme hydrolyzes 
all three phosphoinositides (Wilson et a l ,  1984). A wide variety of 
receptors in numerous tissues has been reported to be coupled to the 
activation of PLC, including the TcR/CD3 complex of T lymphocytes 
(Rhee and Choi, 1992). Indeed, c^TcR-stimulated Jurkat cells rapidly 
produce significant elevations in IPg, IPj and IP (Imboden and Stobo,
1985).
Since the discovery that IP3 can release Ca^  ^ from intracellular 
stores (Streb et a l ,  1983), this property of IP3 has been confirmed in a 
wide variety of tissues (Berridge, 1987; Benidge and Iiwine, 1989). 
Imboden and Stobo (1985) have been able to show that purified IP3  was 
able to release Ca^  ^ from an intiacellulai ATP-dependent pool in 
permeabilized Jurkat cells.
10.1.6. Intracellular IP,-specific receptors
The specificity of the IPs-specific receptor has been demonstrated 
in various tissues where IP and IP2 , the other two products of 
phosphoinositide hydiolysis, were unable to trigger the release of 
intracellular Ca^  ^ (Streb et a l ,  1983; Irvine et a l ,  1986). The initial 
identification of specific IP3 ~binding proteins was achieved using 
radioligand binding assays utilizing membranes from various sources 
(Ferris and Snyder, 1992). The native molecular weight of the IPa-binding 
protein is about 1 MDa (Supattapone et a l , 1988b); however, a purified 
receptor gives a single 260-kDa SDS-PAGE band suggesting a tetrameric 
structure of the native protein (Maeda et a l , 1991).
Ca^  ^ion was found to be a very potent inhibitor of pH]IP3 binding, 
with half-maximal inhibition at approximately 300 nM (Worley et a l ,
1987). The ability of Ca^  ^ to inhibit IP3 binding was reconstituted by the 
addition of detergent extracted membranes to the purified receptor (Danoff
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Iet al., 1988). The inhibition is mediated through a separate, membrane bound 15-kDa monomeric protein designated calmedin (Danoff et al.,
1988). The [^HjlPg binding and IPj-activated flux was monitored in 
homogeneous preparations of IP3 reconstituted into lipid vesicles; from 
such studies it was concluded that IP3 activates release of Ca^  ^ from 
intracellular stores through direct binding to a ligand-activated channel 
(Ferris gf aZ., 1989).
The phosphorylation of the IP3  receptor appears to provide a major 
mechanism of regulation. IP3 receptors were found to be major substrate 
for PKA; solubilized and purified IP3  receptor can be stoichiometrically 
phosphorylated by this protein kinase (Supattapone gf a l , 1988b). In fact, 
these receptors were recognized as Purkinje cell-specific phosphoprotein 
(Walaas et al., 1986; Weeks et al. , 1988). Following reconstitution and 
removal of the denaturing effects of detergents, PKC and Ca  ^Vcalmodulin- 
dependent protein kinase also specifically and stoichiometrically 
phosphorylate the receptor (Ferris et al., 1991). Although all of the 
kinases phosphorylate the IP3 receptor on serines, the location of these 
residues is specific to each of the three protein kinases (Penis et al.,
1991). In cerebellar membrane preparations PKA phosphorylation results 
in a ten-fold decrease in the potency of IP3 for releasing Ca^  ^ (Supattapone 
et al., 1988b). However, since PKA phosphorylation of the Ca^-transport 
ATPase results in enhanced accumulation of Ca^  ^ into the endoplasmic 
reticulum, the total amount of Ca^  ^ releasable by IP3  following PKA 
activation is significantly increased (Supattapone et a l,  1988b). In 
hepatocytes, cAMP-dependent hormones increase the sensitivity of Ca^  ^
stores to IP3 (Burgess et a l , 1991). Thus, the phosphorylation of IP3 
receptor in response to DAG and the subsequent increase in Ca^  ^ may 
provide two separated feedback systems.
The studies on IPs-activated Ca^  ^channels in reconstituted vesicles 
revealed a direct allosteric regulation of the channel by adenine nucleotides ; 
at low concentrations {i.e. 1-100 fiM) ATP markedly enhances the ability 
of IP3 to stimulate release while high concentrations of ATP remain
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ineffective (Ferris et a l , 1990). Using radiolabelled ATP or its analogue, 
a high-affinity ATP recognition site on the purified IP3  receptor was 
directly demonstrated (Ferris et a l ,  1990).
10.1.7. Intracellular IP^-sensitive Ca^ '"' stores
a
It is now clear that a discrete IP^-sensitive organelle exists in cells 
although the precise nature of this organelle is controversial (Rossier and 
Putney, 1991). In the first models, the transfer of Ca^  ^ from the 
extracellular space into the pool was proposed to first directly enter the 
intracellular pool and then enter the cytoplasm via an IPj-sensitive channel 
(Casteels and Droogmans, 1981; Putney, 1986). With a more sensitive 
Ca^  ^ indicator, a transient increase in the [Ca^  ^ji was detected during 
refilling process (Takemura and Putney, 1989; Hallam et a l,  1989;
Shuttleworth, 1990). A phenomenon of ’Ca^  ^overshoot’ was identified in 
cells whose intracellular Ca  ^‘ stores had been depleted in the absence of 
extracellular Ca^+; in such cells the increase in [Ca^+jj was transiently 
lar ger than in cells with intracellular Ca^  ^pool intact (Hallam et a l , 1989).
Thus depletion of the IPg-sensitive Ca^  ^ stores not only increases plasma 
membrane permeability to Ca^  ^but also shows that such depletion triggers 
an increased influx of extracellular Ca^  ^ directly into cytoplasm.
Additional evidence was obtained by depletion of the intracellular 
Ca^  ^ pool by the non-phorbol ester tumour promoter thapsigargin in the 
presence of extracellular Ca^ ,^ and in the absence of any changes in inositol 
phosphates (Jackson et a l ,  1988). This toxin depletes intracellular' Ca^  ^
stores by a specific action on the Ca^^-transport ATPase on intracellular 
membranes; thapsigargin does not inhibit active Ca^ + transport by the 
plasma membrane of cells (Thastrup et a l , 1990). It is thought that once 
the active Ca^  ^uptake into the intracellular pool is inhibited, Ca^  ^diffuses 
through a Teak’ channel. In parotid acinar cells, thapsigargin induced an 
increase in [Ca^ ]^j and sustained influx of extracellular Ca* ;^ subsequent 
ligand stimulated IP3  failed to induce additional Ca^  ^release (Takemura et
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a l,  1989). Combination of thapsigargin and ligand showed synergistic
increase reflecting the combined result of IPj-sensitive channel 
opening and inhibition of active Ca^  ^ uptake (Thastrup et a l ,  1990; 
Thastrup, 1990). Thus, thapsigargin and agonists acting through various 
receptors activate a common Ca^  ^entry pathway (Marier et a l , 1978). It 
is clear that the intracellular Ca^  ^pool and plasma membrane are physically 
separated. However, the ability of the former to affect the plasma 
membrane permeability, suggested that a means of communication 
between the two structures is necessary. The phosphorylated product of IP3  
metabolism, IP4 , was suggested to play a significant role in the regulation 
of Ca^  ^ entry (Irvine et a l ,  1988; Irvine, 1991, 1990). However, much 
of the evidence is contradictory and the mechanism of its action is still 
unclear (Irvine, 1992).
10.2. EXPERIMENTAL
10.2.1. Intracellular Ca^  ^levels measured in dbcAMP-cultured Jurkat cells
10.2.1.1. f f l u c t u a t i o n s  in response to aCD3
The involvement of aCD3 in stimulation of intracellular Ca^  ^
increase was shown directly using a Ca^  ^indicator fura-2 (figure 38). The 
Ca  ^^  concentration started to increase in about 30 sec after the stimulus was 
introduced and continued to do so for 2-3 min. In that time, [Ca^ J^j 
increased from 55-65 nM to 400-550 nM. Subsequently, a marked 
decrease in [Ca^ ]^, was observed until a plateau of 300-350 nM was 
reached at 4.5-5 min of the experiment. The plateau levels in [Ca  ^
induced in dbcAMP-cultured Jurkat cells by <%CD3, were sustained for at 
least 15 min without any signs of decrease (results not shown). The 
observed [Ca  ^ ]; fluctuations in response to aCD3 resembled, both 
quantitatively and qualitatively, those published previously (Imboden and
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Figure 38: Time-course of ceCDS-mediated increase in intracellular Ca^ + 
in dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 3 days and washed twice with HBSS without phenol red. The 
cells were then loaded with fura-2 A, washed and resuspended at 2x10® 
cells/ml in HBSS. OKT3 was added to the final concentration of 50 ng/ml 
and the fluorescence intensity was recorded over time at 510 nm using 
excitation at 340 and 380 nm. Finally, the instrument was calibrated and 
the absolute intracellulai* concentrations were calculated.
600 -1
500 # #
400 -
%
300 -+-f-O
200 -
100 -
50 100 150 200 250 3000
Time (sec)
:
S
T
.■'I
I
i
165
Î
Stobo, 1985).
Although the change in the cell morphology correlates with the 
[Ca^  ^Ji increase, the dynamics of the shape transformation do not reflect 
those shown in figure 38. The rapid onset of [Ca^ J^; increase is contrasted 
with a slower progress of cxCDS-mediated rounding up, which reaches 
maximum at 10-15 min. In addition, the plateau Ca^  ^ levels were shown 
to persist for at least 30 min (Imboden and Stobo, 1985), which 
corresponds to the time associated with substantial recovery of polarized 
morphology by dbcAMP-cultured Jurkat cells. Thus, it is not likely that 
Ca^  ^ is the messenger which directly affects the locomotory machinery. 
The above observations therefore suggest that (1) the increase in [Ca^ J^i is 
purely coincidental or (2) Ca^  ^ is a messenger which activates an 
intracellular pathway which eventually affects the locomotory machinery.
10.2.1,2. [Cé^ Ji fluctuations in response to PHA
The intiacellular Ca^  ^ increase, induced by the mitogenic dose of 
PHA, was slower (figure 39) when compared to that observed with aCD3 
(figure 38). Here, the maximum levels of 250-300 nM were attained after 
3.5-4 min, followed by only slight decrease to pleateau levels of 200-300 
nM. The lack of promient initial peak observed with œCD3, and assuming 
that the source of this peak is intracellular Ca^  ^ pool, PHA seems to 
stimulate primaiily influx of extracellular Ca^  ^ in Jurkat cells. This 
suggestion is supported by the similarity in plateau [Ca^ J^j levels induced 
by the two mitogens. Although the relatively uniform increase in [Ca^ J^, 
by PHA is consistent with the sustained PHA-induced rounding up of 
dbcAMP-cultured Jurkat cells, the latter reaches maximum after 10 min 
compared to 4 min required by the former. This observation further 
challenges the possibility that Ca^  ^ is directly the regulator of changes in 
lymphocyte morphology. However, the two possibilities, outlined above, 
for the involvement of Ca^  ^ in the regulation of the locomotory capacity 
still cannot be delineated. Indeed, PHA may interact with multiple cell
1 6 6
Figure 39: Time-course of PHA-mediated increase in intracellular Ca^  ^
in dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 3 days and washed twice with HBSS without phenol red. The 
cells were then loaded with fura-2 A, washed and resuspended at 2x10® 
cells/ml in HBSS. PHA was added to the final concentration of 1 j i^g/ml 
and the fluorescence intensity was recorded over time at 510 nm using 
excitation at 340 and 380 nm. Finally, the instrument was calibrated and 
the absolute intracellular Ca^  ^ concentrations were calculated.
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10.2.2.1. Effect o f Cd^-jree media
1
I
surface structures tlius activating several biochemical pathways 
simultameously.
10.2.2. Effect of extracellular Ca^ * on the response of dhcAMP-cultured 
Jurkat cells to oiCD3 and PHA
:i‘
I
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The ability of <xCD3 to affect the [Ca^ j^j of dbcAMP-cultuied Jurkat 
cells has been demonstrated. The next series of experiments was used to 
determine the effect of extracellular on the rounding up induced by 
«CDS. The preliminary o:CD3 dose-response experiments in Ca^^/Mg^^- 
free medium, supplemented with EDTA indicated that aCD3 at 
concentrations of up to 20 ng/ml OKT3 is inactive under such conditions 
(figure 40). :To assure that the aCD3-activated signal is affected by the absence 
of Ca^  ^ rather than Mg^^, media containing these ions either separately or 
in combination were prepared. The results obtained with these media 
indicate that extracellular Ca^‘‘ is vital for the CD3-mediated pathway 
(figure 41-A). The presence of EDTA in the Ca^^-free medium is not 
necessary for the inhibition of the aCD3 effect, however it improves the :efficiency of inhibition, probably by chelating the trace Ca^+ ions (figure !42).
To compare the PHA- and aCD3-mediated pathway further, the 
requirement for extracellular Ca^  ^ in the change of cell morphology
induced by PHA was assessed (figure 41-B). Indeed, it was observed that 
PHA also requires the presence of Ca^  ^ in the test medium to mediate the 
change in morphology of the cells.
The presence of extracellular plays a crucial role in the aCD3- 
induced shape change of dbcAMP-cultured Jurkat cells. One of the 
possible functions considered had to do with the binding of tlie monoclonal 
antibody OKT3 to the surface CD3 molecule in a Ca^^-free environment.
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Figure 40: Effect of extracellular calcium on the dose-response of
dbcAMP-cultured Jurkat cells to otCDS. The cells were cultured with 1 
mM dbcAMP for 3 days, washed twice with HBSS/MOPS, and 
resuspended in 1 ml of the medium. The repolarization was carried out in 
calcium-free HBSS/MOPS supplemented with 1 mM EDTA or in regular 
HBSS/MOPS at 37°C for 30 min. The different concentrations of 0KT3 
were added and the incubation was continued for 15 min. The cells were 
finally fixed with glutaraldehyde and the morphology was examined and 
quantified under phase contrast. Round cells (circle), irregular cells 
(square) and polarized cells (triangles).
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Figure 41 : Effect of the absence of extracellular and Mg  ^* on the 
change in morphology of dbcAMP-cultured Jurkat cells stimulated by 
o;CD3 (A) or PHA (B). The cells were cultured with 1 mM dbcAMP for 
3 days, washed twice with HBSS/MOPS, and resuspended in 1 ml of the 
medium. The repolarization was carried out in Ca^^-free HBSS/MOPS 
supplemented with various combinations of Ca^  ^ and Mg^  ^ at 37®C for 30 
min. 0KT3 or PHA was added to a final concentration of 20 ng/ml or 1 
^M respectively and the incubation was continued for 15 min. The cells 
were finally fixed with glutaraldehyde and the morphology was examined 
and quantified under phase contrast. Polarized cells in buffer only (open 
bars), in the presence of ojCDS or PHA (hatched bars).
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Figure 42: Effect of the presence of EDTA on the change in morphology 
of dbcAMP-cuituied Jurkat cells stimulated by o:CD3. The cells were 
cultured with 1 mM dbcAMP for 3 days, washed twice with HBSS/MOPS, 
and resuspended in 1 ml of the medium. The repolarization was cairied 
out in Ca^^-free HBSS/MOPS supplemented with various combinations of 
calcium and EDTA at 37°C for 30 min. OKT3 was added to final 
concentration of 20 ng/ml and the incubation was continued for 15 min. 
The cells were finally fixed witli glutaraldehyde and the morphology was 
examined and quantified under phase contrast. Polarized cells in the 
absence of aCD3 (open bars), in the presence of soluble aCD3 (hatched 
bars).
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However, the staining procedure for the FACS analysis is performed using 
PBS which contains no Ca^  ^ in its formulation. The FACS results clearly 
show the ability of OKT3 to bind to CD3 in a Ca^^-free environment 
(figure 12a-A). Further consideration was given to the conformational 
change, induced by the binding of aCD3 to the TcR/CD3, which may be 
responsible for the transmission of the signal into cytoplasm of the cell. 
Perhaps the conformational change, or its extent, and subsequently the 
intracellulai" signal aie affected in the absence of extracellular Ca^\ 
However, the measurements of [Ca^^]i, in cells responding to aCD3 in 
Ca^^-free medium, showed a response consistent with the TcR/CD3 
mediated signal. Thus, it appears that the extracellular Ca^  ^ is itself a 
messenger delivered dming a controlled Ca^  ^ influx.
10.2.2.2. Effect o f ionophore
Ca^  ^ionophores are hydrophobic agents which specifically bind and 
transport Ca^  ^ ions across plasma membrane of cells. The [Ca^ j^j in such 
cells increases rapidly and irreversibly. The effect of Ca^  ^ ionophore 
A23187 on the morphology of repolarized dbcAMP-cultured Jurkat cells 
was assessed in a time-course experiment (figure 43). The second 
messenger role of Ca® ^  has been shown in the context of the cell 
morphology regulation although a non-specific effect of the ionophore on 
the locomotory machineiy is possible. The dynamics of the shape change 
suggest that a rapid increase in the intracellular Ca  ^' is associated with a 
reversal of the polarization in the Jurkat cells. A slight recovery of the 
polarized morphology is noticeable after 15 min which may be a 
consequence of active removal of the intracellular by the cells.
The addition of HSA to the repolarization medium does not affect 
the extent of repolarization of dbcAMP-cultured Jurkat cells. However, 
the effective concentration of the Ca^  ^ ionophore subsequently added was 
decreased as it is non-specifically bound to the albumin. The concentration 
of the Ca^  ^ ionophore affects its ability to round up Jurkat cells
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Figure 43: Time-course of action of A23187 on dbcAMP-cultured Jurkat 
cells. The cells were cultured with 1 mM dbcAMP for 3 days, washed 
twice with HBSS/MOPS, resuspended in 1 ml of the medium and 
repolarized at 37°C for 30 min. A23187 was added to final concentration 
of 10 and the incubation was continued at 37®C for valions time 
intervals. The cells were finally fixed with glutaraldehyde and the 
morphology was examined and quantified under phase contrast. Round 
cells (circle), irregular cells (square) and polarized cells (triangles).
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Iqualitatively and quantitatively (figure 44-A). At lO'^M the ionophore produced a sustained decrease in polai'ization of dbcAMP-cultured Jurkat 
cells while in the presence of HSA, the response was much lower and
transient, requiring more that 60 min to recover to the initial level of 
polarization. This transient effect was reproduced by lowering of the Ca^  ^
ionophore concentration in the absence of HSA (figure 44-B). Estimating 
from the results shown, 1 mg/ml HSA lowered the effective concentration 
of A23187 about 10-fold.
The data obtained with lower concentration of the Ca^  ^ ionophore 
seem to refute the possibility of non-specific action of A23187 on the 
locomotory machinery. It is more likely that the cells can reverse the 
effect of these lower concentrations by actively pumping the excess 
out of the cell. This return to normal [Ca^  ^ji would then be reflected by 
the recovery of polarized morphology.
I
10.2.3. Involvement of intracellular Ca^  ^ on the repolarization of 
dbcAMP-cultmed Jurkat cells
10,2.3.1. Effect o f thapsigargin on cell polarization
A time-course of thapsigargin action on repolaiized dbcAMP- 
cultured Jurkat cells resulted in rapid rounding up an interesting bi-phasic 
restoration of their polarized morphology (figure 45). The proportion of 
polarized cells decreased rapidly from the initial 67%, reaching the 
minimum of 24% at 5 min. In the next 5 min, the numbers of polarized 
cells were restored to 44% at a rate that reflected the initial decrease.
After this rapid initial rate, the proportion of polarized cells recovered 
slowly, at a rate resembling that following aCDS stimulation, to reach the 
maximum of 56% at 60 min. The final proportion of polarized cells was 
consistently lower than the initial one. The negative control showed 
marginally higher proportion of polarized cells at 60 min, compared to the 
observation made at time 0.
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Figure 44: Effect of HSA on tlie time-course of action of lO^M A23187 
(A); dose-dependent action of A23187 (B). The cells were cultured with 
1 mM dbcAMP for 3 days, washed twice with HBSS/MOPS, resuspended 
in 1 ml of the appropriate medium and repolarized at 37°C for 30 min. At 
time 0, A23187 was added to the cells at lO^M (A) or as indicated (B) and 
the incubation was continued at 37°C for 60 min. The cells were fixed at 
5 and 60 min with glutaraldehyde and the morphology was examined and 
quantified under phase contrast. (A) Round cells (circle), iiregular cells 
(square) and polarized cells (triangles); (B) Polarized cells at 5 min (open 
bars) or 60 min (hatched bars).
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Figure 45: Time-course of the effect of 1 {aM  thapsigargin on repolarized 
dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 3 days, washed twice with HBSS/MOPS, resuspended in 1 ml 
of the medium and repolarized at 37°C for 30 min. Thapsigaigin was 
added to the cells at time 0 and the incubation was continued at 37°C for 
various time intervals. The cells were finally fixed with glutaraldehyde 
and the morphology was examined and quantified under phase contrast. 
Round cells (circle), iiTegular cells (square) and polarized cells (tiiangles).
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10,2.3.2, Effect o f thapsigargin on intracellular levels
177
The transient action of thapsigargin was dose-dependent witli the 
maximum activity detected at concentrations between 5x1 O^M and lO^M 
(figure 46).
The release of from intracellular stores is, under physiological
conditions, mediated by IPa-receptor operated Ca^  ^channels. The release 
of intracellular stores of can be simulated, in the absence of 
inositolphosphates, by thapsigargin.
Direct examination of [Ca^ * ]i in thapsigaigin-treated Juikat cells 
revealed a definite bi-phasic increase observed in aCD3-stimulated cells 
(figure 47). Clearly, the release of intracellular stores, registered as 
the initial peak, is linked to the induction of lower (200-400 nM) but 
sustained increase in [Ca^ ]^j shown also with «CD# and PH A. This plateau 
is maintained by the influx of extracellular Ca^T However, the time- 
course of [Ca^ l^i fluctuations, in response to thapsigargin, revealed 
differences consistent with different mode of action of these activators.
The effect of thapsigaigin was noticeable in about 10 sec, compared 
with aCD3-stimulated increase which commenced about 30 sec after the 
introduction of the antibody. This difference may reflect the need of 
aCD3~stimulated cells to first produce sufficient levels of IP3  prior to the 
release of intracellular' Ca , while thapsigargin acts immediately upon 
penetration into the cytoplasm.
The peak Ca^  ^ levels of 500-800 nM, induced by thapsigargin, were 
noticeably higher than those seen with aCD3. In addition, the variation 
in magnitude of intrcacellular Ca^ + 'spikes’ was much larger, covering at 
times range between 400 and 900 nM. These observations may reflect the 
existence of IPa-insensitive intracellular Ca  ^^  pools (Putney, 1988) accessed 
by thapsigargin but not aCD3.
Figure 46: Dose-dependent action of thapsigaigin on repolarized
dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 3 days, washed twice with HBSS/MOPS, resuspended in 1 ml 
of the medium and repolarized at 37°C for 30 min. Different doses of 
thapsigargin were added to the cells and the incubation was continued at 
37°C for 5 min. The cells were finally fixed with glutaraldehyde and the 
morphology was examined and quantified under phase contrast. Polarized 
cells (triangles).
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Figure 47: Time-course of thapsigargiii-mediated increase in intracellular 
Ca^  ^ in dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 3 days and washed twice with HBSS without phenol red. The 
cells were then loaded with fura-2A, washed and resuspended at 2x10® 
cells/ml in HBSS. Thapsigargin was added to the final concentration of 1 
fiM and the fluorescence intensity was recorded over time at 510 nm using 
excitation at 340 and 380 nm. Finally, the instrument was calibrated and 
the absolute intracellular Ca^  ^ concentrations were calculated.
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10.2.3.3, Role o f extracellular in thapsigargin effect on cell 
polarization
The depletion of intracellular stores causes the initiation of the
influx of extracellular Ca^ .^ To determine whether this influx is necessary 
for the change in cell morphology, a similar time-course was performed in 
Ca^^-free medium. The effect of thapsigargin was abolished under these 
conditions (figure 48). Thus, thapsigargin similarly to the oiCDS requires 
the presence of extracellular to affect the morphology of repolarized 
Jurkat cells. It may be suggested that the influx of extracellular Ca^  ^is the 
key mediator of biological events resulting in the loss of the polarized 
morphology.
10.2.3.4. Role o f intracellular Cd^ stores in the effect o f thapsigargin on 
cell polarization
The thapsigaigin treatment is thought to permanently empty the 
intracellular Ca^  ^stores. The thapsigaigin-pretreated and repolarized cells 
would therefore be expected to be refractory to subsequent doses of 
thapsigaigin. For the purpose of this experiment the dose of thapsigargin 
was lowered to SxlO'^M as thapsigargin at double dose of 10 ®M appeared 
to be toxic. Surprisingly, addition of thapsigargin to such pretreated and 
repolarized cells resulted in a response observed as transient reversal of 
polarization (figure 49-A). However, the initial rapid decline in polarized 
population, observed in normal dbcAMP-cultured Jurkat cells, was 
eliminated. In addition, the response was diminished to about a third of 
that observed in the non-pretreated cells. The recovery of polarized 
morphology in the pretreated cells was faster (within 30 min) and to levels 
slightly higher than those observed at the start of the experiment.
The evidence described suggests that the initial rapid effect of 
thapsigargin, observed as a ’spike’ in Jurkat cell rounding up, correlates 
with the release of from intracellular stores. However, this release
1 8 0 Î
Figure 48: Effect of the absence of extracellular Ca^' on the change in 
morphology of dbcAMP-cultured Jurkat cells stimulated by thapsigargin. 
The cells were cultured with 1 mM dbcAMP for 3 days, washed twice with 
HBSS/MOPS, and resuspended in 1 ml of the medium. The repolarization 
was carried out in normal or Ca^^-free HBSS/MOPS. Thapsigargin was 
added to the cells and the incubation was continued at 37°C for various 
time intervals. The cells were finally fixed with glutaraldehyde and the 
morphology was examined and quantified under phase contrast. Polarized 
cells in the presence (open triangles) and absence (full triangles) of Ca^+.
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Figure 49; Effect of pretieatment of dbcAMP-cultured Jurkat cells with 
thapsigaigin on the response to subsequent stimulation with thapsigargin 
(A) and aCD3 (B). The cells were cultmed with 1 mM dbcAMP for 3 
days, washed twice in HBSS/MOPS and repolarized for 60 min at 37”C in 
the presence of 500 nM thapsigargin. OKT3 and thapsigargin were added 
to the final concentration of 20 ng/ml or 500 nM respectively and the 
incubation was continued for 15 or 5 min respectively. The cells were 
finally fixed with glutaraldehyde and the morphology was examined and 
quantified under phase contrast. Polarized cells preincubated in the 
absence (open tiiangles) and in the presence (full triangles) of tlie agents.
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is most likely amplified by the influx of extracellular as in its absence 
no effect on the cell moiphology was seen. It is possible that transiently 
the [Ca^"]i is sufficiently high to stabilize the microtubule network thus 
resulting in rapid rounding up of the Jurkat cells. The second stage, 
consisting of a slower rate of recovery of the polarized morphology, 
follows a visibly different dynamic. Thus, it is most likely caused by a 
different mechanism also triggered by aCD3. This mechanism requires a 
prolonged increase in [Ca^ ]^i sustained by the influx extracellular Ca^\ In 
the second stage, Ca^  ^probably acts to activate secondary pathways which 
result in cell rounding up observed with aCD3 and in the latter part of the 
thapsigargin-stimulated response.
I
10.2.3.5. Role o f intracellular Ca  ^ stores in the effect o f aCD3 on cell 
polarization
The release of from intracellular stores appears to be an 
important trigger affecting the influx of extracellular Ca^ .^ Thus, the
pretreatment of Jurkat cells with thapsigargin would be expected to 
eliminate the response to the aCD3. However, the effect of o:CD3 did not 
seem to be affected by the pre-treatment (figure 49-B). The difference was 
that the initial and final proportion of polarized cells was lower in the 
pretreated cells which seems to be a consequence of the presence of 
thapsigargin. However, the magnitude of the maximum response was 
identical in the normal and pre-treated cells. The results suggest that the 
lack of Ca^  ^ in the intracellular stores does not affect the aCD3-mediated 
signal again implicating the influx of extracellular Ca^  ^ as the main 
mechanism.
#
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10.2.4. Involvement of channels
The involvement of extracellular Ca^  ^ was further examined using 
verapamil, an inhibitor of Ca^  ^channels. Verapamil on its own showed no
f
effect on the repolarized dbcAMP-cuItnred Jurkat cells at a concentration 
of 10 M  (figure 50). Indeed, when the cells were preincubated with lO^M 
verapamil, the (xCD3 subsequently induced the same effect as the one 
observed in the absence of the channel blocker (figure 51).
The effect of verapamil, at the concentration used, in blocking the 
influx of the extracellular Ca^ ,^ was not confirmed. Thus, two possible 
explanations are available: (1) the dose was insufficient to prevent the 
influx and (2) the Ca^  ^ channels engaged in the influx linked to the 
TcR/CD3 complex signal are verapamil-resistant.
10.2.5. Involvement of calcium-binding protein
The involvement of Ca^^-binding protein calmodulin was examined 
with the help of W-7. This calmodulin inhibitor at the concentration of 10 
M  was found to completely reverse the polarization of the dbcAMP- 
cultured Jurkat cells (figure 52). The effect of this drug was no longer 
detected at 10®M. When the cells were pretreated with lO^M W-7 the 
CD3-mediated pathway was not affected (figure 53). The observations 
suggest that the polarization of the dbcAMP-cultured Jurkat cells is 
maintained by a mechanism which involves calmodulin.
10.3. SUMMARY
In conclusion, the above experiments showed that incubation of 
Jurkat cells with aCD3, PHA and thapsigargin caused a sustained elevation 
of [Ca^ l^î. The effect of aCD3 and PHA results in rounding up of 
dbcAMP-cultured Jurkat cells and is dependent on the presence of 
extracellulai Ca  ^% The connection between an increase in [Ca^ ]^; and the 
regulation of lymphocyte morphology was established when incubation of 
dbcAMP-cultured Jurkat cells with A23187 and thapsigargin caused 
reversal of polarization. The experimental evidence suggests that the
184
Figure 50: Time-course of the effect of lO^M verapamil on repolarized 
dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 5 days, washed twice with HBSS/MOPS, resuspended in 1 ml 
of the medium and repolarized at 37°C for 30 min. Verapamil was added 
and the incubation was continued at 37°C for various time intervals. The 
cells were finally fixed with glutaraldehyde and the morphology was 
examined and quantified under phase contrast. Round cells (circle), 
irregular cells (square) and polarized cells (triangles).
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Figure 51: Effect of 10 verapamil on the morphology change of 
dbcAMP-cultured Jurkat cells stimulated with aCD3. The cells were 
cultured with 1 mM dbcAMP for 3 days, washed twice with HBSS/MOPS 
or calcium-free HBSS/MOPS supplemented with EGTA. Cells were then 
resuspended in 1 ml of the same medium. Verapamil was added and the 
cells were repolarized at 37^C for 30 min. After this time OKT3 was 
added to the final concentration of 20 ng/ml and the incubation was 
continued at 37°C for 15 min. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast. Polarized cells in the absence (open bars) or presence 
(hatched bars) of q:CD3.
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Figure 52: Dose-response of repolarized dbcAMP-cultured Jurkat cells 
to the action of W-7. The cells were cultured with 1 mM dbcAMP for 4 
days, washed and repolaiized at 37°C for 30 min. Various concentrations 
of W-7 were added and the incubation was continued for 80 min. The 
cells were finally fixed and the morphology was examined and quantified 
under phase contrast. Round cells (circle), irregular cells (square) and 
polarized cells (triangles).
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Figure 53: Effect of the pretreatment with W-7 on the morphology 
change of repolarized dbcAMP-cultured Jurkat cells stimulated with aCD3. 
The cells were cultured with 1 mM dbcAMP for 3 days and washed. W-7 
was added to tlie final concentr ation of lO^M and the cells were repolarized 
at 37°C for 1 hr. After this time 0KT3 was added to the final 
concentration of 20 ng/ml and the incubation was continued at 37®C for 15 
min. The cells were finally fixed with glutaraldehyde and the morphology 
was examined and quantified under phase contrast. Polarized cells in the 
absence (open bais) or presence (hatched bars) of g:CD3.
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influx of extracellular is necessary affect the cell morphology with 
playing most likely a role of secondaiy messenger.
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11. INVOLVEMENT OF PROTEIN PHOSPHORYLATION IN THE 
REGULATION OF THE LOCOMOTORY CAPACITY ACQUIRED BY 
dhcAMP-CULTURED JURKAT CELLS
11.1. BACKGROUND
The polarization of dbcAMP-treated Jurkat cells is tiansiently 
inhibited by a signal through the TcR/CD3 complex. This process has 
been shown to require the presence of extracellular Ca  ^ and appears to 
correlate with the increase in [Ca^^f. The intracellular store of Ca®^  is 
released by IP3 , a second messenger generated during the aCD3-induced 
phosphoinositide hydrolysis. The other second messenger generated is 
DAG which is the physiological activator of PKC. Thus, there are two 
possible explanations of the locomotion-related events associated with 
signalling through the TcR/CD3 receptor. First, the involvement of 
inhacellular Ca^  ^ whose elevated concentration may temporarily stabilize 
the polymerization of microtubules or activate Ca^^-dependent intracellular 
enzymes such as protein kinases or phospholipases. Second, the transient 
production of DAG synergizing with the increase in the intracellular Ca^  ^
activates PKC.
The next set of experiments was designed to explore the effect of 
phorbol esters, and other agents affecting the phosphorylation state of 
intracellulai proteins, on the locomotory capacity of dbcAMP-cultured 
Jurkat cells.
11.1.1. Regulation of intracellular processes by protein phosphorylation
The variations in the phosphorylation of proteins has been 
recognized as the most common mechanism of regulation of tiieir function. 
Indeed, an immediate consequence of T cell activation is the 
phosphorylation of a wide range of proteins on seryl, threonyl and tyrosyl 
residues (Alexander and Cantrell, 1989). The protein phosphorylation at
190
11.1.2. PKC and its substrates
f
tyrosine residues has received much attention due to its role in key 
regulatory mechanisms affecting growth and differentiation (Hunter and 
Cooper, 1985). However, 99% of protein phosphoiylation occurs at serine 
and threonine residues and is catalyzed by kinases such as PKA, PKC, and 
MAP kinase (Permutter et ah, 1993). The phosphorylation state of 
proteins is kept at a dynamic equilibrium maintained by the action of 
kinases and phosphatases (Cohen, 1992). It is suggested that stimulation 
of T cells via the TcR leads to activation of a specific set of protein kinases 
and phosphatases, leading to phosphorylation of a specific set of cellular 
proteins (Alexander and Cantrell, 1989). Some of these target proteins 
may be important in the motor and cytoskeletal structures involved in 
lymphocyte locomotion.
PKC was originally detected as an unidentified protein kinase
present in many tissues and activated by limited proteolysis by Ca^- 
dependent neutral thiol protease calpain or by trypsin (Inoue et al,, 1977; 
Takai et a l ,  1977). Subsequently it was shown that PKC could be 
activated in the presence of Ca^  ^ and phospholipid without proteolysis 
{Tdkàïetal, 1979a).
PKC when tested in vitro had a broad substrate specificity 
phosphorylating seryl and threonyl but not tyrosyl residues of many 
endogenous proteins in most tissues (Nishizuka, 1984). In vitro these 
substrates include a number of cell surface receptors, contractile and 
cytoskeletal proteins and enzymes (Turner and Kuo, 1985; Nishizuka, 
1986; 1988). Among the most relevant substrates in T cell activation are 
CD3y, CD3Ô, and CD3e (Samelson et at,, 1985ab, 1986, 1987; Baniyash 
et a l ,  1988b; Breitmeyer et a l ,  1987; Cantrell et a l , 1985, 1987; 
Minami et a l , 1987; Chatila and Geha, 1988; Patel et a l , 1987), CD4 
and CDS (Chatila and Geha, 1988; Acres et a l , 1986, 1987; Blue et a l , 
1987; Hoxie et a l ,  1988), CD45 (Autero and Gahmberg, 1987;
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Schackelford and Trowbridge, 1986), IL-2ra (Gaulton and Eaidley, 1986; 
Schackelford and Trowbridge, 1984, 1986), MHC class I (Autero and 
Gahmberg, 1987; Schackelford and Trowbridge, 1986), and p56'“* 
(Veillette â /., 1988a, 1989a).
11.1.3. Requirements for activation of PKC
Kinetic studies revealed that a small amount of DAG increased
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Activation of PKC requires the "unmasking’ of the regulatory 
domain from the catalytic site. The conformational change is brought 
about by the interaction of PKC with co-factors. PKC interacts dfrectly 
with phospahtidylserine or Ca^  ^but not with DAG or phorbol ester in the 
absence of the former two co-factors. PKC showed preference for 
phosphatidylserine, as this phospholipid was found to be the most effective 
in reconstituting the PKC activity (Takai et a l ,  1979b). Other 
phospholipids may show positive {i.e. phosphatidylethanolamine) or 
negative (i.e. phosphatidylcholine and sphingomyelin) cooperativity 
(Kaibuchi et al., 1981) suggesting the impoilance of the phospholipid 
environment on PKC activity. The four carboxyl groups of serine are 
thought to ligate with Ca^  ^ so that PKC can associate with this membrane-
i fassociated complex prior to its activation with DAG (Ganong et al. , 1986).
I
about 100-fold the affinity of PKC for Ca^ ,^ fully activating it without any 
change in intr acellular Ca^  ^ levels (Takai et a l , 1979b; Kishimoto et al. ,
1980; Kaibuchi et a l ,  1981). PKC requires one molecule of DAG and 
four molecules of phosphatidylserine for complete activation (Hannun et 
a l , 1985, 1986). Thus, the active PKC is a quaternary complex consisting 
of phospholipid, Ca^ ,^ DAG and the enzyme.
1
11.1.4. Heterogeneity of PKC
There are more then one species of PKC molecule showing distinct 
enzymological characteristics with defined tissue expression and
■1
:intracellulai' localization (Nishizuka, 1988; Kikkawa et al. , 1989). At the
present, ten subspecies of PKC have been identified in cDNA libraries 
fi-om various tissues. The first group of classical or conventional PKC 
(cPKC) subspecies (designated a, Bj, Bn, y) was identified during the initial 
screening, while the second group consists of new PKC (nPKC) subspecies 
(Ô, e, p [L] and 0) and the third of atypical PKC (aPKC) subspecies (Ç and
À), so called to reflect their unusual activation requirements. Full 
activation of the cPKCs is thought to require phosphatidylserine, Ca^^, and 
DAG while members of nPKCs do not require Ca^  ^ for activation (Hug 
and Sarre, 1993). PKC(, a member of aPKC family, exhibits a low but 
constitutive activator-independent kinase activity which can be further 
stimulated by phosphatidylserine or unsaturated fatty acids such as 
arachidonic acid (Hug and Sarre, 1993).
PKC was isolated also in lymphocytes (Ogawa et al. , 1981) and in 
lymphoid tissues and leukaemic cell lines (Kuo et al., 1980). Peripheral 
T lymphocytes or leukaemic T cells express PKCa and PKCB (Altman et 
al., 1990; Mills et al., 1988; Beyers et al., 1988; Koretzky et al., 1989;
Shearman et al., 1988) where normal T cells express high levels of PKCB 
compared to PKCa (Shearman et al. , 1988) while leukaemic cell lines such 
as Jurkat express higher levels of PKCa (Alexander and Cantrell, 1989).
11.1.5. Structure of PKC
.1
a
All of the PKC subspecies aie composed of a single polypeptide 
where cPKC comprise four conserved (C1-C4 ) and five variable (V1-V5 ) 
regions (Coussens et al., 1986; Kikkawa et al. , 1987) while the others 
lack C2 .
Cl and Ca make up the regulatory domain presumed to contain Ca^ ,^ 
DAG and phospholipid binding sites while Ca and C4  contain an ATP- 
binding site and show an extensive homology with many other protein 
kinases and thus represent the catalytic domain. The catalytic domain is 
fully active without Ca^% phospholipid and DAG when preferentially
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cleaved from the native PKC by calpain (Kishimoto et at., 1983).
11.1.6. Regulatory functions of PKC
, 1 .
PKC stimulation is clearly associated with the activation of T cells 
(Isakov et al., 1986, 1987) via processes such as the induction of IL-2r and 
IL-2 gene expression; however PKC provides also negative feedback 
control over various steps in intracellular signalling, operating in both 
short-term and long-term responses of the cell (Nishizuka, 1986, 1988).
PKC may inhibit Ca^  ^ mobiUzation by blocking the receptor- 
mediated hydrolysis of phosphoinositides or by stimulating the hydrolysis 
of IP) by activating an IP3  phosphatase (Connolly et a l ,  1988). The 
treatment with phorbol esters was shown to inhibit (Abraham et al., 1987, 
1988) or attenuate (Gelfand et a l ,  1987) mitogen-induced increase in 
phosphoinositide hydrolysis and [Ca^ ]^i perhaps by uncoupling a G protein 
from TcR/CD3 (Mills et al., 1989). In addition, PKC activates in various 
cell types Ca^^-transport ATPase and the Na^/Ca^^ exchange protein both 
of which serve to remove Ca^  ^ from cytoplasm (Nishizuka, 1986; 
Kikkawa and Nishizuka, 1986).
A second mechanism of negative feedback acts through deactivation 
of a receptor stimulated by its ligand. Thus, phosphorylation of EOF 
receptor results in the decrease in its affinity for EGF (Schlessinger, 1986) 
while the treatment of T cells with phorbol esters results in a down- 
regulation of TcR/CD3 (Isakov et al., 1987; Cantrell et al., 1985, 1987; 
Minami et al., 1987; Weyand et a l ,  1987), CD4 (Isakov et a l,  1987; 
Weyand et a l , 1987; Solbach, 1982; Hoxie et a l , 1986; Wang et a l ,
1987) and CD8  (Isakov et a l ,  1987).
PKC itself is also regulated by autophosphorylation (Mochly-Rosen 
and Koshland, 1987); by calpain-catalyzed proteolytic cleavage liberating 
a constitutively active catalytic domain (Kishimoto et a l ,  1983, 1989b) 
which is then gradually depleted from the cell (Young et a l , 1987); and 
by an endogenous pseudosubstrate sequence that acts as a highly specific
I
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and potent PKC inhibitor (House and Kemp, 1987).
11.1.8. Phorbol esters
Î
A
The variable regions identified witliin each PKC subspecies are 
likely to contribute to the different properties with respect to the substrate 
specificity (Ido et al. , 1987) and activation requirements (Hug and Sarre, 
1993). The PKC isoenzymes which differ in their activation requirements 
may thus be regulated independently (Bell, 1986). For example, the 
different PKC subspecies may be activated sequentially in response to 
DAG, arachidonic acid and lipoxin A as these phospholipid metabolites 
appear following the receptor stimulation. In addition, the different 
enzymological properties of PKC shown in vitro (Nishizuka, 1988; 
Shearman et al., 1988) combined with the differential expression and 
localization of the different PKC subspecies may affect the activation 
requirements of the T cells subsets.
Phorbol esters are potent tumour promoters in mouse skin (Slaga et 
al. , 1982) and also induce a range of biological effects in cultured cells 
(Diamond et al. , 1980) including modulation of growth and differentiation.
Early kinetic studies in various cell types suggested that the primary 
site of phorbol ester action is at the plasma membrane (Weinstein et al. ,
1979). Subsequently, phorbol esters were shown to substitute for DAG in 
PKC activation, first in vitro (Castagna et a l ,  1982), and later in intact 
cells (Sano et a l , 1983; Yamanishi et a l , 1983). PKC was identified as 
the phorbol ester receptor based on several lines of evidence. First, the 
similarity between the dose-response of PKC activation and the saturation 
cuiwe for PMA binding to its receptor (Castagna et a l,  1982). Second, 
the similarity between the PKC activation constant and the dissociation 
constant for PDB and its receptor (Kikkawa et a l , 1983; Dunphy et a l ,
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1981; Horowitz er a/., 1981; Soîanki and Slaga, 1981). Finally, tissue 
co-distribution (Kikkawa et al. , 1983; Ashendel et al. , 1983) and co- 
purification (Leach et al. , 1983; Niedel et a l ,  1983; Sando and Young,
1983) of the phorbol ester-binding protein and PKC activity.
The stoichiometry shows that one molecule of phorbol ester binds 
to one molecule of PKC in tlie presence of physiological concentrations of 
Ca^ + and in an appaient excess of phospholipid (Kikkawa et a l ,  1983).
The phorbol esters have an absolute requirement for Ca^  ^and phospholipid 
in binding to PKC and will not bind either to the PKC or to the 
phospholipid, regaidless of Ca^ + presence, unless all four components are 
present simultaneously (Kikkawa et a l ,  1983). The phospholipid 
specificity for PDB binding resembles conditions present during physiologic 
PKC activation with phosphatidylserine being the most effective (Kikkawa 
e ta l ,  1983; Ashendel et a l , 1983; Sando and Young, 1983; Leach et 
a l,  1983). Using a phorbol ester photoaffinity probe it was shown that 
phorbol ester interacts primarily with phospholipid thus presumably 
activating PKC by modifying its phospholipid microenvironment (Delclos 
et a l , 1983).
The molecule of phorbol ester intercalates into the membrane 
phospholipid bilayer where it becomes available for binding by PKC which 
moves towards it from cytoplasm to form the quaternary complex by which 
the enzyme is activated. Thus, the PKC translocation to the membrane is 
suggested to be a critical event in its physiologic activation (Bell, 1986).
Although DAG and PMA stimulate PKC they mediate qualitatively 
and quantitatively different effects (Abraham et al., 1987; Rosoff et a l ,
1988). The activation with mitogens or aTcR antibodies may activate 
some PKC isoenzymes selectively; DAG activates distinct PKC isoforms
-3(Kishimoto et a l ,  1980; Isakov et a l ,  1990), which then phosphorylate various targets (Houslay, 1991). Phorbol esters most likely activate them 
all.
The phorbol esters are much more slowly metabolized than is DAG. 
This is probably responsible for sustained PMA-induced PKC activation
.
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(Kikkawa et al. , 1983) as opposed to the transient activation stimulated by 
mitogens and ckCD3 (Ledbetter et a t ,  1986, 1987; Isakov and Altman,
1987; Kraft and Anderson, 1983; Fanar and Ruscetti, 1986; Nel et a t ,
1987; Manger et a l ,  1987). The importance of persistent PKC 
stimulation in T cell activation was illustrated by the need for repeated 
stimulation with DAG to achieve their activation (Koyasu et a l ,  1987).
In most unstimulated cells PKC activity is recovered from the 
cytosol. The term translocation, in the context of PKC, refers to the 
change in the intracellular site occupied by the enzyme on exposure of 
certain cell types to phorbol esters or natural agonists. PKC translocation 
was first observed in a study of subcellular PKC distribution after phorbol 
ester exposure (Kraft et a l ,  1982; Kraft and Anderson, 1983). In such 
cells, the PKC activity was recovered in a form tightly associated with cell 
membranes.
11.1.9. PKC translocation and depletion
:
The translocation of PKC activity is fairly consistently observed in 
response to phorbol esters, however the results vary with natural agonists 
(Rana and Hokin, 1990). However, activation of PKC in T cells 
stimulated with phorbol esters, mitogens, o:CD3, or aCDl is accompanied 
by translocation of the PKC activity from cytoplasm to the plasma 
membrane (Ledbetter et a l , 1986, 1987; Isakov and Altman, 1987; Kraft 
and Anderson, 1983; Farrar and Ruscetti, 1986; Nel et a l ,  1987;
Manger et a l ,  1987). Phorbol esters and Ca^  ^ act in synergy to activate 
and translocate PKC in T cells (Isakov and Altman, 1987).
The treatment of intact 3T3 cells with 4x10 ’M PDB for 48 his 
resulted in a complete disappearance of active PKC (Rodrigues-Pena and 
Rozengurt, 1984).
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111.1-10. PKC inhibitors
Staurosporine is a very potent PKC inhibitor of microbial origin 
whose ICso against PKC, PKA and Ca^^/calmodulin-dependent protein
kinase is 0.01, 0.12 and 0.04 fiM respectively (Davis et a l ,  1989). 
Recently, new PKC inhibitors based on staurosporine have been developed 
and some became available either commercially or as an experimental 
sample. These reagents include Ro31-8220 (Davis et a l ,  1989), 
CGP041251 (Meyer et a l ,  1989), and GF109203X (Toullecf^al, 1991). 
Although some of these inhibitors me not as potent as staurosporine, they 
display superior selectivity for PKC. For example, Ro31-8220 has an IC5 0  
against PKC, PKA and Ca^^/calmodulin-dependent protein kinase of 0.01,
I.5 and 17 fiM respectively (Davis et a l ,  1989). An important 
characteristic observed with staurosporine is its high toxicity.
II.1.11. Serine-threonine phosphatases
The phosphorylation of CD3 and CD4 is reversible suggesting the 
involvement of phosphatases in the activation process.
The regulation of phosphatase activity is largely unknown and the 
phosphatase activity may differ depending on Ser/Thr sites involved. 
Thus, two Ser sites in CD3y are differentially phosphorylated by selective 
action of PKC and phosphatases (Davies et a l , 1987).
It is assumed that T cells contain the four major phosphatases found 
in mammalian cells (Ingebritsen and Cohen, 1983). It was confirmed that 
T cells contain the type 1 and type 2A phosphatases and calcineurin and 
these are present in cytosolic and plasma membrane associated forms 
(Alexander et a l ,  1988). In vitro experiments showed that type 2A 
phosphatases me the most active form of phosphatase involved in 
dephosphorylation of CD3y (Alexander and Cantrell, 1989) suggesting that 
type 2A play a key role in reversing PKC-mediated phosphorylation events 
(Parker et a l , 1986).
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11.1.12. Involvement of phosphoiylation in cell locomotion
PKC appears to be involved in the locomotion of leukocytes as 
suggested by several lines of evidence. Phorbol esters, the activators of 
PKC, have been shown to induce atypical cell morphology in fresh human 
blood lymphocytes while an overnight culture resulted in shapes similar to 
tlie classical locomotor morphology (Wilkinson et a t ,  1988). Studies 
investigating the connection between protein phosphorylation and the 
locomotion of neubophils found that directional locomotion (Gallin and 
Wright, 1978), as well as polaiization or locomotor activity (Roos et a l ,  
1987) are suppressed by PKC activators. H-7, a specific PKC inhibitor 
(Hidaka et a l ,  1984), elicited within few seconds vigorous shape changes 
and F-actin redistribution in non-mofile spherical neutiophils (Keller et a l , 
1990). In contrast, a specific staurosporine type PKC inhibitor 
CGP041251, at concentrations of up to 1 fiM, did not affect the 
morphology and F-actin localization in non-motile neutr ophils (Niggli and 
Keller, 1993). CGP041251 inhibited front-tail polarity in fNLPNTL- 
activated neutrophils and this inhibition correlated with inhibition of 
phosphorylation of a 67-kDa protein. Staurosporine and K252a, similarly 
to PM A, suppress cell polarity and locomotor activity of Walker 
carcinosarcoma cells (Zimmermann and Keller, 1992).
11.2. EXPERIMENTAL
11.2.1. Effect of PMA on the repolarization of dhcAMP-cultured Jurkat
A time-course of repolarization in the presence and in the absence 
of 10 ®M PMA was determined (figure 54). Surprisingly, the normal 
repolarization of dbcAMP treated cells was almost completely abolished 
after a 10-min treatment. It can be seen that significant inhibition of 
repolarization was evident after only 1 min in the presence of PMA. The
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Figure 54: Time-course of repolarization of dbcAMP-cultureti Jurkat cells 
in the presence of PMA. The cells were cultured with 1 mM dbcAMP for 
3 days, washed twice with HBSS/MOPS and resuspended in 50 lA of the 
medium at room temperature. The experiment was initiated by the addition 
of HBSS/MOPS containing 10 ®M PMA and the cells were incubated at 
37®C for various intervals. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast. Round cells (circle), irregular cells (squaie) and polarized 
cells (triangles).
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time-course of 10 ®M PMA action on repolarized dbcAMP-cultmed Jurkat 
revealed that the polaiization event observed in these cells was reversed 
noticeably 20 sec after addition of PMA (figure 55). The maximum 
inhibition of the repolarization was observed 10 min after the introduction 
of PMA which confirmed the preliminary observation. The cells, rounded 
up following the PMA treatment, were phase bright and resembled 
glutaraldehyde-fixed ftesh blood cells.
The dose-response curve revealed that the full effect of PMA was 
achieved at 10®M while 10^“M PMA had a very slight effect on the 
repolarized cells (figure 56). The action of PMA does not require the 
presence of extracellular Ca^  ^ as can be seen from the dose-response 
experiments in Ca^-free EDTA-supplemented medium (figure 56).
11.2.2. Effect of PKC depletion by long-term culture with PMA
11.2.2. L  Effect on PMA-induced shape change
The cells were incubated with dbcAMP in the presence or absence 
of lO^M PMA for 3 days. After this incubation the cells were washed 
twice in a medium and repolarized for 30 min at 37^C. The cell density 
obtained at the end of the incubation was 1.24x10® and 1.22x10® cells/ml 
with and without PMA respectively. Thus, the PKC depletion had no 
effect on the inhibition of the cell growth. Indeed, long-term culture with 
PMA has no effect on the activity of cAMP-dependent protein kinase 
(Rodrigues-Pena and Rozengurt, 1984) which is thought to be the primary 
enzyme to mediate the effect of cAMP (Kammer, 1988). Cells removed 
fiom the culture containing PMA did not profoundly react by shape change 
in response to a new challenge with PMA at concentration between 10 “M 
to 10®M. When treated with these two extreme PMA concentrations, the 
populations of polarized, irregular and round cells were as follows: 25.7% 
and 26.7%, 60.0% and41.00%, and 14.3% and 32.3%. Normal dbcAMP 
treated cells cultured without PMA show a very significant change in
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Figure 55: Time-course of the effect of PMA on repolarized dbcAMP- 
cultured Jurkat cells. The cells were cultured with 1 mM dbcAMP for 3 
days, washed twice with HBSS/MOPS and repolarized at 37°C for 30 min. 
PMA was added to final concentration of 10®M and the incubation was 
continued for various time intervals. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast. Round cells (circle), irregular cells (square) and polarized 
cells (triangles).
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Figure 56: Dose-response of repolarized dbcAMP-cultured Jurkat cells 
stimulation with PMA. The cells were cultured with 1 mM dbcAMP for 
3 days, washed twice with HBSS/MOPS and repolarized at 37®C for 30 
min. Various concentrations of PMA were added and the incubation was 
continued for 15 min. The cells were finally fixed with glutaraldehyde and 
the morphology was examined and quantified under phase contrast. Round 
cells (circle), irregular cells (square) and polarized cells (triangles).
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morphology under identical conditions : 65.3% and 0%, 26.3% and 4.3%, 
and 8.3% and 95.7% for polarized, ÜTegular and round cells respectively. 
The dose-response to PMA of cells cultured with or without PMA shows 
the most striking difference when the changes in proportions of cells 
displaying the round morphology are considered (figure 57-A). It is 
evident that while the proportion of round cells in PMA-treated cells 
remained relatively constant, the proportion of round cells in identically 
treated normal Jurkat cells sharply increased at PMA concenhation of 10 
^M and higher. The results indicate that, in the PMA treated cells, the 
most prevalent morphology is irregular. The presence of predominantly 
irregular cells in PMA-treated cells may by analogous to that reported by 
Wilkinson et al. (1988) using lymphocytes fresh from blood. In these 
experiments the irregular cells were non-motile. An explanation may lie 
in the strongly hydrophobic nature of PMA. It is conceivable that the 
PMA effect observed on the fresh blood cells (Wilkinson et al. , 1988) and 
on the PMA-cultured Jurkat cells is due to insertion of the hydrophobic 
molecule into the membrane lipid bilayer rather than due to its activity on 
PKC. Such disruption of normal membrane lipid environment and its 
effect on the cytoskeleton structures could result in an irregular cell shape.
11.2,2.2, Effect on aCD3~induced shape change
i
The PKC depleted cells were used to determine whether PKC is 
involved in the pathway mediated by ojCD3 which leads to the reversal of 
Jurkat cell polarization. While the proportion of round cells in Jurkat 
cultures supplemented with only dbcAMP increased in a dose-dependent 
manner following the 15 min incubation, this proportion remained virtually 
unchanged in the PMA-treated cells (figure 57-B). This observation 
strongly suggests the crucial role played by PKC in the c%CD3 effect.
2 0 4
7:
'S
Figure 57: Effect of PKC depletion on response to PMA (A), PHA (B), 
and aCD3 (C) by repolarized dbc AMP-cultured Jurkat cells. The cells 
were cultured with 1 mM dbcAMP with or without lO^M PMA for 3 days, 
washed twice with HBSS/MOPS and repolarized at 37°C for 30 min. 
Various concentrations of PMA, PHA, and aCD3 were added and the 
incubation was continued for 15 min. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast. Round cells previously cultured in die absence (full line) 
and presence (dotted line) of PMA.
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I L 2.2.3. Effect on PHA-induced shape change
the depletion of PKC (figure 57-C). Thus, it can be suggested that under
a PMA-sensitive PKC.
i .
3
The PHA-mediated effect on the polarized cells was not affected by
I
these conditions PHA effect is mediated by a pathway that does not involve
11.2.3. Effect of PKC inhibitors on repolarization of dbcAMP-culture 
Jurkat cells
11,2.3.1, Toxicity effects o f PKC inhibitors
Staurosporine and the available derivatives of this PKC inhibitor 
were tested widi polarized dbcAMP-cultured Jurkat cells to establish their 
effect on the polarized cells as well as their toxic effect on the Jurkat cells 
in general. Staurosporine at lO'^M was very toxic resulting in numerous
dead cells and thus reliable counts could not be performed. A dose- 
response curve for staurosporine in figure 58-A indicates a rapid decrease 
in the number of polarized cells at 10’M dose, which was reflected by a 
corresponding increase in the number of irregular cells. The lack of an 
increase in a number of round cells would suggest that the effect of 
staurosporine on the morphology of the cells was non-specific and probably 
due to its toxicity.
A dose-response curve for Ro31-8220 in figure 58-B shows that this 
drug is about 100-fold less potent as an inhibitor of polarization than 
staurosporine in terms of dose-response. A slight effect of this drug on 
polarization occurred at lO^M dose while a severe inhibition of polarized 
morphology was seen at lO’^ M. At this dose, many cells appeared 
irregular with unusual morphology characterized by numerous protrusions 
or ’blebs’ on the cell surface. This effect is clearly due to the toxicity of 
Ro31-8220 at this concentration.
The remaining two drugs, CGP041251 and GF109203X were found
i:
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Figure 58: Dose-response of repolarized dbcAMP-cultured Jurkat cells 
to staurosporine (A), Ro31-8220 (B), CGP041251 (C), GF109203X (D), 
and H-7 (E). The cells were cultured with 1 mM dbcAMP for 3 days, 
washed twice with HBSS/MOPS and repolarized at 37^C for 30 min. 
Various concentiations of the PKC inhibitors were added and the 
incubation was continued for 15 min. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast. Round cells (circle), irregular cells (squaie) and polaiized 
cells (triangles).
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to have no effect at concentrations up to lO'^M (figure 58-C and 58-D).
Based on tlie above observations, staurosporine, Ro31-B220, 
CGP041251, and GF109203X were used in the subsequent experiments at 
maximum non-toxic concentrations of 10 *M, lO ’M, lO^M, and lO^M 
respectively.
11.2.3.2. Effect o f PKC inhibitors on the PMA-stimulated response
Staurosporine was used to determine the effect of PKC inhibitor in 
preventing the response of Jurkat cells stimulated by PMA. In preliminary 
experiments, preincubation with staurosporine at concentrations as low as 
lO^^M was shown to interfere with the KF’M PMA-induced rounding up 
of dbcAMP-cultured Jurkat cells. In subsequent experiments, the 
concentrations of PMA used were ones that produce an intermediate (10 
®M) and full (10 ®M) response as seen from the dose-response experiments 
(figure 56).
Figure 59 shows the results of one of two experiments which 
illustrated the efficiency of various PKC inliibitors in preventing PMA- 
induced rounding up of Jurkat cells. H-7 and Iso H-7 proved to be quite 
ineffective and thus were eliminated from further investigations. 
Staurosporine used at 10 ®M was as effective as GF10920X or CGP041521 
used at lO^M and lO’M respectively. Ro31-8220 was slightly less 
effective at lO^M but cleaily partially inhibited the PMA-stimulated effect.
Having established that the PKC inliibitors partially inhibit the 
effect of PMA on the polarization, it was of interest to determine whether 
these agents are capable of reversing the effects of PMA. Jurkat cells were 
first rounded up using PMA and then the time-course of change in 
morphology was observed following the addition of CGP041521 (figure 
60). The recovery of a polarized and an irregular morphology continued 
over a period of at least 60 min. In contrast, the inhibition was shown to 
be relatively rapid, resulting in a full effect following only a 30-min 
preincubation with the inhibitors. The difference in dynamics of PMA
2 0 8
Figure 59: Inhibition of PMA-stimulated morphology change in
repolarized dbcAMP-cultured Jurkat cells preincubated with PKC 
inhibitors. The cells were cultured with 1 mM dbcAMP for 3 days, 
washed twice with HBSS/MOPS and repolarized at 37”C for 30 min in the 
presence of 10'®M staurosporine, 10 ’M Ro31-8220, lO^M GF109203X, 10 
"M CGP041521, 10"M H-7, and lO^M Iso-H7. PMA was added to final 
concentration of 10 ^ M and the incubation was continued for 15 min. The 
cells were finally fixed with glutaraldehyde and the morphology was 
examined and quantified under phase contrast.
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Figure 60: Time-course of repolarization of dbcAMP-cultured Jurkat cells 
rounded up with PMA and then treated with a PKC inhibitor. The cells 
were cultured with 1 mM dbcAMP for 3 days, washed twice with 
HBSS/MOPS and repolarized at 37°C for 30 min. Subsequently, PMA 
was added to final concentration of 10 ^ M and the incubation was continued 
for 15 min. Finally, CGP041521 was added to final concentration of 10 
’M and the incubation was continued for various time intervals. The cells 
were finally fixed with glutaraldehyde and the morphology was examined 
and quantified under phase contrast. Round cells (circle), irregular cells 
(square) and polarized cells (triangles).
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effect inhibition and reversal may rest in the hydrophobic nature of the 
phorbol ester. It can be suggested that the PKC inhibitors bind to the PKC 
molecule and subsequently interfere with the binding of and activation by 
PMA. However, these inhibitors may be inefficient in displacing PMA 
from PKC once the phorbol ester binds to its receptor.
11.2.33. Effect o f PKC inhibitors on the aCD3- and PHA-stimulated 
response
So far, it was shown that PKC has a prominent role in the shape 
change of polarized Jurkat cells as shown by rounding up of cells on 
specific stimulation by PMA. Also, it has been established that PKC is 
one of the enzymes stimulated by aCD3-generated DAG. The transient 
character of the response to aCD3 may reflect the fast rate of DAG 
metabolism. Thus, specific inhibition of PKC would be expected to 
abolish the transient rounding up of Jurkat cells in response to cvCD3. All 
of the PKC inhibitors tested showed a dose-dependent inhibition of the 
a:CD3-mediated rounding up of Jurkat cells (figure 61). The minimum 
effective dose of staurosporine (EDjo lO^M) was about 1000-fold lower 
than that of Ro31~8220 (ED^o 2xlO'M) or GF109203X (ED^o > 10 "M). 
The latter two inhibitors showed virtually identical activity.
The requirement for signalling stimulated by aCDS and PHA are 
similai" although the change in morphology of repolarized Jurkat cells 
induced by these agents are qualitatively different. Having identified PKC 
as the key enzyme in the observed effect, a set of PKC inhibitors was used 
to alter the PHA-induced morphology changes (figure 62). A significant, 
approximately 50% inhibition was obseiwed in the presence of lO'^M 
staurosporine, lO’M Ro 31-8220, and lO’M CGP041251. This apparent 
involvement of PKC, as suggested by the effect of PKC inhibitors, is in a 
sharp contrast with the lack of effect of PMA-induced PKC depletion on 
the PHA-stimulated rounding up, A posiible explanation of this 
discrepancy may rest in the documented heterogeneity of PKC isoenzymes.
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Figure 61: Dose-dependent inhibition of aCDS-stimulated morphology 
change in repolarized dbcAMP-cultured Jurkat cells preincubated with PKC 
inhibitors. The cells were cultured with 1 mM dbcAMP for 3 days, 
washed twice with HBSS/MOPS and repolarized at 37°C for 30 min in the 
presence of various concentrations of staurosporine, Ro31-8220, or 
GF109203X, 0KT3 was added to final concentration of 20 ng/ml and the 
incubation was continued for 15 min. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast. Staurosporine (square), Ro31-8220 (diamond) and 
GF109203X (circle).
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Figure 62: Inhibition of PHA-stimulated morphology change in
repolarized dbcAMP-cultured Jurkat cells preincubated with PKC 
inhibitors. The cells were cultured with 1 mM dbcAMP for 3 days, 
washed twice with HBSS/MOPS and repolaiized at 37°C for 30 min in the 
presence of lO^M or 10®M staurosporine, 10’M Ro31-8220 and 10’M 
CGP041521. PHA was added to final concentration of 1 /ig/ml and the 
incubation was continued for 15 min. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast.
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Perhaps PHA stimulates an isoenzyme unaffected by PMA but affected by 
the specific inhibitors. On the other hand, a prolonged PMA exposure may 
activate an alternative pathway exploited by the non-specific mitogen PHA.
Rounding up of repolarized Jurkat cells stimulated through the PGE^ 
receptor were not affected by the PKC inhibitors (results not shown). 
Thus, the increase in [cAMP]j induced by PGEj most likely affects the 
locomotoiy machinery by a mechanism independent of PKC.
11.2.3,4. Effect o f PKC inhibitors on thapsigargin- and Ca^ * ionophore- 
stimulated response
I
Thapsigargin induces rounding up similar to that seen with aCD3.
Thapsigaigin releases Ca^  ^ from intracellular stores and the extracellular 
Ca^  ^ must be present for the transient response to take place. Although, 
thapsigargin is not known to stimulate the production of DAG or to 
stimulate PKC directly, it was speculated that the intracellular Ca^ + 
concentration could temporarily rise to a level sufficient to activate PKC 
in the absence of the physiological activator DAG. Alternatively, Ca^  ^
may stimulate a biochemical pathway which results in products capable of 
stimulation of certain PKC isoforms. Indeed, other components of
glycerolipid metabolism, such as cardiolipin, arachidonic acid, and lipoxin 
A were shown to be such stimulators (Hug and Sarre, 1993). If PKC is iinvolved in Ca^-mediated changes in cell morphology, the thapsigargin- 
stimulated rounding up should be susceptible to the inhibition by PKC 
inhibitors. To test this hypothesis, repolarized Jurkat cells were 
preincubated with the PKC inhibitors and then stimulated with 
thapsigaigin. Figure 63 shows that the PKC inhibitors decreased the extent 
of thapsigargin-induced rounding up in a dose-dependent manner. 
However, the PKC inhibitors were more effective on aCD3-induced 
rounding up, when compared to thapsigargin, as suggested by a steeper 
dose-response curve (figure 61). The minimum effective doses of PKC
1:
Figure 63; Dose-dependent inhibition of thapsigargin-stimulated 
morphology change in repolarized dbcAMP-cultured Jurkat cells 
preincubated with PKC inhibitors. The cells were cultured with 1 mM 
dbcAMP for 4 days, washed twice with HBSS/MOPS and repolarized at 
37°C for 30 min in the presence of various concentrations of staurosporine, 
Ro31-8220, GF109203X, or CGP041521. Thapsigargin was added to final 
concentration of 500 nM and the incubation was continued for 5 min. The 
cells were finally fixed with glutaraldehyde and the morphology was 
examined and quantified under phase contrast. Staurosporine (square), 
Ro31-8220 (diamond), GF109203X (circle) and CGP041521 (triangle).
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finhibitors measured with thapsigargin compared approximately with that 
observed with aCD3. GF109203X (ED3 0  >  lO ’M) was only slightly more 
effective than Ro31-8220 (ED30 > lO'M). CGP041251 (ED30 W M ) was 
about 10-fold more effective than either of the above drugs. Staurosporine 
(ED50 2x1 O^M) again proved to be the most active, being 10-fold more 
effective than CGP041251 and about 100-fold better than GF109203X or
2 1 6
Ro31-8220. Although staurosporine apparently nearly abolished the 
thapsigargin effect, the result may be difficult to interpret because 
staurosporine at 10'®M tends to induce unusual morphologies. The 
exaggerated morphological change suggests a toxic effect of staurosporine.
The stimulation of dbcAMP-cultured Jurkat cells with thapsigargin 
triggers a release of intracellular Ca^  ^ stores and the subsequent influx of 
extracellular Ca^ .^ This increase can be also induced using Ca^‘ 
ionophores and it was shown that such a treatment results in a rounding up 
of the cells. The pretreatment of the repolarized cells with PKC inhibitors 
affected dose-dependently the ability of A23187 to change the morphology 
of the repolarized Jurkat cells (figure 64). Thus, the effects induced by 
Ca^  ^ mobilizing agents aie also mediated by the PKC.
11.2.4. Inhibition of protein phosphatase and the effect on polarized 
morphology
The above experiments suggest that PKC plays a key role in 
regulating the shape change of locomotory cells. The equilibrium 
established by the phosphorylation activity of kinases and the 
dephosphorylation activity of phosphatases would determine the 
phosphorylation state of a specific intracellular protein which in turn would 
determine the morphology and locomotory capability of tlie cell. The data
V
so far suggests that the polarized morphology is associated with a low 
degree of protein phosphorylation. Conversely, a state of high protein 
phosphorylation results in rounding up of the cells. Based on the proposed 
reversible biochemical reaction, rounding up should be achieved either by
Figure 64: Dose-dependent inhibition of A23187-stimnlated morphology 
change in repolarized dbcAMP-cultured Jurkat cells preincubated with PKC 
inhibitors. The cells were cultured with 1 mM dbcAMP for 3 days, 
washed twice with HBSS/MOPS and repolarized at 37°C for 30 min in the 
presence of various concentrations of staurosporine, Ro31-8220, 
GF109203X or CGP041521. A23187 to final concentration of 10 ®M was 
added and the incubation was continued for 5 min. The cells were finally 
fixed with glutaraldehyde and the morphology was examined and quantified 
under phase contrast. Staurosporine (square), Ro31-8220 (diamond) and 
GF109203X (circle).
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activation of PKC, as was shown above, or by inhibition of the
more effective than CGP041521 (ED^ 2xlO'^M).
phosphatase.
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11.2.4.1. Effect o f calyculin A on polarized Jurkat cells
Calyculin A is a specific inhibitor of protein phosphatases. As 
predicted, calyculin A was shown to round up repolarized Jurkat cells. 
The speed of changes in morphology (figure 65) resembles changes 
observed in the presence of PMA (figure 55). The rounding up of the 
repolarized cells was complete by 5 min after the application of either 
calyculin A or PMA. The dose-response experiments with calyculin A 
revealed that the minimum effective dose is 10 "M and the estimated EDjo 
dose for polarization inhibition in Jurkat cells was 2x1 O^M (figure 6 6 ).
11.2.4.2. Effect o f PKC inhibitors on the morphological changes induced 
by calyculin A
The data showed that preincubation with PKC inhibitors notably 
inhibits the rounding up in response to calyculin A (figure 67). The 
activity of PKC inhibitors was similar to that seen using aCD3. 
Staurosporine (ED5 0  2xlO^M) was about 1000-fold more potent than 
GF109203X (ED;, 10 ‘M) orRo31-8220 (ED„ > lO ’M) and about 100-fold
11.2.5. Translocation of PKC to the membrane of activated Jurkat cells
PKC activity translocated to the plasma membrane of dbcAMP- 
cultured Jurkat cells stimulated with aCD3, PHA, thapsigargin and PMA 
was measured (figure 6 8 ). The activity was determined at crucial time- 
points identified in experiments dealing with the changes in cell 
morphology. The time-course of the o:CD3- and thapsigargin-stiraulated 
effect was shown to be transient with maximum rounding up at 15 and 5 
min respectively. In both cases, the cells experienced substantial recovery
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Figure 65: Time-course of the action of calyculin A on repolaiized 
dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 3 days, washed twice with HBSS/MOPS and repolarized at 
37^C for 30 min. Calyculin A was added to final concentration of 2xlO ®M 
and the incubation was continued for various time intervals. The cells 
were finally fixed with glutaraldehyde and the morphology was examined 
and quantified under phase contrast. Round cells (circle), irregular cells 
(square) and polarized cells (triangles).
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Figure 66: Dose-response of repolaiized dbcAMP-cultured Jurkat cells 
to calyculin A. The cells were cultured with 1 mM dbcAMP for 3 days, 
washed twice with HBSS/MOPS and repolarized at 37°C for 30 min. 
Various concentrations of calyculin A were added and the incubation was 
continued for 5 min. The cells were finally fixed with glutaraldehyde and 
the morphology was examined and quantified under phase contrast. Round 
cells (circle), irregular cells (square) and polarized cells (triangles).
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Figure 67: Dose-dependent inhibition of calyculin A-stimulated
morphology change in repolarized dbcAMP-cultured Jurkat cells 
preincubated with PKC inhibitors. The cells were cultured with 1 mM 
dbcAMP for 3 days, washed twice with HBSS/MOPS and repolarized at 
37*^ 0 for 30 min in the presence of various concentrations of staurosporine, 
Ro31-8220, GF109203X, or CGP041521. 10 ®M calyculin A was added 
and the incubation was continued for 5 min. The cells were finally fixed 
with glutaraldehyde and the morphology was examined and quantified 
under phase contrast. Staurosporine (square), Ro31-8220 (diamond), 
GF109203X (circle) and CGP041521 (triangle).
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■Figure 6 8 : PKC activity translocated to the membrane of dbcAMP-
cultured Jurkat cells stimulated with aCD3, PHA, thapsigargin, and PM A. 
The cells were cultured with 1 mM dbcAMP for 3 days, washed twice with 
HBSS/MOPS and repolarized at 37^C for 30 min. Aliquots of tlie 
stimulators were added to the final concentration of 50 ng/ml, 1 ftg/ml, 1 
fiM, and 10®M respectively. The incubation was continued for various 
time intervals as shown below each bar. The cell extract representing the 
cytoplasmic and membrane fraction was then prepared and assayed for 
PKC activity using a commercial kit. Results were expressed as percent 
increase relative to the corresponding buffer control. Figure represents 
similar results obtained in a duplicate experiment and in several preliminary 
experiments.
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of polar ized morphology within 30 min after the introduction of a stimulus. 
PKC was proposed to play an important role in the mechanism leading to 
the loss of polarized morphology of dbc AMP-cultured Jurkat cells. The 
dynamics of the increase in PKC activity translocated to the plasma 
membrane supported this view. The membrane-associated PKC activity in 
cells stimulated with aCD3 or thapsigargin, for 15 and 5 min respectively, 
increased by 40% when compared to the buffer control. As predicted by 
the shape change observations, the PKC activity in cells stimulated with 
either agent declined to about 20% by 30 min after stimulation. In 
contrast, PHA and PMA, which induce permanent rounding up of 
dbc AMP-cultured Jurkat cells, induced an increased membrane-bound PKC 
activity at 15 and 5 min respectively and still higher activity after 30 min 
of stimulation. An important limitation of the assay used should be noted. 
Although the method accurately estimates the amount of PKC in the cell 
fractions examined, the activation status of these enzymes in vivo is 
uncertain. Indeed, the method relies on the assumption that membrane- 
associated PKC is activated. In addition, to stimulate PKC, in cell
fractions examined, to phosphorylate a specific substrate PMA is used 
together with other activation co-factors such as phosphatidylserine and 
Ca^ .^ Thus, PKC isoforms that are PMA insensitive or that may require 
other than these classical PKC activators would not be detected. However, 
the PMA-depletion experiments suggested that such PKC isoforms may not 
be involved in the lymphocyte morphology regulation or that their role is 
limited.
11.2.6. Expression of PKC isoforms in Jurkat cells
I
The overwhelming evidence of PKC involvement in the regulation 
of lymphocyte motility prompted the inquiry into the identity of the PKC 
isoform responsible. The expression of PKC isoforms in Jurkat from 
routine culture, culture containing 1 mM dbcAMP, and from culture 
containing dbcAMP and 10 ^ M PMA was examined. For this purpose. $
■I
Western blot of the whole cell protein extract, sepmated by SDS-PAGE 
was performed and probed with a panel of monoclonal antibodies (figure 
69 and 70). PKCa, PKCy, PKCe, PKC9, PKCi, PKCX, PKC/x, and 
PKCÇ were detected. The first four isoforms are known to be PMA- 
sensitive and in agreement with this fact, the PKC expression was 
significantly lowered as indicated by visibly lighter or missing bands in 
lane 3. Thes isoforms may play a crucial role in the aCDS-stimulation 
rounding up of Jurkat cells as indicated by the PKC-depletion experiments.
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Interestingly, the optical density of bands obtained with PKCor, 
PKCy, and PKCe appeared to be higher in dbcAMP-cultured Jurkat (lane 
2) cells compared to the cells from routine culture (lane 1). The amount 
of pmtein examined in the three lanes was relatively similar as indicated 
by similar density of other PKC bands and of some non-specific bands. 
Thus, the difference in optical density of the bands noted above reflects the 
actual differences in PKC expression. This apparent contradiction between 
the increased PKC expression and acquisition of polarization in dbcAMP- 
cultured cells may be explained in three ways: (1) dbcAMP acts
downstream of PKC thus counteracting the increased phosphorylation of 
proteins regulating the motility; (2) dbcAMP culture results in massive 
induction of protein phosphatases which would dephosphorylate the 
regulatory proteins; or (3) dbcAMP-cultured Jurkat cells are depleted of 
endogenous activators of the crucial PKC isoforms. Indeed, the PKC 
expression may not be a reliable measure of PKC activity in vivo as a 
constitutively motile variant of MOLT-4 cell line did not appear different 
form the non-motile MOLT-4 when PKC expression was examined (Dr. 
Matthews personal communication). Yet the motility in these cell lines 
was subject to regulation by PKC activators and inhibitors.
The differences in optical density of bands obtained with different 
monoclonal antibodies (such as PKCa and PKCy) cannot be translated into 
conclusions with respect to the quantitative differences in the expression of 
these two PKC isoforms. The difficulty lies in accounting for the different 
affinities of the monoclonal antibodies used.
t
Figure 69: Protein kinase C expression in Jurkat cells from routine 
culture (lane 1), from culture containing 1 mM dbcAMP (lane 2) and 
from culture containing 1 mM dbcAMP with lO^M PMA (lane 3). 
Western blots of whole cell protein extracts were performed using 
monoclonal antibodies specific for various PKC isoforms. Molecular 
weight markers are shown in kDa. Molecular weight of expected band 
is represented by arrow (> ) . Frame A PKCor (82 kDa), frame B PKCB 
(80 kDa), frame C PKCy (80 kDa), frame D PKCÔ (78 kDa), frame E 
PKCe (90 kDa), and frame F PKC0 (79 kDa).
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Figure 70: Protein kinase C expression in Jurkat cells from routine 
culture (lane 1), from culture containing 1 mM dbcAMP (lane 2) and 
from culture containing 1 mM dbcAMP with lO'^M PMA (lane 3). 
Western blots of whole cell protein extracts were performed using 
monoclonal antibodies specific for various PKC isoforms. Molecular 
weight markers are shown in kDa. Molecular weight of expected band 
is represented by arrow (> ) . Frame A PKCi (74 kDa), frame B PKC A 
(74 kDa), frame C PKC/x (115 kDa), and frame D PKC$ (72 kDa).
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11.3. SUMMARY
In conclusion, the above experiments showed that incubation of 
dbcAMP-cultured Jurkat cells with PMA caused a rapid, dose-dependent 
reversal of polarization. Depletion and inhibition experiments showed that 
this effect of PMA is due the activation of PKC. In addition, the 
involvement of PKC in the effect of cxCD3, PHA, A23187 and 
thapsigargin was suggested. Direct measurements of PKC activity in 
dbcAMP-cultured Jurkat cells stimulated with «CDS, PHA, thapsigargin
and PMA revealed dynamics that link the PKC activation to the changes 
in cell morphology obseiwed. In addition, Western blots revealed that the 
PMA-sensitive PKC isoforms that may be responsible for this regulatory 
activity are PKCa, PKCy, PKCe, or PKC0. Changes in phosphorylation 
equilibrium caused by incubation of dbcAMP-cultured Jurkat cells with 
calyculin A caused changes in morphology similar to those observed with 
PMA.
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12. TNVOLVEMENT OF TYROSINE PHOSPHORYLATION AND G 
PROTEIN IN SURFACE RECEPTOR COUPLING TO 
INTRACELLULAR SIGNALLING PATHWAYS
the pathways that link TcR/CD3 complex with the locomotory machinery.
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12.1. BACKGROUND
Lymphocytes monitor the status of their environment by receiving 
messages in the form of soluble factors released by tissues, as well as by 
a physical contact with neighbouring cells. Such events, taking place on
,the extracellular face of cell membrane, are transmitted into the cytoplasm 
of a cell via receptors. Most such receptors fall into one of three known 
classes: ( 1 ) channel-linked receptors; (2 ) catalytic receptors whose
cytoplasmic domain constitutes a PTK or is associated with a non-receptor 
TPK; and (3) G protein-linked receptors. G proteins are well established 
to perform various functions in activation and inactivation of intracellular 
enzymes which are ultimately responsible for the generation intracellular 
messenger molecules. Similarly, protein-tyrosine phosphorylation regulates 
the activity of ever-expanding range of intracellular enzymes and regulatory 
proteins.
The role of the TcR/CD3 complex in the acquisition of locomotory 
capacity in PBL has been documented (Wilkinson and Higgins, 1987a).
In addition, the locomotory capacity of dbcAMP-cultured Jurkat cells is 
regulated by signals generated upon stimulation of TcR/CD3 complex.
Both, the increase in [Ca^ j^j and the activation of PKC were demonstrated
-to reverse the polarization in these cells. The increase in [Ca^ ]^, and the 
activation of PKC via the generation of DAG, are the result of activation 
of inh acellular PLC. The activity of PLC was shown to be regulated by 
G proteins associated with surface molecules in numerous cell types. In 
addition, an increasing evidence links tyrosine phosphorylation as a 
regulatory linkage between the various surface structures and PLC- 
generated second messengers in T cells. The purpose of the following 
experiments was to determine the involvement of PTK and G proteins in
...
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12.1.1. Role of protein-tyrosine phosporvlation signal transduction
12.1.1.1. Lymphocyte surface molecules involved in antigen-mediated 
activation
T lymphocyte activation normally requires the interaction of 
clonotypic TcR with a peptide antigen presented on the MHC molecule of 
an antigen-presenting cell. The signal transduction is mediated by the 
associated CD3 complex and the (/q  chains, described in a previous 
chapter. In addition, CD4/CD8 co-receptor molecules participate in the 
antigen recognition event and function to increase the antigen-receptor 
binding affinity and constitute an essential element in the signal 
transduction pathway. The CD4 and CD8  molecules are expressed on 
mutually exclusive subsets of T lymphocytes and interact with distinct 
invariant determinants on class II and class I MHC molecules respectively.
12.1.1.2. Non-receptor PTK
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CD4 and CD8  are transmembrane molecules that belong to the 
immunoglobulin superfamily and share only limited sequence homology. 
CD4 is a 55-60 kDa glycoprotein that is expressed in a monomeric form, 
while CD8  is expressed as a homodimer of two 32-34 kDa a chains or a 
heterodimer of an a  and a 25-26 kDa B chain.
One of the earliest events that follows T cell activation via the TcR %is rapid increased tyrosine phosphorylation of several endogenous substrates 
(Samelson et al., 1986; Baniyash et al., 1988b; Hsi et al., 1989; June 
et al., 1990a) including TcR (  chain and the proto-oncogene vav (Margolis 
et al., 1992). Of particular interest is the tyrosine phosphorylation of 
PLCyi in response to TcR/CD3-mediated PTK activation (Park et a l,
1991; Secrist et a l ,  1991; Weiss et a l , 1991).TPK generally belong to 
either the receptor class or the non-receptor class of enzymes. The 
receptor TPK bind polypeptide growth factors, such as PDGF, EGF, FGF,
CSF-1 and insulin, by theii' extracellular sequences forming the large 
glycosylated extracellular ligand-binding domain. The transmission of 
intracellular signals is initiated by activation of their intrinsic PTK activity 
mediated by cytoplasmic catalytic domains. The members of the non­
receptor TPK class associate with other surface proteins which generally 
lack endogenous enzyme activity. None of the surface molecules involved 
in antigen-induced lymphocyte activation posses a PTK domain in their 
cytoplasmic portion (Ashwell and Klausner, 1990). However, several of 
the surface molecules engaged during such activation associate with at least 
three non-receptor PTK that may function as their signal transducing
element.
12.1.1.3. Lymphocyte activation-associated PTK
Several non-receptor PTK have been proposed to mediate signalling 
functions in lymphocytes (Perlmutter et al., 1988; Bolen, 1991). 
However, recent studies have identified the involvement of three
f
cytoplasmic PTK in proximal TcR signalling. These PTK are members of 
two distinct families: p59^ and p56^  ^are src-related PTK while ZAP-70 
(zeta chain-associated protein) is a .^^-related PTK.
The p56'"* (Casnellie et a l,  1982; Voronova and Sefton, 1986; 
Adler et a l ,  1988; Perlmutter et a l ,  1988) is expressed almost 
exclusively in lymphocytes, including all mature T cells and thymocytes 
(Marth et a l ,  1985; Veillette et a l ,  1987; Reynolds et a l ,  1990). 
Initially, its participation in antigen-induced T cell activation was based on 
finding that p56'"  ^ is directly associated with the cytoplasmic domains of 
CD4 and CD8 0 : co-receptor molecules (Rudd et a l , 1988; Veillette et a l , 
1988b; Barber et a l , 1989) and later with IL-2rB (Hatakeyama et a l , 
1991). The p56‘'* interacts with CD4/CD8 through a region in its amino- 
terminal which is unique among the rrc-related PTK (Shaw et a l , 1989). 
A specific p56'‘*-binding consensus region of 13 amino acids was identified 
in the cytoplasmic tail of CD4 and CD 8 a  (Barber et al., 1989; Zamoyska
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et al., 1989) where six residues were found to be essential in the cysteine- 
dependent association (Vega et a l ,  1990; Turner et a l ,  1990; Shaw et 
a l,  1990). Indeed, T cell hybridomas with mutations in CD4 p56'"’'- 
binding sequence were unable to respond to antigen (Gleichenhous et al., 
1991). In addition, antibody-mediated cross-linking of CD4 or CD8 
substantially increases in vitro PTK activity of p56'"’' (Veillette et a l,  
1989ab; Luo and Sefton, 1990). The functional involvement of p56'"‘' in 
TcR-mediated signalling was also confirmed. Insulin-specific T cell 
hybridomas transfected with activated forms of p56*'’' showed increased 
sensitivity to the antigen as measured by IL-2 production (Abraham et a l , 
1991). In addition, the Ick' mutant of Jurkat could not mobilize 
intracellulai Ca^  ^ in response to g:CD3 stimulation despite normal 
expression of TcR/CD3 and p59^ (Straus and Weiss, 1992). Similarly, a 
mouse CTLL T cell line lacking pSô’"'^  expression showed a defective TcR- 
mediated cytotoxic activity (Kamitz et a l , 1992). All four domains of the 
PTK seem to be required for coupling of TcR-stimulated signals (Caron et 
a l ,  1992).
There aie two isoforms of p59^^, p59*^ (neuronal type) and p59^^  ^
(haematopoietic cell type), which result from mutually exclusive splicing 
of alternative seventh exons (Cooke and Perlmutter, 1989). The 
association of p59^“ with TcR/CD3 and its involvement in propagating 
signals through this complex was suggested by five lines of evidence: (1) 
the expression of p59^ by thymocytes correlates with the acquisition of 
TcR responsiveness during their differentiation into mature T cells (Cooke 
et a l ,  1991); (2) co-immunoprecipitation with the CD3e component
(Samelson et al., 1990); (3) co-capping of the TPK with the TcR complex 
(Gassman et a l ,  1992); (4) enhancement of TcR responsiveness by
overexpression of p59^ (Cooke et a l , 1991); and (5) mice with elevated 
p59‘^” activity (Katagiri et a l ,  1989) show constitutive tyrosine 
phosphorylation of the TcR Ç chain (Samelson et a l ,  1986). Thus, it is 
suggested that p59^ linked with CD3e is essential for the TcR-linked signal 
transduction by mediating the phosphorylation of the TcR C chain.
2 3 1
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12.1.1.4. Structure o f non-receptor PTK
it
Expression of the p60’^‘' and ZAP-70 TPK appeal's to be limited to 
cells of haemopoietic origin, suggesting that their function is linked to cell 
type-specific signal tiansduction. ZAP-70 (Chan et a l ,  1992b) is 
expressed exclusively in T cells and natural killer cells while pbO'^ *' occurs 
predominantly in B cells, thymocytes and myeloid cells. In contrast to 
p59^^ and pSb'*, ZAP-70 associates with the TcR (  chain (Chan et a l , 
1991) and CD3e (Wange et a l ,  1992; Straus and Weiss, 1993) only 
following TcR stimulation. This association requires the presence of p59*  ^
and p56'" .^ These PTK efficiently phosphorylate the CD3e and the TcR Ç 
chain (Straus and Weiss, 1993; Qian et a l,  1993) which in turn recruit 
ZAP-70 to the activated receptor complex (Chan et a l , 1994).
A tyrosine-based activation motif, present in a number of other 
signal transducer elements, was identified in the TcR C chain (3 copies) as 
well as in CD3e (Samelson and Klausner, 1992). This so called ARAM 
consists of two tyrosine-containing sequences (YXXL) separated by six to 
eight amino acids (Reth, 1989). These ARAM are potential sites for 
phosphorylation upon activation through the TcR and are able to function 
in coupling of the receptor complex to cytoplasmic signalling machinery 
(Romeo et a l,  1992; Irving et a l ,  1993). Indeed, CD3e chain is 
phosphorylated at these two tyrosine residues upon T cell activation in vivo 
(Sancho et a l ,  1993). Efficient association is mediated by both SH2 of 
ZAP-70 and phosphotyrosine in ARAM of the (  chain and CD3e of 
activated TcR (Wange et a l , 1993). The proximity of ZAP-70 and TcR 
complex results in tyrosine phosphorylation of ZAP-70 (Iwashima et a l , 
1993) which in turn acquires the capability to recruit SH2-containing 
mediators of intracellular signalling. 1
The family of non-receptor PTK includes at least 24 members. The 
common domain relationships between the different families are shown in 
figure 71. The major area of sequence homology between the non-receptor
2 3 2 3
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Figure 71: Diagramatic representation of structures of known non­
receptor PTK members. The amino-terminus is on the right side of the 
figure. The following abbreviations are used: SH, Src homology domain; 
JH, Jak homology domain; PH, pleckstrin homology domain. JHl and 
JH2 constitute PTK and PTK-like domain respectively. Size of and 
spacing between various domains is not shown to scale.
SH3 SH2 C a t a l y t i c  Domain CSH1]3
S rc ,  Yes,  Fyn, Lyn, Lck, BIk, Hck, F g t ,  Yrk
J a k 1 , J a k 2 ,
Jak  3, Tyk2
Syk, ZAP-70
JH 7 JH 6 JH 5  JH4 JH3
- O C H X K
3 1 ^ 1 1 1
JH2 JH1
I tk  CTsk],
B tk ,  Tec
F e s /F p s ,  Per
Csk
A bI, Arg
Fak
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PTK occurs in the catalytic domain which includes ATP binding site and 
tyrosine autophosphorylation site. The catalytic domain is responsible for 
the PTK activity.
The members of the src family, along with a single isoform of the 
abllarg family have an exclusive mechanism for promoting then 
association with the inner surface of the plasma membrane. This 
mechanism is based on the post-translational myristylation of a common
glycine residue at position two (Marchildon et a l , 1984; Voronova et al. , 
1984).
The SH3 domains (Stahl et a t ,  1988; Mayer et a l ,  1988) are 
thought to recognize proline-rich peptide ligands which are present in some 
guanine nucleotide exchange factors and GTPase activating proteins (Ren 
et al., 1993). In adition, SH3 domains are found in actin-binding proteins 
including myosin, spectrin, and a yeast cytoskeletal protein (Drubin et a l , 
1990) and function as possible mediators of interactions of such molecules 
with the components of the cytoskeleton.
The SH2 domains found in non-receptor PTK are capable of high
affinity binding to selected phosphotyrosine proteins (Pawson, 1989;
Matsuda et a l , 1991. The highly conserved sequence FLVRES of SH2 is
thought to be required to bind to amino acids that flank the
phosphotyrosines fitting into a specific binding pocket of SH2 (Pazin and
Williams, 1992). The SH2 domain may interact with a phosphotyrosine
residue on an adjacent domain in the same molecule (such as tyrosine
528,505 or 527 of p59^, p56*‘^  or p60®% respectively) thus downregulating
the PTK activity (Matsuda et a l , 1990). Indeed, mutation or deletion of
the SH2 domain produces a transforming p59^ protein (Hirai and Varmus,
1990; O’Brien et a l ,  1990; Kawakami et a l ,  1988; Semba et a l,  
. .1990). Similarly, replacement of the regulatoiy tyrosine residue with 
phenylalanine or serine induces a constitutive activation of the kinase 
(Kmiecik and Shalloway, 1987; Piwnica-Worms et a l ,  1987; Marth et 
a l ,  1988). The negative regulatory site at the carboxy terminus of src 
family PTK is tyrosine phosphorylated by p50“  ^(Perlmutter et a l , 1988).
■I
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In addition, SH2 regions were identified also in cytoplasmic 
proteins involved in mitogenic pathways such as PLCy (Stahl at al., 1988; 
Suh et al., 1988), the regulatory subunit (p85) of PI 3 kinase (Escobeno 
et al., 1991; Skolnik er a /., 1991; O tsucr« /., 1991), the ras-GTPase 
activating protein (McCormick, 1989) that regulates ras activity 
(Downward et al., 1990), and the crk, abl, and vav oncogene products
(Mayer et a l ,  1988). Thus, SH2 domains mediate the recognition and 
association of such cytoplasmic proteins with PTK-linked receptors 
containing phosphotyrosine residues (Koch et a l ,  1991).
Ail PTK studied autophosphoiylate on tyrosine residues in response 
to ligand binding (Pazin and Williams, 1992). The phosphotyrosine 
residues then serve as highly selective sites for binding of SH2-containing
cytoplasmic signalling components. Such components thus bind to 
activated, autophosphoiylated receptors and themselves become substrates 
for serine/tyrosine phosphorylation (Margolis et a l ,  1991; Anderson et 
a l,  1990). For example, PDGFB receptor binds upon activation, among 
others, PI 3-kinase on tyrosine 708 and 719 (Coughlin et a l ,  1989; 
Escobeno et a l ,  1991; Kazlauskas et a l ,  1992), GTPase-activating 
protein on tyrosine 739 (Kazlauskas et a l , 1992; Fantl et a l , 1992) and 
PLCy binds on tyrosine 977 and 989 (Pazin and Williams, 1992). The 
tight interaction of the SH2 of PLCyi is followed by tlie tyrosine 
phosphorylation of its tyrosine 771, 783 and 1254; the resulting 
conformational change in PLCyi allows its SH3 domain to interact with the 
membrane cytoskeleton causing the translocation of PLCy i from cytosol to 
the cellular membrane (Rhee, 1991). Interestingly, coexpression of p59^, 
but not p56'" ,^ with TcR C chain produced tyrosine phosphorylation of the 
C chain and PLCyi and calcium mobilization in response to receptor cross- 
linking (Hall et a l,  1993). The coexpression of the phosphotyrosine 
phosphatase CD45 enhanced these effects presumably by activating the 
p59*  ^kinase (Pingel and Thomas, 1989; Koretsky et a l ,  1990, 1991).
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ï12.1.1.5. PLC is activated by PTK
Contrary to some reports (Kim et al., 1990) several lines of 
evidence implicate a regulatory role for tyrosine phosphorylation in 
activation of PLCy. The tyrosine phosphoiylation of several intracellular 
substrates, stimulated by activation through TcR/CD3, precedes measurable 
hydrolysis of PI(4,5)Pz and [Ca^ j^i increase (June et a l,  1990a). In 
addition, PLCy is catalytically activated by tyrosine phosphorylation by 
growth factor receptors (Nishibe et al., 1990; Goldschmidt-Clermont et 
a l,  1991; K im eta l, 1991). PDGF- and EGF-induced activation of PLC 
is independent of G proteins (Hasegawa-Sasaki et al., 1988; Cattaneo and 
Vincentini, 1989; Hepler et a l ,  1990; Johnson and Gamson, 1987; 
Huang and Ives, 1989). Treatment of cells with EGF or PDGF promoted 
the association of PLCyi with the receptors as detected by 
coimmunoprecipitation (Wahl et a l , 1989a; Huckle et a l , 1990) and this 
association was dependent on the receptor PTK activity (Mollenaar et al., 
1988; Escobeno et a l,  1988; Margolis et a l,  1990; Morrison et a l ,  
1990; Kumjian et a l , 1991). The tyrosine phosphorylation seems to be 
isoenzyme specific as the treatment with PDGF or EGF results in the 
increase of phosphorylation of PLCyi, hut not PLCBi or PLCÔi (Wahl et 
a l,  1989ab; Meisenhelder et al., 1989; Margolis et a l , 1989; Kumjian 
et a l ,  1989; Nishibe et a l,  1989). The phosphorylation is independent 
of receptor internalization (Wahl et a l,  1989a; Meisenhelder et a l .
t
1989). Similai'ly, stimulation of Jurkat cells with o:CD3 resulted rapidly 
and transiently in phosphorylation on serine and tyrosine residues of PLCyi 
while PLCBi was not affected (Park et a l,  1991).
12.1.1.6. PTK inhibitors interfere with TcRICD3-mediated lymphocyte 
activation
Further evidence for a requirement for a regulatory role of tyrosine 
phosphorylation in activation of PLCy by a TcR/CD3 was derived from
j.
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studies of the effects of inhibitors of protein tyrosine phosphorylation (June 
et al., 1990b; Mustelin et al., 1990; Stanley et al., 1990; Trevillyan et 
al., 1990; Augustine et al., 1991 ; Norton gf aA, 1991). The best known
,of these inhibitors are the benzoquininoid ansamycin antibiotic herbimycin 
A (June et al., 1990b) and the isoflavone genistein (Mustelin et al., 1990;
Trevillyan et al., 1990; Norton et al,, 1991). Herbimycin A is an in vivo 
inhibitor of 5rc-related PTK which acts by depleting the intracellular level 
of the enzymes (Uehara et al., 1989ab). In T cells, herbimycin A binds 
to the carboxy-terminus of 5rc-related PTK via sulphydryl groups and 
increases their rate of degradation. As a result, the steady-state levels of 
5rc-related PTK pSfr** and p59^ are reversibly depleted by 90-97 % (June 
et al., 1990b). In contrast, genistein is an in vitro PTK inhibitor acting by 
non-competitive inhibition of ATP hydrolysis (Akiyama et al., 1987).
Previous studies have shown that herbimycin A reduces the 
iramunoprecipitated activity of p56^ and p59^ while the activity of serine- 
threonine kinase c-raf, and aluminum fluoride-induced activation of G 
protein-associated PLC remain unaffected (June et al., 1990b). In 
addition, the expression of IL-2r and IL-2 secretion, induced by the 
combination of calcium ionophore and a phorbol ester, are not inhibited by 
herbimycin A (June et al., 1990b). Thus, the target for herbimycin A is 
likely to be a src family member proximal to PKC.
Genistein has been shown to inhibit the TcR/CD3-induced tyrosine 
phosphorylation of CD3C in human PBL (Mustelin et al., 1990). In 
addition, genistein inhibits the appearance of a number of tyrosine 
phosphoproteins normally induced by the activation of PBL by antigen 
(Norton et al., 1991). Genistein inhibits the production of IL-2 in 
response to stimulation via TcR/CD3, as well as by the combination of 
calcium ionophore and a phorbol ester (Mustelin et al., 1990; Trevillyan 
et al., 1990). Thus, the target for genistein activity is most likely distal 
to the activation of PLC.
In Jurkat cells transfected with the human muscarinic receptor type 
1 (hMRl), different isoenzymes of PLC can be activated in response to
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carbachol as well as to «TcR (Goldsmith et a l ,  1989). However, the 
pathways involved in signalling through these two receptors are different
A pertussis toxin-sensitive G protein is known to be involved in
2 3 8
where the seven transmembrane-domain hMRl activates PLCB in a PTK- 
independent manner via a G protein (Nathanson, 1987; Dohlman et a l , 
1987; Peralta et a l ,  1987; Matesic et a l,  1989). In such a system, 
herbimycin A markedly inhibited the resting and induced levels of 
phosphotyrosine-containing proteins, including PLCyi and TcR C chain, 
and prevented activation of PLC by aTcR but not by carbachol (Graber et 
a l,  1992). However, genistein inhibited activation of PLC by both 
TcR/CD3 and hMRl but the inhibition was only partial. In contrast to 
herbimycin A, genistein was cytotoxic and inhibited protein synthesis in 
both Jurkat cells and PBL (Graber et a l , 1992).
12.1.2. Role of G protein in signal transduction
12,1.2.1. G proteins and leukocyte locomotion
i
chemotactic-factor induced activation of neutrophils (Becker et a l ,  1985;
Snyderman et a l ,  1986). The migration of lymphocytes into filters was 
also inhibited by pertussis toxin (Spangrude et a l , 1985a), as was inhibited 
the capacity of lymphocytes to cross HEV and enter lymph nodes in vivo 
(Spangimde et a l , 1984; Braaten cr a /., 1984). However, T lymphocytes 
that have been rendered incapable of normal recirculation by pertussis toxin 
exhibit normal blastogenesis after stimulation with T cell mitogens 
(Spangrude et a l ,  1984; 1985b). Similarly, pertussis toxin had little 
inhibitory effect on growth-induced locomotor capacity stimulated by 
q;CD3 (Wilkinson and Watson, 1990). On die other hand, pertussis toxin 
inhibited immediate polarization in response to PCS or IL-8 in lymphocytes 
direct from blood or after overnight culture with PCS; an overnight 
exposure to pertussis toxin rendered lymphocyte locomotor responses to 
chemoattractants insensitive to this toxin (Wilkinson and Watson, 1990).
Iv$
In a different system, cultured high endothelial cells stimulated rat lymph
12.1,2.2. G proteins couple receptors to PLCfij activation
12.1.2.3. Structure o f Œg
II
node lymphocyte motility by two mechanisms: one which was rapid and
■pertussis toxin-sensitive and one which was slower, pertussis toxin
insensitive and dependent on lymphocyte adhesion to the high endothelial 
cells (Harris, 1991).
1The involvement of G proteins in PLC activation has been 
suggested as a result of numerous studies which have shown that GTP and 
its nonhydrolyzable analogues stimulate phosphatidylinositol metabolism in i
permeabilized cells, crude membrane fractions, or partially purified enzyme 
preparations (Fain et al., 1988). Also, direct stimulation of G proteins 
with AIF4  or GTPyS was shown to activate PLC in intact or permeabilized 
T cell populations (Cogeshall and Altman, 1989). In addition, type 1 
muscarinic receptor, known to be coupled to G proteins in other systems, 
was transfected to Jurkat resulting in ligand-induced PLC activation 
(Goldsmith et al. , 1989). The search for a G protein involved in the PLC 
activation uncovered a new family of pertussis toxin-insensitive G proteins 
designated G,; these G proteins specifically activate PLCfii but not PLCyi 
or PLCÔ1 (Taylor et al., 1991; Taylor and Exton, 1991).
I
aMembers of the family lack the cysteine residue four amino acids 
from the carboxy terminus constituting the site for ADP-ribosylation 
catalyzed by pertussis toxin (Strathman and Simon, 1990; Wilkie et al.,
1991). (Xq has a threonine for alanine substitution in the sequence GAGES 
known to be important for GTPase activity in cxi and These G„ bind 
GTPyS only with slow rates and stoichiometry probably due to high- 
affinity GDP binding.
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12.1.2.4. Mechanism o f PLC activation by
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As suggested eailier (Smith et a l ,  1986), cxq stimulates PLC and 
tills stimulation occurs over a wide range of Ca^  ^ concentrations. The 
binding of results, in addition to increasing the maximal activity of 
PLC, in a changed apparent affinity of the enzyme for Ca^  ^ from 1 fjiM to 
0.1 (Smrcka et a l ,  1990).
i:
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12.1.2.5. Pertussis toxin-sensitive coupling of PLC
Pertussis toxin-sensitive activation has been demonstrated when this 
toxin blocked phosphatidylinositol metabolism, induced by chemoattractant 
in leukocytes or in HL-60 (Kikuchi et al., 1986; Nakamura and Ui, 1985;
Varghese et a l ,  1984); cx; and o!„ reconstituted the PLC activity in 
pertussis toxin-treated HL-60 cells (Kikuchi, 1986). Indeed, the formyl- 
peptide receptors were shown to couple to both a-^  and a» (Gierschik and 
Jakobs, 1987) and to co-purify with (Polakis et a l , 1988). Similarly, 
pertussis toxin blocked PLC activation in Xenopus oocytes stimulated by 
muscarinic receptors (Moriarty et a l , 1990). The responsiveness could be 
restored by microinjection of G„ but not Gi and GTPy S-preactivated % 
mimicked the receptor stimulation.
Effects of pertussis toxin on receptor-regulated PLC activation have 
been observed with receptors previously thought to be pertussis toxin- 
insensitive (Pfeilschifter and Bauer, 1986; Shayman et a l , 1987). There 
is evidence that different receptors can be coupled to PLC, in a single cell, 
by G proteins of different pertussis toxin sensitivity (Voyno-Yasenetskaya 
et a l , 1989; Perney and Miller, 1989; Ashkenazi et a l , 1989). In 
contrast, a receptor may be coupled to PLC by pertussis toxin-sensitive G 
protein in one cell type and by an insensitive one in another (Moriarty et
■
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12.2. EXPERIMENTAL
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12.2.1. Involvement of PTK in the acquisition of polarized morphology
The majority of PBL activated by a prolonged culture with PPD 
(Wilkinson, 1986) or with aCD3 (Wilkinson and Higgins, 1987a) acquire 
the locomotory capacity. In addition to the two PTK inhibitors described 
above, several additional reagents (Gibco #31698A) were used in the 
preliminary study. These PTK inhibitors included: Methyl 2,5-
dihydroxycinnamate (MDC), lavendustin A, RCAM-lysozyme, tyrphostin, 
and 2-hydroxy-5-(2,5-dihydroxybenzyl) aminobenzoic acid (HD A A).
While lavendustin A and HDAA seem to inhibit the PTK similarly to 
genistein, by inhibition of ATP hydrolysis, MDC and tyiphostin were
■shown to block the substrate binding to the EGF receptor-associated PTK IIand also inhibit EGF receptor autophosphorylation. RCAM-lysozyme is 
an inhibitor of insulin receptor kinase autophosphorylation.
Genistein and tyrphostin, with minimum effective dose of 10 ng/ml 
(data not shown), resulted in a slight but noticeable decrease in polar ization 
in cultures activated with PPD. None of the inhibitors, with the exception
Iof herbimycin A (Prof. P C. Wilkinson, personal communication), affected the polarization observed following a culture with cxCD3. Thus, it appears 
that the target PTK, affected by genistein, is engaged upon activation by 
antigen only. Indeed, the CD4 molecule and the associated pSb'"*" PTK 
plays an important accessory role during such an activation process. On 
the other hand, herbimycin A affects a broad range of src family PTK 
including TcR/CD3-associated p59^. It can therefore be concluded, that 
the acquisition of the locomotory capacity is a consequence of the same 
biochemical processes that ultimately result in the full activation of the 
lymphocytes.
1
12.2.2. Involvement of PTK in the maintenance of the polarized
morphology by Jurkat cells
242
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The same set of PTK inhibitors was applied to dbcAMP-cultured 
Jurkat cells prior to the treatment of these motile cells with aCD3. Only 
a pretreatment with herbimycin A, at 50 ng/ml for 30 min, resulted in a 
50% inhibition of the cxCD3-induced roimding up of Jurkat cells (figure 
72). This result agrees with the results obtained with aCDS-cultured PBL 
as well as with the studies of PLC activation in Jurkat cells in response to 
the cxCD3 activation (Graber et al. , 1992).
In the next series of experiments, herbimycin A was used in an 
attempt to disrupt the response of Jurkat cells to PMA and PHA. Both of 
these agents were found to induce rounding up of polarized Jurkat cells.
In contrast to aCD3, whose effect is transient, PMA and PHA effect is 
permanent. Figure 73 shows the results obtained in a typical experiment.
Rounding up of the cells in response to PMA was not affected at either 10 
®M or 10 ®M (figure 73-A) and PHA was equally effective in the presence 
and the absence of the PTK inhibitor (figure 73-C). Again, rounding up
of cells in cxCD3 was consistently eliminated at all doses, following the %preincubation with herbimycin A (figure 73-B).
These results clearly show that both PMA and PHA bypass tlie PTK 
necessary for signal delivery through the TcR/CD3. Indeed, PMA binds 
to and directly activates the PKC, a signal element down stream of PTK- 
regulated PLC. PHA binds to a variety of surface structures and thus has 
the potential to induce a number of signalling pathways. Clearly, PHA is 
able to bypass the PTK-dependent mechanisms and activate the pertinent 
biochemical processes in PTK-depleted Jurkat cells.
12.2.3. Effect of herbimycin A pretreatment on tyrosine phosphorylation 
of Q!CD3-stimulated Jurkat cells
The effect of herbimycin A on the aCD3-stimulated changes in
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Figure 72: Effect of valions PTK inhibitors on aCD3-induced
morphology change of dbcAMP-cultured Jurkat cells. The cells were 
cultured with 1 mM dbcAMP for 3 days, washed twice with HBSS/MOPS 
and repolarized at 37°C for 30 min in the presence of 50 ng/ml herbimycin 
A or 1 fjbglml of lavendustin A, RCAM-lysozyme, tyrphostin, genistein, 
methyl[2,5-diOH] cinnamate, or 2-(OH)-[2,5-diOH]benzyl] aminobenzoic 
acid. OKT3 was added to final concentration of 20 ng/ml and the 
incubation was continued for 15 min. The cells were finally fixed with 
glutaraldehyde and the morphology was examined and quantified under 
phase contrast.
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Figure 73: Effect of herbimycin A on (A) PMA-, (B) aCD3-and (C) 
PHA-induced morphology change of dbcAMP-cultured Jurkat cells. The 
cells were cultured with 1 mM dbcAMP for 3 days, washed twice witli 
HBSS/MOPS and repolarized at 37^C for 30 min in the presence of 50 
ng/ml herbimycin A. Different concenhations of PMA, OKT3, or PHA 
were then added and the incubation was continued for 15 min. The cells 
were finally fixed with glutaraldehyde and the morphology was examined 
and quantified under phase contiast. Polarized cells preincubated in the 
absence (open bar) and presence (hatched bar) of herbimycin A.
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12.2.4. Effect of pertussis toxin on repolarized dbcAMP-cultured Jurkat 
cells
*
dbcAMP-cultured Jurkat cells was shown. The effect of this PTK inhibitor 
on the inhacellular protein-tyrosine phosphorylation was examined using 
Western blotting of whole-cell protein extracts separated by SDS-PAGE 
(figure 74). Comparison of lane 1 and 3 reveals that preincubation for 30 
min with 50 ng/ml herbimycin A (lane 3) does not affect the basal level of 
proteins containing phosphotyrosine residues. The activation with (%CD3, 
of dbcAMP-cultured Jurkat cells repolarized for 30 min in buffer (lane 2),
i
resulted in an increase of protein-tyrosine phosphorylation of several
substrates detected as bands whose optical density increased when 
compared to the contiol (lane 1). In contrast, preincubation with
herbimycin A in most cases disabled the ability of Jurkat cells to increase
protein-tyrosine phosphoiylation in response to aCD3 (lane 4). Thus, 
many bands remained unchanged when compared to the control (lane 3) 
and in some case even decreased in density {i.e. major band at about 115 
kDa). Such observation suggests that specific phosphatases are also 
activated by ckCD3 and for certain substrates may dominate after the 
equilibrium is disturbed by the PTK inhibitor.
IThe locomotory machinery of dbcAMP-cultured Jurkat cells was shown to be dose-dependently blocked by pertussis toxin (figure 75). The 
repolarization of these cells was noticeably reversed by a 10 ng/ml dose, 
where the decrease in polarized cells was reflected in a corresponding 
increase in the number of cells with an inegular outline. A dose of 100 
ng/ml was necessary to bring about an increase in the round cells.
The sensitivity of the TcR/CD3 signal to pertussis toxin suggests the 
involvement of a G protein at some point in the signalling pathway. 
However, the connection of this G protein with the activation of PLCB is 
unclear. In addition, the location of the G protein with respect to 
TcR/CD3, PKC or Ca^  ^ mobilization could not be determined and will
■;r
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Figure 74: Effect of Herbimycin A on tyrosine phosphorylation induced 
in dbcAMP-cultured Jurkat cells stimulated with aCD3. Jurkat cells 
were cultured for 3 days in the presence of 1 mM dbcAMP. Cells were 
then washed and preincubated with (lane 3 and 4) or without (lane 1 and 
2) 50 ng/ml Herbimycin A for 30 min at 37°C. aCD3 was added to the 
final concentration of 10 ng/ml (lane 2 and 4) and the incubation was 
continued for 15 min. Finally, cells were washed with ice-cold 
TBS/vanadate and Western blots of whole cell extracts were performed. 
Bands containing phosphotyrosine residues were visualized using a 
specific HRPO-conjugated monoclonal antibody. Molecular weight 
markers of 97, 69, and 46 kDa are shown in the left margin.
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Figure 75; Dose-response of repolarized dbcAMP-cultured Jurkat cells 
to treatment with pertussis toxin. The cells were cultured with 1 mM 
dbcAMP for 3 days, washed twice with HBSS/MOPS and repolarized at 
37°C for 30 min. Pertussis toxin was then added and the incubation was 
continued for 30 min. The cells were finally fixed with glutaraldehyde and 
the morphology was examined and quantified under phase contr ast. Round 
cells (circle), irregular cells (square) and polarized cells (triangles).
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requiie further study.
12.2.5. Effect of pertussis toxin on the TcR/CD3 signal
In an attempt to determine if a peitussis toxin-sensitive G protein couples 
the TcR/CD3 signal, the dbcAMP-cultured Jurkat cells were preincubated 
with 1 ng/ml dose of the toxin. At this dose, pertussis toxin was found to 
have a slight effect on the repolaiization of the cells, A time-course of 
aCD3-stimulated shape change of the repolarized cells was then observed 
(figure 76). It can be seen that although tlie aCD3 effect was not 
suppressed, a significant inhibition was observed.
12.3. SUMMARY
In conclusion, the above experiments showed that incubation of 
PBMC with herbimycin A uncoupled pathways responsible for aCD3- 
mediated lymphocyte activation while genistein and tyrphostin affected the 
PPD-stimulated pathways. In line with these results, the preincubation of 
dbcAMP-cultured Jurkat cells with herbimycin A, but not with any other 
PTK inhibitors tested, uncoupled TcR/CD3 from signalling pathway which 
ultimately leads to the reversal of polarization. Several intracellular protein 
substrates for PTK were shown to be affected by the PTK inhibitor. The 
results further suggested that pertussis toxin-sensitive G protein is involved 
in the maintenance of the locomotoiy capacity in dbcAMP-cultured Jurkat 
cells. In addition, such G protein seems to be involved in the aCD3- 
stimulated pathway that ultimately leads to the reversal of cell polarization.
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Figure 76: Effect of peitussis toxin on o:CD3“induced morphology change 
of dbcAMP-cultured Jurkat cells. The cells were cultured with 1 mM 
dbcAMP for 3 days, washed twice with HBSS/MOPS and repolarized at 
37°C for 30 min in the presence of 1 ng/ml pertussis toxin. 0KT3 was 
added to final concentration of 20 ng/ml and the incubation was continued 
for 15 min. The cells were finally fixed with glutaraldehyde and the
morphology was examined and quantified under phase contrast. Polarized 
cells preincubated in the absence (open triangles) or presence (full 
triangles) of pertussis toxin.
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13. GENERAL DISCUSSION AND CONCLUSIONS
Resting lymphocytes display a round shape and are non-motile. 
Although the normal Jurkat cells are actively dividing, their shape 
resembles that of resting lymphocytes. Such a dividing Jurkat cell redirects 
most of its intracellular resources to the synthesis of new proteins and 
nucleic acids, ultimately resulting in a generation of a daughter cell. From 
a physiological point of view, the lack of motility is not surprising. The 
maintenance of a locomotory activity places demands on the intracellular 
energy resources and, in addition, engages intracellular machinery 
instrumental in the events of cell division. Indeed, the DNA-labelling 
experiments showed that the majority of Jurkat cells are in the S and G^/M 
phase of the cell cycle. This indicates that the progress through Gq/G i 
phase of the Jurkat cell cycle is very rapid. In contrast, the majority of 
PBL are resting lymphocytes and by definition at Go phase. The 
acquisition of locomotory capacity in lymphocytes was shown to be 
associated with the transcription of new genes and active protein synthesis 
in lymphocytes transiting through Gi phase (Wilkinson, 1986). To induce 
locomotion in Gq lymphocytes, a progress into Gj phase of the cell cycle 
must be initiated, usually by activation with antigen, mitogens or aCD3. 
Thus, the manipulation required to induce the locomotory capacity in the 
PBL and Jurkat cells is quite opposite. While a positive signal is requtied 
to remove the block which maintains PBL at Go, a block must be applied 
in the Jurkat cell cycle which slows down or arrests their progress through 
Gi. A prolonged culture in the presence of dbcAMP was successfully used 
to retain the majority of the Jurkat cells in Gi. This was confirmed (1) by 
DNA-labelling experiments, (2) by lack of cell division in these cells and 
(3) by the decrease in cell size to one more resembling the size of resting 
lymphocytes. The microscopic observations revealed a concominant 
acquisition of locomotory capability in such dbcAMP-cultured Jurkat cells. 
It is not clear if the increase in cell motility is coincidental with the arrest
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in Gi phase or if the cell motility is a property of cells in the Gj phase of 
cell cycle. Although far from definite proof, the data indicate that the first 
suggestion is most likely. There is no question that a low rate of cell 
division (presumably with the accumulation of cells in the Gq/G i phase) is 
required for the subsequent acquisition of locomotory capacity. The low 
rate of division was achieved either by a prolonged culture with a relatively 
high dose of dbcAMP (0.75 to 1 mM) or temporarily, using the lag phase 
Jui'kat cells. The increase in tlie numbers of motile cells was self-evident 
at the high dbcAMP concentrations. However, in the second case, the 
relatively low concentration of dbcAMP (0.25 to 0.50 mM) was able to 
induce cell locomotion for the duration of the low-rate lag phase cell 
division. When the cells returned to near-log phase giowth, these low 
dbcAMP doses were no longer able to induce cell motility. Thus, the cell 
growth seems to be affected by culture in the presence of high doses of
TidbcAMP, while locomotory capability can be induced through a separate 
mechanism by a lower dose of dbcAMP in cells present in the Gi phase of 
cell cycle.
The regulation of locomotory machinery was shown to involve 
protein phosphoiylation catalyzed by at least one of the PMA-sensitive 
PKC isoforms. The evidence was accumulated in experiments where (1) 
PKC was specifically activated by PM A, (2) PKC was depleted from the 
cells by prolonged incubation with PMA, (3) the PKC activity was 
inhibited by agents relatively specific for PKC, and (4) protein 
phosphorylation was altered by inhibition of protein phosphatase. The 
Western blot analysis has confirmed four such PKC isoform candidates: 
PKCa, PKCy, PKCe, or PKC0. The results consistently indicated that an 
increase in PKC-catalyzed protein phosphorylation leads to an inhibition of 
locomotory capacity. Thus, the scheme depicted in figure 77 can is 
suggested for a mechanism that regulates the motility of dbcAMP-cultured 
Jurkat cells. In this scheme, ’Protein’ and ’Protein-P’ are 
dephosphorylated and phosphoiylated forms of the putative regulatory 
protein involved in the mechanism responsible for the change in cell
2 5 1
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Figure 77 : Proposed signalling mechanisms involved in the regulation of 
morphological changes associated with a locomotory response in T cell line 
Jurkat. Italics indicate regents used to activate or inhibit various stages of 
the pathway. Asterisks (*) indicate activated species of various 
biochemically active molecules. Triangles signify an effect, positive or 
negative if preceded by a ’ +  ’ or a respectively. Hatched arrows show 
reaction where an enzymatic activity of an activated species is utilized. 
Blank arrows indicate conversion brought about by intracellular 
biochemical or biological events.
R + [ >
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morphology. The equilibrium in dbcAMP-cultured Jurkat cells is biased 
so that the regulatory protein is constitutively dephosphorylated. By 
pharmacological intervention, this bias can be changed so that the round 
cell morphology is induced. This situation is analogous in fresh resting 
PBL (Prof. P.C. Wilkinson, personal communication). In these cells, the 
equilibrium is biased towards the phosphorylated form of the regulatory 
protein resulting in a round morphology. By interfering with the 
phosphorylation process using one of the specific PKC inhibitors, a 
majority of the cells are induced to polarize within 30 min. The 
involvement of phosphatase in this process was ascertained when the 
preincubation of the fresh PBL with calyculin A eliminated the polarizing 
effect of the PKC inhibitors.
In support of the scheme described above, Thorp et al. (1994) 
showed that a specific PKC inhibitor GF109203X caused, within an hour, 
an increase in shape-changing in freshly isolated PBL. Similarly, 
Zimmermann and Keller (1992) showed that another specific PKC 
inhibitor, CGP41251, caused a dose-dependent increase in the polarization 
of Walker carcinoma cells. In addition, Keller et al. (1990) showed that 
neutrophils can be stimulated to change shape upon addition of H-7. In 
contrast, less specific PKC inhibitors such as staurosporine and H-7 were 
found to inhibit motility not only in a spontaneously shape-changing val iant 
of U937 monocytoid cells and orCD3-activated PBL (Thorp et al. , 1994) 
but also in spontaneously and colchicine-stimulated Walker carcinoma cells 
(Zimmermann and Keller, 1992). Surprisingly, GF109203X also inhibited 
motility in U937 cells (Thorp et al. , 1994). A presence of multiple PKC 
isotypes involved in the induction and in the maintenance of the locomotory 
morphology was suggested to explain the contradicting experimental results 
(Thorp et a l ,  1994). Perhaps these contradicting results reflect the 
differences in susceptibility of these isoenzymes to the various PKC 
inhibitors. Indeed, the differential tissue expression, and differences in 
activation requirements of PKC isoforms are very likely building blocks for 
numerous complex regulatory systems (Kikkawa et al. , 1989). In addition
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to the mentioned classical PMA-sensitive PKC isoforms, PMA-insensitive 
isoforms PKCi, PKCÀ, PKC/tt, and PKCC were detected. Their 
involvement in the acquisition and maintenance of lymphocyte locomotion, 
downstieam of the classical PKC, is conceivable.
Smprising but consistent observations revealed that the increase in 
[Ca^ ]^j also results in loss of locomotory morphology. This evidence was 
obtained in experiments where [Ca^ J^i was elevated (1) directly using a 
Ca^ "* ionophore A23187, (2) via a TcR/CD3-medaited intracellular Ca^"*" 
release, and (3) directly using thapsigargin to pharmacologically induce the 
release of intracellular Ca  ^*^ stores. The presence of extracellular Ca^  ^ is 
vital for locomotion inhibition. Thus, the role of an intracellular Ca^  ^
release serves to trigger a massive influx of extracellular Ca^^. The large 
increase in [Ca  ^ then leads to the changes in the cell morphology.
The inhibition or ’rounding up’ caused by tlie activation of PKC 
and by the elevation of [Ca^ J^i were found to use the same intiacellular 
mechanism, namely increase in phosphorylation of regulatory proteins. 
Indeed, the preincubation of Jurkat cells with PKC inhibitors dose- 
dependently decreased the effect of [Ca^  ^ ]; induced by the agents 
mentioned above. In addition, the depletion of PKC virtually disabled the 
TcR/CD3-mediated locomotion inhibition. How is Ca^  ^ capable of 
affecting the phosphorylation of intracellular proteins?
Mammalian cells express several Ca^^/calmodulin-dependent protein 
kinases (Stull et al., 1986). Receptor-mediated increases in [Ca^ j^i were 
suggested to activate protein kinases and lead to the appearance of new 
phosphoproteins (Tsien et al. , 1982b). Indeed, a 5 min heatment of Jurkat 
cells with ionomycin or aTcR resulted in an appearance of the same set of 
two cytoplasmic acidic phosphoproteins suggesting that these reagents 
activate the same protein kinases (Imboden et a l ,  1985). Ionomycin 
treatment also caused increased phosphorylation in human peripheral blood 
T cells (Chaplin et a l ,  1980), including phosphorylation of the CD3y, 
CD4 and CD8 in quiescent blood T cells (Cantrell et a l ,  1989; 
Breitmeyer et a l , 1987). Unlike PMA, which induced phosphorylation of
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serine 126 of CD3y, ionomycin induced phosphorylation of serine 123 and 
126 (Cantrell et a l , 1989). Thus, the relative similarity and overlap in the 
phosphoiylation patterns of Ca  ^^  /calmodulin-dependent protein kinases and 
PKC could result in similar physiological changes in the cells. However, 
the relative specificity of the PKC inhibitors used, as well as that of PMA- 
mediated PKC depletion, provide evidence contradicting the involvement 
of a Ca^^/calmodulin-dependent protein kinase. Thus, some PKC isoform 
must be directly or indirectly activated by an elevated [Ca^ ]^;.
The activation of PKC by increasing [Ca^ ]^i has been documented. 
Although ionomycin alone, at a concentration of 200-300 nM, does not 
cause PKC translocation to the T cell membrane (Isakov and Altman,
1987), increasing the Ca^' concentration from 100 nM to 500 nM was 
shown to promote the association of PKC with membranes (Wolff et a l , 
1985). Such a Ca^^-mediated binding is reversible and occurs within the 
range of receptor-mediated [Ca^ j^i increases but below the 5 to 50 /xM 
required for Ca^  ^ to activate PKC in the absence of DAG. An alternative 
mechanism may activate PKC, whereby a [Ca^ ]^, increase to 1-10 juM 
range enables calpain to cleave the native PKC thus liberating the active 
kinase domain (Kishimoto et a l ,  1983). Indeed, several PKC substrates 
have been shown to be phosphorylated in response to Ca^  ^ionophore alone 
(Chatila et a l ,  1989). However, the quantitative measurements of the 
increases in [Ca^ ]^i indicated that such high concentrations were never 
attained with any of the activators used; the peak concentrations detected 
were about 500 nM, 300 nM, and 600 nM for aCD3, PMA and 
thapsigargin respectively. Thus, there must be a mechanism whereby an 
increase in the [Ca^+k results in the generation of PKC activators such as 
DAG, free fatty acid and lysophospholipids.
The likely link between [Ca^^k increases and the activation of PMA- 
sensitive PKC is therefore formed by a Ca^^-sensitive regulatory 
component. Upon its activation, a second messenger is produced which in 
turn activates the PKC; additional complexities involved in the activation 
of PKC have been described (Asaoka et a l , 1992; Nishizuka, 1992). An
2 5 5
alternative source of DAG, the PKC coactivator, is PCh. PCh is 
hydrolyzed by activated PLD, resulting in the production of phosphatidic 
acid which is then converted to DAG by the removal of its phosphate. 
Mammalian PLD is associated mainly with the paiticulate fraction and its 
kinetic properties vary greatly from tissue to tissue. Rat brain PLD shows 
a considerable activity at submicromollar Ca^ + concentrations. PKC 
activity stimulated by PCh-derived DAG may be gieatly enhanced by cis- 
unsaturated fatty acids, including oleic, linoleic, linolenic, aiachidonic and 
docosahexaenoic acids. Indeed, PLA2  hydrolyzes phospholipids to liberate 
such free fatty acids together with lysophospholipids. Arachidonic acid- 
selective and -non-selective cytosolic PLA2  are both present within cells. 
The enzymes are active in the presence of Ca^  ^ at concentration below 1 
/LtM. They appear to translocate to membrane in response to agonists that 
mobilize intracellular Ca^L Thus it is conceivable that a rise in [Ca^  ^ji 
may induce an increase in the activity of certain PKC isoforms.
The signal coupling of TcR/CD3 to the intracellular machinery that A.;'
affects Jurkat cell motility was also briefly examined. The involvement of
PLC in the regulation of motility in dbcAMP-cultured Jurkat cells is very
likely. Antigen receptors on B cells and T cells associate with PLC and 
upon stimulation induce generation of Ca^  ^ and DAG as second 
messengers; the increase of [Ca^ j^i and the activation of PKC were both 
found to play a role in the regulation of Jurkat cell motility. The 
involvement of G proteins in the signalling pathways of neutrophils and 
mast cells leading to PLC activation has been accepted (Harnett and Klaus,
1988), Mechanisms coupling these surface receptors with PLC in B and 
T cells have been discussed by Harnett and Rigley (1992). In B cells it has 
been shown that surface IgM and IgD receptors are coupled to the PLC15 
by pertussis toxin-sensitive forms of Gp. Although in T cells, a membrane- 
bound PLC isoform has been shown to be under G protein control, such 
a G protein-coupled PLC has not been found associated with TcR.
The activation of PLCyl in Jurkat cells, stimaulated through 
TcR/CD3, involves tyrosine phosphorylation by nonreceptor PTK p56^
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amd p59^^ (Rliee and Choi, 1992). PTK inhibition data reported in this 
document indicate that Jurkat cell rounding up that was induced by aCD3, 
but not by PHA or PMA, is coupled by a mn-lck PTK. Western blot 
analysis confirmed that 30-min preincubation with herbimycin A resulted 
in a significant decrease in tyrosine phosphorylation of numerous 
intracellular substrates; PTK p59^ known to be associated with the CD3 
molecule, and PLCy are possible candidates. However, the identification 
of these substrates would require further investigation using methods such 
as immunoprécipitation with specific monoclonal antibodies.
Results presented in this document have further suggested an 
involvement of a peitussis toxin-sensitive G protein coupling the pathway 
involved in the maintenance of motility of the dbcAMP-cultured Jurkat 
cells. Interestingly, the TcR/CD3-mediated signal was also significantly 
inhibited in pertussis toxin-pretreated Jurkat cells. This latter effect was 
observed at pertussis toxin concentrations 10- to 100-fold lower than tliose 
necessary to partially reverse the Jurkat cell polaiization on its own. This 
difference in pertussis toxin sensitivity may indicate the presence of 
multiple G proteins downstream of PLCy.
The presence of both the pertussis toxin-sensitive G protein and of 
a non-receptor PTK in a single regulatory pathway is interesting. Harnett 
and Rigley (1992) suggested the possibility of coupling by a 
nonclassical/PTK-activated G protein. Two members of the ras 
superfamily of small G proteins, Rho and Rac, were suggested to be 
involved in various aspects of cytoskeleton regulation. These include the 
control of focal adhesion, stress fibers, and of actin components which are 
involved in membrane ruffling (Chavrier et al., 1993). Clearly, the 
components of the signal transduction pathway responsible for the 
regulation of motility in the Jurkat cells and in lymphocytes in general need 
to be identified and further characterized.
The existence of a regulatory protein, reversibly phosphorylated as 
a means in regulation of cell motility, reflects the reversible character of 
this physiological behaviour in leukocytes. The components of cellular
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locomotory machinery and their regulation have been recently reviewed 
(Stossel, 1993). Indeed, the binding of Ca^^-calmodulin to MARCKS or 
the phosphorylation of MARCKS by PKC suggest a possible mechanism 
for the control of locomotion. In addition, many of the proteins in focal 
contacts are substrates for protein kinases, have intrinsic protein kinase
iactivity, or both. It is likely that phosphorylation reactions govern binding 
activities of these proteins to each other and to actin. The identification of 
the regulatory proteins is in progress. ^^P-labelling has shown that the 
PMA-induced switch from motüe to non-motile MOLT-4 is associated with 
increased phosphorylation of a number of proteins separated by SDS-PAGE 
(Southern et a l ,  1995). However, the identification and localization of 
these proteins will require furtlier study.
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14. ABBREVIATIONS
aCD3
alg
<%TcR
AC
ATP
»C
Ca"+
monoclonal antibody specific for CD3
monoclonal antibody specific for immunoglobulin
monoclonal antibody specific for T cell receptor chain
accessory or antigen presenting cell(s)
adenosine trisphosphate
degrees Celsius
calcium ion
[Ca^  ^]i intracellular Ca^  ^ concentration
cAMP adenosine-3’,5’-cyclic monophosphate
[cAMP]i intracellular cAMP concentration
cAMPS adenosine-3 ’, 5 ’ -cyclic monophosphothioate (Rp-isomer)
CD cluster of differentiation
Con A concanavalin A
CTL cytotoxic T lymphocytes
DAG diacylglycerol
dbcAMP dibutyryl cAMP
dHaO distilled water
DMSO dimethyl sulphoxide
DNA deoxy nucleic acid
ED5 0  50% effective dose
EDTA ethylenediaminetetra-acetic acid
EGTA ethylene glycol-bis(B-am inoethylether)N ,N ,N ’,N ’,
tetr aacetic acid 
FACS fluorescence-activated cell sorting
Fc crystallizable fragment of immunoglobulin
FCS foetal calf serum
FSC forward scatter measured by FACS instrimentation
Gj phase first gap phase of cell cycle
Ga phase second gap phase of cell cycle
G« alpha subunit of GTP-binding protein
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Gfl beta subunit of GTP-binding protein
G, gamma subunit of GTP-binding protein
G inhibitory GTP-binding protein
G stimulatory GTP-binding protein
GTP guanosine trisphosphate
HBSS Hanks’ balanced salt solution
HEV high endothelial venules
hr(s) hour(s)
hrIL-8 human recombinant IL-8
HSA human serum albumin
IBMX isobutylxanthine (phosphodiesterase inhibitor)
IFN-y interferon gamma
IgG immunoglobulin gamma
IL-1 interleukin 1
IL-2 interleukin 2
IL-2r(B) IL-2 receptor (beta chain)
IL-4 interleukin 4
IL-8 interleukin 8
IP inositol phosphate
IP, inositol bisphospahte
IP3 inositol trisphosphate
1 litre(s)
M molar
magnesium ion
mg milligram(s)
fig microgram(s)
min minute(s)
ml milliliter(s)
ixi microliter(s)
mM millimolar
fiM miciomolai
M phase mitosis phase of cell cycle
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MHC major histocompatibility complex
MIP-Ig: macrophage inflammatory protein la
MLC mixed lymphocyte culture
mRNA messenger RNA
NAP-1 neutrophil activating protein 1
ng nanogram
PBL peripheral blood lymphocytes
PBMC peripheral blood mononuclear cells
PBS phosphate buflfed saline
PCh phosphatidyl choline
PCV postcapillary venule(s)
PDB phorbol 12,13 dibutyrate
PE phycoerythrin
PGE, prostaglandin E,
PHA phytohaemagglutinin
PI phosphatidylinositol
PI(4)P phosphatidylinositol 4-phosphate
PI(4,5)Pi phosphatidylinositol 4,5-bisphosphate
PKA cAMP-dependent protein serine/thieonine kinase
PKC Ca^^-dependent protein serine/threonine kinase
PLAz phospholipase A,
PLC phospholipase C
PLD phospholipase D
PMA phorbol 12-myristate 13-acetate
PPD purified protein derivative of Mycobacterium tuberculosis
PTK protein tyrosine kinase
S phase synthetic phase of cell cycle
sec second(s)
SSC side scatter measured by FACS instrumentation
Seph- Sepharose bound-
RNA ribonucleic acid
TBS Tris-buffered saline
2 6 1
TcR T cell antigen receptor
Ty suppressor T lymphocyte
TjLt helper T lymphocyte
W-7 N-(6-aminohexy l)-5-chloro-1 -naphthalenesulfonamide
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